Ethical Dilemmas in End-of-Life Care for Patients with Severe Persistent Mental Illness: A Research and Clinical Framework

Abstract

This article examines the complex ethical challenges at the intersection of end-of-life care and severe persistent mental illness (SPMI), a vulnerable population with significantly reduced life expectancy. It synthesizes current research to explore foundational ethical principles, methodological approaches for clinical application, strategies for optimizing care amid challenges like capacity assessment and treatment futility, and comparative analyses of existing care models. Designed for researchers, scientists, and drug development professionals, the analysis highlights critical gaps in evidence, underscores the necessity of patient-inclusive research, and identifies implications for developing ethical, evidence-based interventions and care models that uphold autonomy, dignity, and justice for this underserved population.

Mapping the Ethical Landscape: Core Principles and Dilemmas in SPMI End-of-Life Care

Severe and Persistent Mental Illness (SPMI) represents a significant global public health challenge, not only due to the direct suffering caused by the psychiatric conditions but also because of a profound and persistent mortality gap. Individuals with SMI, including schizophrenia, bipolar disorder, and major depressive disorder, experience a reduction in life expectancy of 10 to 25 years compared to the general population [1] [2]. This disparity, rightly described as a "public health scandal," reflects a complex interplay of biological, psychological, social, and systemic factors [1]. Within the context of ethical dilemmas in end-of-life research for persistent mental illness, understanding the epidemiology and vulnerability factors underlying this mortality gap is paramount. This whitepaper provides a comprehensive technical guide for researchers and drug development professionals, synthesizing current epidemiological data, delineating vulnerability factors, outlining core research methodologies, and framing the critical ethical imperatives for addressing this ongoing crisis.

Epidemiological Landscape of the Mortality Gap

The elevated mortality rates among individuals with SPMI are a consistent finding across diverse healthcare systems and geographical regions. The scale of this disparity is most commonly expressed through standardized mortality ratios (SMRs) and years of life lost (YLL).

Quantifying the Mortality Disparity

A prospective longitudinal study from the Netherlands found that almost 11% of SMI patients had died over a 6-year follow-up period, with an all-cause SMR of 4.51 (95% CI 3.07–5.95). This indicates that individuals with SMI were 4.5 times more likely to die than their counterparts in the general population [3]. The mortality gap was significant for both genders, with an SMR of 4.89 for men and 3.94 for women [3]. A more recent Romanian cohort study focusing on schizophrenia followed 635 patients for 10 years and found that 19.37% had died, with a mortality rate of 21.3 per 1000 person-years. The mean age at death was 58.97 years, reflecting a 17-year reduction in life expectancy compared to the Romanian general population [4].

Table 1: Causes of Mortality in SPMI Populations

Cause of Death	Proportion of Excess Deaths	Key Findings	Source
Natural Causes	~86%	Physical illnesses are the primary driver of the mortality gap.	[3]
- Cardiovascular Disease	Major Contributor	A leading driver; patients are at significantly higher risk.	[3] [5]
- Respiratory Diseases	Significant Contributor	Patients are 6.6 times more likely to die prematurely.	[5]
- Infections (e.g., Pneumonia)	17.07% (in schizophrenia cohort)	A major cause, potentially linked to medication side effects and care settings.	[4]
Unnatural Causes	~14%	Accounts for a smaller but significant portion of excess mortality.	[3]
- Suicide	~9% of excess mortality	Risk is particularly high in the early stages of illness.	[5] [4]

Public and Professional Awareness Gaps

Despite the overwhelming evidence, a significant chasm exists between the epidemiological reality and public perception. A UK survey revealed that the public vastly underestimates the impact of SMI on life expectancy, guessing an average reduction of just 7 years, versus the actual 15- to 20-year gap [5]. Furthermore, half of the public mistakenly believes suicide is the most common cause of excess death, whereas in reality, preventable physical conditions account for the vast majority [5]. This misperception underscores a critical failure in knowledge translation and highlights an urgent need for awareness campaigns targeted at both the public and healthcare professionals.

Multifactorial Vulnerability Framework

The premature mortality observed in SPMI is not a direct result of the mental illness per se, but rather a consequence of a complex web of interacting vulnerability factors. These can be systematically grouped into several tiers.

Patient-Level Factors

• Clinical Characteristics of SPMI: The symptoms and cognitive impairments associated with SMI can directly hinder self-care and help-seeking behaviors. Multivariate analysis has shown that more severe symptoms of disorganization are associated with a 2.36-fold increased risk of premature death (HR: 2.36, 95% CI 2.21–2.52) [3]. A decline in cognitive functioning can also impede a patient's ability to manage chronic physical conditions [1].
• Health Behaviors and Lifestyle: Individuals with SPMI are more likely to engage in health-risk behaviors. A longer history of tobacco use is a significant independent predictor of mortality (HR: 1.03, 95% CI 1.02–1.03) [3]. Other factors include unbalanced diet, physical inactivity, and substance abuse, which collectively contribute to the development of metabolic syndrome, cardiovascular disease, and respiratory illnesses [1].
• Reluctance to Seek Care: Patient-related barriers, such as the neglect of physical health needs, anosognosia, and reluctance to attend check-up visits, further delay diagnosis and treatment of physical comorbidities [1].

Treatment and Medication-Related Factors

• Iatrogenic Effects of Psychotropics: The intake of antipsychotic and antidepressant medications can have significant metabolic side effects, including weight gain, diabetes, and dyslipidemia, which elevate long-term cardiovascular risk [1] [4]. Certain antipsychotics, notably clozapine, are also associated with an elevated risk of serious infections like pneumonia, which accounts for nearly 30% of all clozapine-related deaths [4].
• Pharmacological Management: Evidence suggests that treatment choice matters. The use of second-generation antipsychotics has been significantly associated with reduced all-cause mortality (HR = 0.37, p < 0.001) [4]. Furthermore, low frequency of hospitalization (a potential marker of stability and effective community care) is also linked to better survival outcomes (HR = 0.09, p < 0.001) [4].

Systemic and Socioeconomic Factors

• Healthcare System Fragmentation: A long-standing separation of psychiatry from other branches of medicine creates a "structural comorbidity" [1]. There is often a lack of clarity regarding responsibility for the physical health of patients with SPMI, poor communication between psychiatrists and primary care physicians, and a general failure of healthcare systems to integrate care [1] [2].
• Socioeconomic Position (SEP) and Area-Level Factors: Lower SEP is a powerful determinant of health outcomes. A large Danish register-based cohort study found that mortality rate differences between people with and without mental disorders were generally greater in lower SEP groups for most natural causes of death [6]. A systematic review also confirmed that residence in areas of higher deprivation is consistently associated with an increased risk of mortality in SMI [7].
• Social Connectedness: Qualitative research incorporating the lived experience of service users and peer specialists identifies social connectedness as a powerful theme, accounting for nearly a quarter of all coded factors related to risk and protection against early mortality [8]. Loneliness and social isolation are critical, under-addressed risk factors that operate beyond conventional social determinants of health [8].

Table 2: Summary of Key Vulnerability Factors and Associated Evidence

Vulnerability Tier	Specific Factor	Nature of Association	Source
Patient-Level	Severe Disorganization	HR: 2.36 for mortality	[3]
	Tobacco Use	HR: 1.03 per year of use	[3]
Treatment-Level	Second-Generation Antipsychotics	Protective (HR = 0.37)	[4]
	Psychotropic Side Effects	Contributes to metabolic syndrome, cardiovascular risk, and infections.	[1] [4]
Systemic-Level	Healthcare Fragmentation	Leads to neglect of physical comorbidity.	[1] [2]
	Area-Level Deprivation	Consistent association with increased mortality.	[7]
	Low Social Connectedness	Qualitative data highlight as a major risk factor.	[8]

The following diagram maps the logical relationships between these multifactorial vulnerabilities and their contribution to the SPMI mortality gap.

Essential Research Methodologies and Protocols

For researchers investigating the SPMI mortality gap, a firm grasp of core epidemiological and clinical trial methodologies is essential. The following section outlines key experimental approaches and the requisite tools for this field of study.

Core Epidemiological Study Designs

• Prospective Cohort Studies: This design is foundational for identifying predictors of mortality. As exemplified in the Dutch study, it involves recruiting a baseline sample of SMI patients, conducting comprehensive assessments (e.g., psychopathology, substance use, physical health), and then following them over a defined period (e.g., 6 years) to track mortality [3]. The key outcome measures are SMRs and hazard ratios (HRs) derived from multivariate Cox regression models, which control for potential confounders [3] [4].
• Retrospective Cohort Studies Using Registries: Leveraging nationwide administrative and health registries, as done in Denmark, allows for large-scale, long-term follow-up of entire populations [6]. This design provides immense statistical power to examine cause-specific mortality and interactions with factors like SEP. Analysis involves calculating mortality rate ratios (MRRs) and mortality rate differences (MRDs) using Poisson regression models to assess both relative and absolute risk [6].
• Cross-Sectional Surveys on Awareness: To gauge public and professional understanding of the mortality gap, nationally representative surveys, like the one conducted in the UK, are employed. These studies quantify misperceptions and are critical for informing advocacy and educational interventions [5].

Key Data Collection Instruments and Metrics

The validity and reliability of research findings depend on the use of standardized, psychometrically sound assessment tools.

Table 3: Research Reagent Solutions for SPMI Mortality Studies

Tool/Reagent Category	Specific Instrument / Metric	Primary Function in Research	Psychometric Properties
Psychopathology Assessment	Brief Psychiatric Rating Scale-Expanded (BPRS-E)	Semi-structured interview to measure severity of positive, negative, depressive, and disorganization symptoms.	Good reliability and validity across multiple studies. [3]
Side Effect Monitoring	Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS)	Assesses psychological, neurological, autonomic, and hormonal side effects of antipsychotic medication.	Good test-retest reliability (r = .811) and concurrent validity. [3]
Substance Use & Lifestyle	Measurements in the Addictions for Triage and Evaluation (MATE)	Assesses years of smoking, current alcohol/drug use, substance dependence, and abuse.	Good inter-rater/interviewer reliability. [3]
Mortality Outcome	Standardized Mortality Ratio (SMR); Cause of Death (ICD-10 codes)	Quantifies mortality disparity vs. general population; categorizes causes of death for analysis.	Standardized epidemiological metric. [3] [4]

Qualitative and Mixed-Methods Approaches

To explore the lived experience and identify unmet needs, qualitative methodologies are indispensable. Using a grounded-theory approach, researchers can conduct semi-structured interviews with service users and certified peer specialists to generate novel insights into risk and protective factors, such as the role of social connectedness, which may be missed by purely quantitative methods [8]. The analytical process involves iterative coding of transcripts to identify overarching themes, with validation through member-checking [8].

The following diagram illustrates a generalized workflow for a comprehensive research program investigating the SPMI mortality gap, integrating multiple methodological approaches.

Ethical Imperatives and a Call to Action

The stark mortality gap faced by individuals with SPMI is not an inevitability but a manifestation of systemic neglect and ethical failure. Framing this within the context of end-of-life research raises profound ethical dilemmas, including the just allocation of healthcare resources, the protection of a vulnerable population in clinical trials, and the obligation to address preventable suffering. The data presented herein compel a multilevel response.

The World Health Organization (WHO) has developed international guidelines calling for a multilevel approach [1]. This involves coordinated action from all stakeholders: policy-makers must prioritize and fund integrated care models; healthcare systems must break down silos between mental and physical health care, ensuring clear accountability; and educational bodies must embed the management of physical health in SPMI into the curricula of all healthcare professionals [1] [2]. For researchers and drug development professionals, the ethical mandate is clear: move beyond a sole focus on psychiatric symptom reduction and embrace a holistic view of health. This includes developing and testing interventions that proactively manage cardiometabolic risks, fostering social connectedness, and advocating for healthcare policies that grant individuals with SPMI an equal right to a long and healthy life. Closing this mortality gap is not merely a technical challenge, but a fundamental test of our collective commitment to health equity.

Within end-of-life care for individuals with severe persistent mental illness (SPMI), the principle of patient autonomy presents complex ethical challenges. SPMI, characterized by chronic, serious psychiatric disorders resulting in significant functional impairment, affects a vulnerable population with a life expectancy 10-20 years lower than the general population [9]. This mortality gap, combined with the inherent vulnerability of this population, creates a critical interface where decision-making capacity (DMC) must be carefully evaluated to balance respect for self-determination with the ethical obligation to prevent harm.

Clinicians and researchers often encounter a fundamental tension: the duty to respect patient choices while ensuring that those choices reflect authentic preferences rather than symptoms of mental pathology. This tension is particularly acute in end-of-life contexts, where decisions carry profound, irreversible consequences. Evidence suggests that 65% of older patients with serious mental illness retain DMC for end-of-life decisions and can meaningfully engage in advance care planning [10]. This finding challenges assumptions that chronological age or psychiatric diagnosis alone determine decision-making abilities. This technical guide examines the assessment frameworks, ethical dimensions, and practical methodologies for evaluating DMC and authentic choice in this specialized context, providing researchers and clinicians with evidence-based tools for navigating these complex determinations.

Conceptual Foundations

Defining Decision-Making Capacity and Its Components

Decision-making capacity in healthcare refers to a patient's ability to understand, appreciate, reason, and communicate choices about proposed treatments or interventions [11]. This medical construct differs from competence, which is a global legal determination made by courts. Capacity is decision-specific and can fluctuate over time, meaning a patient may have capacity for some decisions but not others, depending on complexity and risk [11].

The four core components of DMC include:

• Understanding: Ability to comprehend the benefits, risks, and alternatives to a proposed treatment
• Appreciation: Ability to recognize how this information applies to one's own situation
• Reasoning: Ability to logically process information by weighing options against personal values
• Communication: Ability to express a consistent choice [11]

These capacities must be evaluated within the context of SPMI, where symptoms may fluctuate but do not necessarily preclude autonomous decision-making. The Mental Capacity Act (implemented in England and Wales) provides a legal framework emphasizing that capacity should be presumed unless established otherwise, and that unwise decisions do not automatically indicate incapacity [12] [13].

Authenticity in the Context of SPMI

Authenticity refers to the congruence between a person's decisions and their enduring values and beliefs [12]. In SPMI, assessing authenticity presents unique challenges, as clinicians must distinguish between decisions reflecting core identity versus those driven by psychiatric symptoms, medication effects, or institutionalization.

Factors complicating authenticity assessments in SPMI include:

• Pathology influence: Determining whether choices are authentic or prompted by clinical symptoms [14]
• Adaptation to care: Long-term care dependence potentially undermining autonomous choice [14]
• Communication barriers: Symptoms impairing clear expression of values and preferences
• Stigma effects: Internalized stigma potentially affecting self-perception and choices

The concept of palliative psychiatry has emerged as an approach focusing on quality of life when curative approaches prove ineffective for SPMI, creating additional ethical dimensions for evaluating authentic choice in treatment-resistant cases [15].

Assessment Methodologies

Structured Capacity Evaluation

A structured approach to capacity evaluation is essential for reliable assessment, particularly when working with patients with SPMI. The recommended protocol includes sequential steps to ensure comprehensive evaluation while minimizing assessment errors [11].

Table 1: Capacity Evaluation Protocol

Step	Procedure	Purpose	Tools/Examples
1. Communication Assessment	Identify and address physical, language, or jargon barriers	Eliminate "pseudo-incapacity" from communication issues	Hearing/vision aids, interpreters, plain language
2. Identify Reversible Causes	Evaluate for infection, medication effects, metabolic issues	Address temporary capacity impairments	Medical workup, medication review
3. Directed Clinical Interview	Assess understanding, appreciation, reasoning, and expression	Evaluate core capacity elements	Questions about condition, treatment options, consequences
4. Formal Assessment Tools	Administer standardized capacity instruments	Objectify clinical impressions	ACE, HCAT, MacCAT-T
5. Cognitive Testing	Evaluate overall cognitive functioning	Provide context for capacity findings	MMSE, MoCA
6. Consultation	Seek specialized input when uncertainty remains	Resolve complex cases	Psychiatry, ethics committee

The initial clinical interview should employ specific questions targeting each capacity domain. For understanding: "What is your understanding of your condition?" For appreciation: "Why do you think your doctor has recommended this treatment for you?" For reasoning: "What factors are most important to you in deciding about your treatment?" For expressing a choice: "What do you want to do?" [11].

Standardized Assessment Instruments

Formal assessment tools improve accuracy in determining DMC, with several validated instruments available for clinical and research use.

Table 2: Standardized Capacity Assessment Tools

Instrument	Assessment Focus	Key Features	Psychometric Properties
Aid to Capacity Evaluation (ACE)	Specific treatment decisions	Assesses all 4 capacity elements; scenario-specific	Likelihood ratio of 8.5 for predicting incapacity [11]
Hopkins Competency Assessment Test (HCAT)	Generalized capacity	Evaluates understanding of medical concepts; not decision-specific	Efficient for surrogate decision-making needs [11]
MacArthur Competence Assessment Tool for Treatment (MacCAT-T)	Treatment decisions	Semi-structured interview; flexible to specific decisions	Well-validated across populations [11]
Assessment of Capacity to Consent to Treatment (ACCT)	Healthcare decision-making	Includes values assessment; minimizes memory demands	Cronbach α=0.88-0.96 [10]
Capacity to Designate a Surrogate (CDS)	Surrogate designation	Specifically assesses capacity to choose surrogate	High interrater reliability; validated for dementia [16]

The ACCT instrument incorporates innovative approaches by assessing healthcare values across three domains: impact of treatment choices on valued activities and relationships, preferred decision-making style, and views on quality versus length of life [10]. This values assessment provides crucial context for determining authenticity.

Figure 1: Capacity Assessment Clinical Decision Pathway

Research Reagent Solutions for Capacity Assessment

Table 3: Essential Assessment Tools and Their Functions

Tool/Category	Specific Function	Application Context
ACCT Instrument	Assesses decision-making capacity and healthcare values	Evaluates understanding, appreciation, reasoning with minimal memory demands [10]
CDS Tool	Specifically evaluates capacity to designate surrogate decision-maker	Identifies patients who lack treatment DMC but retain surrogate designation capacity [16]
Mini-Cog	Brief cognitive screening (3-item recall + clock draw)	Provides additional information for capacity evaluations [10]
ACE (Aid to Capacity Evaluation)	Structured evaluation of 4 capacity elements	Objective assessment of decision-specific capacity [11]
Semi-structured Clinical Evaluation	Clinical assessment of end-of-life DMC	Flexible evaluation adapted to individual patient needs [10]

Quantitative Evidence Base

Research has identified specific factors correlating with impaired decision-making capacity in patients with SPMI. Understanding these evidence-based correlations helps clinicians identify cases requiring more thorough assessment while avoiding discriminatory assumptions based solely on diagnosis.

Table 4: Factors Correlating with Impaired Decision-Making Capacity

Factor	Correlation Significance	Clinical Implications
Lower Mini-Cog scores	p < 0.001 [10]	Cognitive screening provides valuable data but shouldn't determine capacity alone
Schizophrenia spectrum disorders	p = 0.0007 [10]	Specific diagnosis should trigger assessment but not presume incapacity
Involuntary admission status	p < 0.0001 [10]	Legal status reflects current impairment but capacity may fluctuate
Duration of SPMI (30-39 years)	p = 0.025 [10]	Illness chronicity correlates with impairment but not determinative
Advanced age	Higher prevalence in medical inpatients [11]	Age alone should not determine capacity; assessment essential

Quantitative studies reveal that the prevalence of incapacity varies significantly across populations. While healthy older adults show an incapacity prevalence of approximately 2.8%, this rate rises to 26% in medical inpatients, 54% in Alzheimer disease patients across all stages, and peaks at 68% in persons with learning disabilities [11]. These statistics highlight the importance of context-specific assessment rather than blanket assumptions.

Research specifically examining older adults with serious mental illness found that a significant majority (65%) demonstrated capacity for end-of-life decisions despite their psychiatric conditions [10]. This finding underscores the potential to overestimate incapacity in SPMI populations if thorough assessments are not conducted.

Ethical Frameworks and Applications

Principles of Biomedical Ethics

The four principles of biomedical ethics provide a comprehensive framework for analyzing ethical dilemmas in end-of-life care for persons with SPMI [9] [14].

Autonomy in SPMI contexts requires careful evaluation of decision-making capacity rather than automatic restriction based on diagnosis. The tension between respecting "pure" patient autonomy and providing optimal care creates significant ethical challenges [14]. Factors complicating autonomy assessments include determining whether choices are authentic or prompted by psychiatric symptoms, communication difficulties, and caregiver perceptions of vulnerability that may lead to disproportionate paternalism [14].

Justice considerations highlight disparities in access to quality end-of-life care and the presence of stigma affecting treatment of persons with SPMI [9] [14]. Equity issues manifest through limited access to palliative care services, undertreatment of physical pain, and disparities in advance care planning discussions compared to general population patients.

Beneficence and Non-maleficence principles generate ongoing debates regarding applying palliative approaches in psychiatry and the concept of futility in psychiatric treatment [14]. The emerging field of palliative psychiatry focuses on harm reduction and avoiding burdensome interventions with questionable benefit when curative approaches prove ineffective for SPMI [15].

Virtue Ethics and Professional Attitudes

Beyond principle-based ethics, virtue ethics emphasizes the character traits and attitudes that healthcare providers should cultivate when working with SPMI populations at end-of-life. Key virtues include compassion, non-abandonment, and upholding dignity for patients who often lack extensive social networks [14]. These professionals serve as crucial advocates for ensuring patient preferences are respected.

The ethical dialogue surrounding end-of-life care for persons with SPMI predominantly involves healthcare professionals and relatives rather than patients themselves [14]. This dynamic reflects a significant gap in including firsthand patient perspectives in both clinical decision-making and research, potentially undermining authenticity assessments.

Figure 2: Ethical Framework for End-of-Life Care in SPMI

Advance Care Planning and Surrogate Decision-Making

Advance care planning (ACP) presents particular challenges and opportunities in the SPMI population. The drafting and implementation of advance directives requires careful consideration of how mental health symptoms may influence decisions during periods of capacity. Evidence suggests that many persons with SPMI can effectively engage in ACP discussions when providers optimize communication and decision-making capacity [10].

The Capacity to Designate a Surrogate (CDS) tool represents a significant advancement, enabling clinicians to identify patients who lack treatment decision-making capacity but retain the ability to choose a surrogate decision-maker [16]. This instrument assesses three key dimensions: consistent ability to name a surrogate, understanding the surrogate's role, and providing a rationale for the choice. Research demonstrates that some patients who lack medical decision-making capacity can still validly designate a surrogate who understands their values and preferences [16].

Thematic analysis of reasons for surrogate choice reveals thirty-three unique rationales falling into three overarching themes: emotional bonds, practical considerations, and shared values [16]. This nuanced understanding helps clinicians assess the authenticity of surrogate designation even when patients cannot make complex treatment decisions.

Evaluating decision-making capacity and authentic choice in end-of-life care for persons with SPMI requires nuanced assessment that respects autonomy while acknowledging the potential influence of psychiatric symptoms. Evidence confirms that most older patients with SPMI retain decision-making capacity, challenging stereotypes and discriminatory practices based solely on diagnosis or age [10].

Future research should prioritize including firsthand accounts of persons with SPMI to better understand their values and preferences in end-of-life contexts [14]. Additionally, further development and validation of specialized assessment tools like the CDS instrument will enhance patient-centered care for vulnerable populations [16]. The emerging field of palliative psychiatry offers promising approaches for focusing on quality of life when curative paradigms prove ineffective for severe, persistent mental illness [15].

Healthcare providers have an ethical imperative to initiate advance care discussions, optimize decision-making capacity through appropriate supports, and protect autonomous decision-making to the greatest extent possible. By implementing structured assessment protocols, utilizing validated tools, and maintaining awareness of the ethical dimensions involved, clinicians and researchers can ensure that persons with SPMI receive end-of-life care aligned with their values and preferences.

Caring for persons experiencing Severe and Persistent Mental Illness (SPMI) at the end of life presents distinctive ethical challenges that intersect with complex clinical realities. Individuals with SPMI, including conditions such as schizophrenia, bipolar disorder, and severe depression, face a mortality rate 10-20 years higher than the general population, largely due to significant physical health comorbidities [17]. This health disparity creates an urgent need for equitable palliative and end-of-life care, yet ethical guidance in this domain remains underdeveloped. Recent research highlights that this vulnerable population is at risk of receiving suboptimal end-of-life care due to multiple systemic barriers, including stigma among healthcare professionals, fragmented care systems, and insufficient advanced care planning [17]. This technical guide examines how the four fundamental principles of biomedical ethics—autonomy, beneficence, nonmaleficence, and justice—apply and frequently conflict within this specialized context, providing researchers and clinicians with a structured framework for ethical decision-making.

The Four Principles of Biomedical Ethics

The principles of biomedical ethics provide a foundational framework for analyzing moral problems in medicine and research. These principles, first comprehensively articulated by Beauchamp and Childress, have evolved to address complex healthcare scenarios [18].

Definition and Historical Context

The four-principle approach includes:

• Beneficence: The obligation to act for the benefit of patients, encompassing moral rules to protect and defend rights, prevent harm, and help persons with disabilities [18]. This principle extends beyond avoiding harm to actively promoting patient welfare.
• Nonmaleficence: The obligation to avoid harming patients, supported by rules such as do not kill, do not cause pain or suffering, do not incapacitate, and do not deprive others of goods of life [18]. In practical application, this requires physicians to weigh benefits against burdens of interventions.
• Autonomy: Respect for the individual's right to self-determination, recognizing all persons have intrinsic worth and should have power to make rational decisions [18]. This principle underpins informed consent, truth-telling, and confidentiality.
• Justice: The obligation to distribute benefits and burdens fairly, ensuring equitable access to care and resources [18].

Table 1: Core Principles of Biomedical Ethics

Principle	Definition	Derivative Applications
Autonomy	Respect for individual self-determination and decision-making capacity	Informed consent, truth-telling, confidentiality
Beneficence	Obligation to act for the benefit of patients	Positive requirements to benefit patients and promote welfare
Nonmaleficence	Obligation not to inflict harm intentionally	Weighing benefits against burdens of interventions
Justice	Obligation to provide individuals with what they are due	Fair distribution of resources and equitable care access

Historically, the first two principles (beneficence and nonmaleficence) can be traced to the Hippocratic tradition, while autonomy and justice gained prominence later in the evolution of medical ethics [18]. In modern practice, all four principles require balancing, with no single principle automatically overriding others.

Application to SPMI End-of-Life Contexts

Autonomy and Decision-Making Capacity

Respecting autonomy for persons experiencing SPMI requires careful assessment of decision-making capacity, which may fluctuate due to the nature of mental illness. The philosophical foundation of autonomy, as interpreted by Kant and Mill, affirms that all persons have unconditional worth and should exercise their capacity for self-determination [18]. However, this principle encounters unique challenges in SPMI contexts where illness may impact cognitive abilities or where longstanding structural barriers limit genuine autonomy.

Recent qualitative studies involving 73 stakeholders in Flanders, Belgium, revealed that autonomy remains a central ethical concern in end-of-life care for persons experiencing SPMI [19]. Caregivers reported significant tensions between respecting immediate choices and supporting long-term wellbeing, particularly when patients made decisions that appeared influenced by symptoms rather than stable values. One study participant noted difficulties in "maintaining autonomy for care users" while ensuring their safety and wellbeing [19].

Advanced care planning (ACP) emerges as a critical tool for promoting autonomy in SPMI populations. However, research indicates that ACP is significantly underutilized in this population, creating ethical vulnerabilities when patients can no longer express their preferences [17]. The systematic review by J.D. et al. (2025) identified "absence of advanced care planning" as a key challenge in providing adequate end-of-life care for people with SPMI [17].

Beneficence and Recovery-Oriented Care

The principle of beneficence requires physicians to provide care that positively benefits patients, going beyond mere avoidance of harm. In SPMI contexts, this necessitates integrating recovery-oriented approaches with palliative perspectives—a challenging balance that requires careful consideration of the patient's holistic wellbeing.

The Oyster Care Model, developed in Flanders, exemplifies an innovative approach to implementing beneficence in SPMI care [20]. This model uses the metaphor of a shell to represent a palliative approach focusing on quality of life, creativity, and holistic personhood. The model operates through four pillars:

• Physical care adequately responding to somatic needs
• Psychological care focusing on mental comfort and wellbeing
• Social care providing structure for daily activities and contacts
• Existential care enhancing experience of life as valuable and meaningful

The mission of this model is to "adapt the environment as much as possible to the care user, rather than the other way around" [20]. While beneficent in intention, this approach raises ethical concerns about potential paternalism or insufficient recovery orientation, highlighting the nuanced application required for this principle.

Nonmaleficence and Treatment Considerations

Nonmaleficence obliges caregivers to avoid harm, particularly relevant in SPMI end-of-life care where interventions may carry significant risks. The doctrine of double effect becomes particularly important when managing refractory symptoms at end of life, where treatments intended to relieve suffering may have foreseen but unintended harmful effects [18].

In SPMI contexts, unique considerations for nonmaleficence include:

• Medication management: Balancing psychotropic treatments with palliative medications to avoid adverse interactions or undue sedation
• Communication approaches: Avoiding harm through inappropriate disclosure or, conversely, through withholding meaningful information
• Behavioral interventions: Applying the least restrictive interventions necessary when managing challenging behaviors

Qualitative research reveals that caregivers often struggle with decisions about medical assistance in dying (MAID), where the line between relieving suffering and causing death raises profound ethical questions [20]. In regions where MAID is legally permitted for psychiatric suffering, such as Belgium, these tensions are particularly acute.

Justice and Resource Allocation

The principle of justice demands fair distribution of healthcare resources, raising significant concerns in SPMI care where disparities in access to palliative services are well-documented. Persons with SPMI face what researchers have termed "double discrimination"—both from mental health stigma and from limited access to specialized palliative care [17].

Recent systematic reviews identify several justice-related barriers in SPMI end-of-life care:

• Structural stigma among healthcare professionals leading to inequitable referral patterns
• Lack of integrated care policies between mental and physical health services
• Insufficient training in palliative care among mental health professionals
• Resource allocation decisions that disadvantage those with complex mental health needs

Quantitative analysis reveals that resource allocation concerns exist at both organizational and societal levels, creating systemic barriers to equitable care [19]. These disparities represent fundamental justice issues that researchers and policymakers must address.

Table 2: Ethical Conflicts in SPMI End-of-Life Care

Ethical Conflict	Clinical Manifestation	Stakeholder Perspectives
Autonomy vs. Beneficence	Care user refusing medically indicated treatment based on distorted thinking	Caregivers balance respect for choices with duty to provide beneficial care
Justice vs. Resource Constraints	Limited access to specialized palliative care for SPMI populations	Organizations struggle with allocating limited resources equitably
Nonmaleficence vs. Autonomy	Administration of sedating medications against care user wishes	Teams weigh potential harm of symptoms against harm of overriding preferences
Beneficence vs. Justice	Providing intensive, resource-heavy care to one individual	Systems balance individual needs against population-level fairness

Ethical Conflict Resolution Framework

Resolving ethical conflicts in SPMI end-of-life care requires a systematic approach that acknowledges the contextual nature of these dilemmas. A four-pronged method of ethical problem-solving has been proposed for clinical settings [18].

Systematic Approach to Ethical Dilemmas

The ethical decision-making framework involves:

• Case Analysis: Thoroughly gathering relevant clinical, psychological, social, and cultural information
• Principle Identification: Determining which ethical principles apply and how they conflict
• Stakeholder Perspective-Taking: Considering the viewpoints of all involved parties—care users, family members, caregivers, and the broader care system
• Resolution Seeking: Developing solutions that minimize ethical compromise while maximizing respect for all principles

Recent research in Flanders demonstrates that ethical dilemmas in SPMI care are "predominantly addressed at the team level," with some organizations employing specialized resources such as "ethics reference persons" or "ethics pubs" for challenging situations [19]. However, the same study found that existing ethical guidelines and advisory structures were "often not well known or not perceived as easily accessible to frontline staff," highlighting an implementation gap in ethical support systems.

Diagram 1: Ethical Decision-Making Framework for SPMI Care

Research Implications and Methodological Considerations

Empirical Research in Bioethics

The field of bioethics has witnessed significant growth in empirical research approaches over recent decades. Quantitative analysis of nine peer-reviewed bioethics journals from 1990-2003 revealed that empirical studies increased from 5.4% of publications in 1990 to 15.4% in 2003—a statistically significant trend (χ² = 49.0264, p<.0001) [21]. This movement toward evidence-based ethics underscores the importance of grounding ethical frameworks in observable realities, particularly in complex contexts like SPMI end-of-life care.

Table 3: Empirical Research Trends in Bioethics (1990-2003)

Journal	Total Empirical Studies	Percentage of Total Publications
Nursing Ethics	145	39.5%
Journal of Medical Ethics	128	16.8%
Journal of Clinical Ethics	93	15.4%
Bioethics	22	6.6%
Other Journals	47	<5% each

Most empirical studies in bioethics employed quantitative methodologies (64.6%, n=281), with qualitative approaches being less frequently utilized [21]. The most common research topic was "prolongation of life and euthanasia" (n=68), directly relevant to SPMI end-of-life contexts.

Research Protocols for SPMI Ethics Studies

Conducting ethical research with SPMI populations requires specialized methodologies that accommodate unique vulnerabilities while respecting autonomy. Based on successful recent studies, the following protocol elements are essential:

Participant Recruitment and Consent

• Implement extended consent processes with verification of understanding
• Utilize supported decision-making approaches where appropriate
• Establish clear protocols for participant capacity assessment
• Include provisions for trusted support persons during consent process

Qualitative Data Collection

• Conduct semi-structured interviews in familiar environments
• Allow flexible scheduling to accommodate participant needs
• Train researchers in SPMI-specific communication techniques
• Implement "stop" protocols if participants experience distress

Recent studies successfully employing these methods have demonstrated the feasibility of including persons experiencing SPMI in qualitative research, despite additional challenges such as needing "extra flexibility when scheduling interviews" or allocating "more time than usual to review the information documents" [20].

Statistical Analysis Tools

Robust statistical analysis is essential for empirical ethics research. Recent technological advances have produced accessible tools that enable researchers to conduct sophisticated analyses without extensive programming expertise.

StatiCAL represents one such innovation—an open-access, interactive tool for statistical analysis of biomedical data [22]. This R-based application provides a graphical user interface that allows researchers to perform descriptive statistics, graphical representations, univariate and multivariate analyses, logistic regression, and survival analyses without programming knowledge. The tool includes specific functionalities for:

• Data management and variable manipulation
• Patient subgroup selection and analysis
• Generation of publication-ready tables and figures
• Nomogram creation for risk prediction models

Such tools democratize statistical analysis capabilities, making rigorous empirical ethics research more accessible to investigators without formal biostatistical training.

Table 4: Research Reagent Solutions for SPMI Ethics Studies

Tool/Resource	Function	Application Context
Semi-Structured Interview Guides	Elicit rich qualitative data on experiences and preferences	Exploring stakeholder perspectives on end-of-life care
Decision-Making Capacity Assessment Tools	Evaluate ability to understand, appreciate, and reason about treatment choices	Determining capacity for informed consent in research and care
StatiCAL Statistical Software	Conduct basic to intermediate statistical analyses without programming	Analyzing quantitative data on care patterns and outcomes
Ethical Dilemma Documentation Framework	Systematically record and categorize ethical conflicts	Identifying patterns in ethical challenges across cases
Advanced Care Planning Documentation Templates	Facilitate structured discussions about future care preferences	Supporting autonomy through planned decision-making

The application of biomedical ethics principles to end-of-life care for persons experiencing SPMI reveals both profound conflicts and opportunities for moral growth in healthcare systems. As research in this field continues to evolve, several critical needs emerge: better integration of empirical and normative approaches, development of more accessible ethical support systems for frontline clinicians, and intentional addressing of justice concerns that currently limit equitable care access. The four principles—autonomy, beneficence, nonmaleficence, and justice—provide a durable framework for navigating these complex issues, but their application requires contextual sensitivity and willingness to acknowledge tensions that resist easy resolution. Future research should prioritize inclusive methodologies that amplify the voices of persons with lived experience of SPMI, while also developing practical tools that help clinicians translate ethical principles into compassionate care at life's end.

Palliative psychiatry represents an emerging subspecialty at the intersection of palliative medicine and psychiatry, addressing the needs of patients with severe and persistent mental illness (SPMI) for whom conventional, recovery-oriented treatments have proven ineffective [23]. This approach acknowledges that some forms of SPMI may be irremediable – unresponsive to optimal available treatments – and necessitates a fundamental shift in goals of care from symptom reduction to improvement in quality of life, harm reduction, and relief of suffering [23]. With research indicating that persons with SPMI have a significantly reduced life expectancy of up to 10-20 years compared to the general population, the imperative for developing structured palliative approaches in psychiatry becomes evident [9] [24].

The conceptual foundation of palliative psychiatry challenges traditional psychiatric paradigms by accepting that for some patients, continued aggressive treatment attempts may yield diminishing returns while increasing the burden of side effects and iatrogenic harm [23]. This paper delineates the scope, ethical dimensions, and practical applications of palliative psychiatry, framing it within the broader context of ethical dilemmas in end-of-life care for persons experiencing SPMI.

Conceptual Framework and Definitions

Palliative Psychiatry in Narrow and Broad Senses

Palliative psychiatry can be conceptualized in both narrow and broad senses, reflecting the evolution of palliative care concepts in medicine [23]. In its narrow sense, palliative psychiatry refers to the provision of end-of-life care for persons dying directly from a mental illness. This includes cases such as terminal anorexia nervosa where further curative treatment is deemed futile and potentially harmful [23]. In these situations, the focus shifts decisively to optimizing quality of life until death occurs.

In its broader sense, palliative psychiatry encompasses approaches aimed at improving quality of life through means other than reduction of SPMI symptoms, focusing on harm reduction and relief of suffering for patients who may not be imminently dying [23]. This broader conceptualization aligns with the World Health Organization's definition of palliative care as an approach that "improves the quality of life of patients and their families facing problems associated with life-threatening illness" but is not limited to end-stage disease [24]. This broader application may include patients with treatment-resistant schizophrenia, refractory depression, or other SPMI forms where the balance between treatment benefits and burdens becomes unfavorable.

Distinction from Palliative Care Psychiatry

A crucial distinction exists between palliative psychiatry and palliative care psychiatry. The former concerns care for persons dying from mental disorders, while the latter addresses mental disorders or psychiatric symptoms in persons receiving palliative care for life-threatening somatic illnesses [23]. This differentiation clarifies the unique focus of palliative psychiatry on addressing the challenges posed by irremediable mental illness itself, rather than managing psychiatric comorbidity in physically ill patients.

Figure 1: Conceptual Framework of Palliative Psychiatry and Its Distinctions

Ethical Dimensions and Dilemmas

Core Ethical Principles in Palliative Psychiatry

The ethical framework for palliative psychiatry can be understood through the four principles of biomedical ethics, each presenting unique challenges in the context of SPMI [9] [25].

Autonomy and Decision-Making Capacity: Respecting patient autonomy requires careful assessment of decision-making capacity in persons with SPMI, where pathology may influence choices and communication difficulties complicate understanding [9]. Tensions arise between respecting patient self-determination and paternalistic approaches aimed at protecting patients from harm. The use of advance directives and shared decision-making processes becomes crucial yet challenging in this population [9].

Beneficence and Non-Maleficence: The principles of doing good and avoiding harm require careful balancing in palliative psychiatry [25]. With each unsuccessful treatment attempt, the probability of achieving symptom reduction declines while the risk of somatic and psychological side effects increases [23]. This worsening benefit-harm ratio necessitates consideration of when further curative interventions may become more burdensome than beneficial.

Justice: Equity issues emerge in access to quality care for persons with SPMI, who often face structural stigma and resource allocation disadvantages [9]. The significantly reduced life expectancy in this population highlights systemic failures in addressing both mental and physical health needs across the care continuum [9] [26].

Specific Ethical Challenges

Several specific ethical challenges dominate the landscape of palliative psychiatry:

Futility Determinations: Deciding when psychiatric treatment is "futile" remains contentious, with limited prognostic tools and evidence-based criteria for determining irremediability in mental disorders [9] [23]. A survey of Swiss psychiatrists found that 72.4% considered curative approaches futile in cases of severe anorexia nervosa, indicating professional recognition that some SPMI may not respond to further treatment [24].

Medical Assistance in Dying (MAiD): In jurisdictions where euthanasia or physician-assisted suicide is legal for irremediable psychiatric suffering, complex questions arise regarding capacity assessments, determination of irremediability, and the distinction between palliative approaches and life-ending interventions [9] [26]. Belgium's experience with euthanasia for psychiatric suffering demonstrates the controversial nature of these practices [26].

Resource Allocation: Persons with SPMI often require substantial healthcare resources, raising distributive justice concerns about appropriate investment in palliative psychiatric services versus other healthcare needs [26]. Ethical care demands attention to both individualized approaches and fair resource distribution across populations [26].

Table 1: Ethical Principles and Applications in Palliative Psychiatry

Ethical Principle	Definition	Application in Palliative Psychiatry	Key Challenges
Autonomy	Right to self-determination and decision-making [25]	Respecting patient choices through advance care planning, supported decision-making [9]	Determining decision-making capacity; balancing autonomy with beneficence [9]
Beneficence	Obligation to act for the benefit of patients [25]	Shifting goals from cure to quality of life improvement [23]	Determining when palliative approach is most beneficial; avoiding therapeutic nihilism [23]
Non-maleficence	Duty to avoid causing harm [25]	Minimizing iatrogenic harm from ineffective treatments [23]	Balancing risk of continued treatment against risk of premature transition to palliative care [23]
Justice	Fair distribution of healthcare resources [25]	Ensuring equitable access to palliative approaches for SPMI [9]	Addressing structural stigma; allocating limited mental health resources appropriately [9] [26]

Clinical Scope and Practice Applications

Target Populations and Indications

Palliative psychiatry approaches may be appropriate for patients with specific forms of SPMI that have proven refractory to evidence-based treatments. Survey research indicates that psychiatrists recognize certain conditions as having potential terminal trajectories that may warrant palliative approaches [24].

Table 2: Potential Indications for Palliative Psychiatry Approaches

Condition	Rationale for Palliative Approach	Clinical Considerations
Treatment-resistant schizophrenia	Risk of iatrogenic harm from polypharmacy; limited efficacy of available treatments for negative symptoms; significant functional impairment [23] [27]	Focus on minimizing side effects rather than maximizing efficacy; higher threshold for hospitalization during deterioration; quality of life interventions [27]
Severe and enduring anorexia nervosa	Pattern of partial remissions and repeated hospitalizations; patient refusal of weight restoration; high mortality risk [23] [27]	Shift focus from weight gain to quality of life; harm reduction; somatic monitoring; relational support [23]
Chronic refractory depression	Worsening benefit-harm ratio with successive treatment failures; psychological side effects including demoralization and hopelessness [23]	Acceptance-based approaches rather than change-oriented therapy; pharmacological interventions for symptom relief rather than remission [27]
Severe personality disorders	Long-term suicidality and self-harm despite multiple treatment attempts; system alternating between rejection and overprotection [27]	Relational support rather than intensive change-focused therapy; acceptance of self-destructive behavior as coping strategy; crisis stabilization [27]

Assessment and Outcome Measurement

A significant challenge in implementing palliative psychiatry is the lack of validated instruments specifically designed to measure quality of life and treatment outcomes in this approach [28]. Current research indicates that standard psychiatric measures focusing on symptom reduction may not capture the relevant outcomes for palliative approaches, necessitating development of new assessment frameworks that prioritize patient-defined quality of life indicators [28].

Key domains for assessment in palliative psychiatry include:

• Physical comfort and management of psychiatric medication side effects
• Psychological and emotional well-being independent of core psychiatric symptoms
• Social connectedness and relational quality
• Existential meaning and purpose
• Functional abilities in valued life activities
• Autonomy in decision-making and care participation

Research Methodologies and Experimental Approaches

Qualitative Research Designs

Understanding the experiences of persons with SPMI, their families, and clinicians requires robust qualitative methodologies. A recent study employed in-depth qualitative interviews with 73 participants, including care users, family members, caregivers, and ethics experts [26]. The methodology included:

Participant Recruitment: Purposeful sampling from seven mental health care organizations across multiple provinces, representing diverse care settings including residential care, assisted living, and ambulatory services [26].

Data Collection: Semi-structured interviews following a pre-constructed topic guide, covering themes such as care approaches, end-of-life care needs, ethical considerations, and existential questions. Interviews ranged from 30 minutes to over two hours, averaging approximately one hour [26].

Analysis Approach: Content analysis to identify recurring themes and reflect on ethical practices, with researchers maintaining reflexivity through discussion of assumptions and expected results [26].

Quantitative Survey Research

Survey methodology has been effectively employed to assess psychiatrist attitudes toward palliative approaches in psychiatry. One study implemented a cross-sectional survey of 1,311 psychiatrists in Switzerland with a 34.9% response rate [24]. Key methodological components included:

Instrument Development: Survey based on research questions with case vignettes drawing on previously published material, revised by an advisory group including experts and trainees in psychiatric practice and research [24].

Data Collection: Hard copy survey distribution with prepaid return envelopes, followed by reminder postcards four weeks later to enhance response rate [24].

Measurement Approach: 7-point Likert scales for attitude assessment, with additional questions about treatment prioritization and case-specific judgments [24].

Clinical Characterization Studies

Characterization of psychiatric consultations in palliative care settings provides important data on implementation needs. One study employed a retrospective, descriptive, cross-sectional design involving 97 patients in a palliative care unit [29]. The methodology included:

Data Extraction: Electronic medical record review focusing on demographic characteristics, consultation reasons, psychiatric diagnoses, and treatments provided [29].

Statistical Analysis: Comparisons of clinical characteristics, consultation reasons, and diagnoses according to age and gender using appropriate statistical tests including Mann-Whitney U, χ², and Fisher exact tests [29].

Table 3: Key Research Reagents and Methodological Tools

Research Tool	Function	Application in Palliative Psychiatry Research
Semi-structured interview guides	Elicit rich qualitative data on experiences and perspectives [26]	Understanding stakeholder views on end-of-life care, ethical dilemmas, and quality of life priorities [26]
Case vignettes	Standardize clinical scenarios for attitude assessment [24]	Evaluating psychiatrist judgments about futility and appropriateness of palliative approaches [24]
Likert scale attitude measures	Quantify perspectives on care approaches [24]	Assessing professional acceptance of palliative psychiatry concepts across different diagnostic groups [24]
Electronic health record data extraction protocols	Systematize clinical data collection [29]	Characterizing current psychiatric consultation practices in palliative care settings [29]
Quality of life assessment instruments	Measure patient-defined outcomes [28]	Evaluating effectiveness of palliative approaches beyond symptom reduction (note: requires further development) [28]

Implementation Challenges and Future Directions

Barriers to Implementation

Several significant barriers impede the systematic implementation of palliative psychiatry approaches:

Conceptual Misunderstandings: Palliative care is often conflated with hospice and end-of-life care, leading to resistance from clinicians, patients, and families who may perceive palliative approaches as "giving up" [24] [28]. Surveys indicate that even among psychiatrists, understanding of palliative care concepts varies significantly [24].

Prognostic Uncertainty: Unlike many somatic illnesses, mental disorders lack validated prognostic tools to reliably identify patients who are unlikely to respond to further treatment [23]. This complicates determinations of irremediability and appropriate timing for transitioning to palliative approaches.

Systemic and Resource Barriers: Mental health systems often emphasize recovery-oriented care without adequate resources or frameworks for integrating palliative approaches [26]. Reimbursement structures typically do not support the interdisciplinary, longitudinal care models required for effective palliative psychiatry [30].

Future Research Priorities

Advancing the field of palliative psychiatry requires addressing several key research priorities:

Development of Operational Criteria: Establishing consensus-based criteria for identifying patients who may benefit from palliative psychiatry approaches is fundamental to systematic implementation [28]. This includes defining irremediability in psychiatric contexts and creating clinical staging models that incorporate palliative needs.

Outcome Measure Validation: Creating and validating patient-centered outcome measures that capture quality of life domains relevant to persons with SPMI is essential for evaluating the effectiveness of palliative approaches [28].

Intervention Development and Testing: Designing specific interventions for palliative psychiatry and evaluating their effectiveness through rigorous controlled trials represents a critical research direction [23]. This includes adapting palliative care techniques such as dignity therapy, meaning-centered interventions, and systematic symptom assessment for psychiatric populations.

Educational Framework Development: Creating training programs and competencies for mental health professionals in palliative psychiatry principles and practices requires systematic development and evaluation [30].

Figure 2: Implementation Challenges and Research Priorities in Palliative Psychiatry

Palliative psychiatry represents a necessary evolution in mental health care for persons with severe and persistent mental illness that has proven refractory to conventional treatments. By shifting the focus from symptom reduction to quality of life improvement, harm reduction, and relief of suffering, this approach addresses significant gaps in current mental health care systems. The ethical dimensions of this care are complex, requiring careful attention to autonomy, beneficence, non-maleficence, and justice in contexts characterized by uncertainty and vulnerability.

As research in this emerging field advances, development of operational criteria, validated outcome measures, evidence-based interventions, and specialized training programs will be essential to realizing the potential of palliative psychiatry to provide compassionate, person-centered care for some of the most vulnerable individuals in mental health systems. Framed within broader ethical considerations in end-of-life care for persons with SPMI, palliative psychiatry represents a promising approach to addressing the needs of patients for whom recovery-oriented models have proven insufficient.

Equity in access to quality end-of-life (EOL) care represents a fundamental bioethical challenge, particularly for vulnerable populations such as those experiencing severe and persistent mental illness (SPMI). The World Health Organization recognizes palliative care as a cornerstone of healthcare systems, yet only approximately 14% of those in need currently receive it [31]. This disparity raises critical questions about justice, autonomy, and dignity in healthcare delivery. For persons experiencing SPMI, the challenges are compounded by diagnostic overshadowing, communication difficulties, impaired decision-making capacity, and societal stigma that collectively create significant barriers to appropriate EOL care [19] [26]. These individuals experience a significantly reduced life expectancy—up to 15 years shorter than the general population—largely due to severe co-occurring somatic conditions, making concern toward EOL care paramount [26].

The ethical imperative to address these disparities stems from the fundamental principles of biomedical ethics: autonomy, beneficence, nonmaleficence, and justice [25]. In the context of SPMI, each principle presents unique challenges. Autonomy conflicts with questions of decision-making capacity, beneficence requires balancing psychiatric treatment with palliative approaches, nonmaleficence demands avoiding therapeutic nihilism, and justice necessitates fair distribution of limited resources [25] [26]. This technical guide examines the complex intersection of stigma and structural injustice that limits equitable access to quality EOL care for persons experiencing SPMI, providing researchers and clinicians with evidence-based frameworks to address these critical ethical dilemmas.

Ethical Foundations and Theoretical Frameworks

Core Principles in End-of-Life Care Ethics

The ethical delivery of EOL care to persons experiencing SPMI requires careful navigation of universal bioethical principles within mental health contexts. Autonomy respects a patient's right to self-determination, yet this becomes complex when patients experience fluctuating decision-making capacity [25]. For these individuals, autonomy protection often necessitates innovative approaches such as supported decision-making, advance care planning adapted for psychiatric contexts, and clearly defined healthcare proxies [25] [26]. The principle of beneficence requires physicians to defend the most useful intervention for a given patient, which may involve balancing recovery-oriented approaches with palliative care when further curative treatments offer diminishing returns [25].

Nonmaleficence, embodied by the maxim "first, do no harm," must consider both the harms of overtreatment and the harms of undertreatment in SPMI populations [25]. This is particularly relevant when considering the use of restrictive measures or the potential neglect of somatic conditions due to diagnostic overshadowing. The principle of justice requires fair distribution of health resources and impartiality in service delivery [25]. Research indicates that resource allocation, both at organizational and societal levels, represents a significant ethical concern in EOL care for persons experiencing SPMI, with tensions existing between creative, individualized care and institutional policies [19] [26]. Finally, fidelity demands honesty with dying patients about their prognosis, which requires special sensitivity and adaptation when communicating with those experiencing SPMI [25].

The Oyster Care Model: An Integrated Ethical Framework

The Oyster Care Model represents an innovative approach to addressing ethical challenges in EOL care for persons experiencing SPMI. Developed in Flanders, Belgium, this model complements recovery-oriented care and uses the metaphor of a shell to represent a palliative approach focusing on quality of life, creativity, and a holistic view of the person [26]. The model's mission is to adapt the environment to the care user rather than the reverse, dynamically scaling care up or down according to the care user's rhythm [26].

Table 1: The Four Pillars of the Oyster Care Model

Pillar	Description	Ethical Principle
Physical Care	Adequately responding to somatic impairments	Beneficence
Psychological Care	Focusing on mental comfort and well-being	Nonmaleficence
Social Care	Providing structure for daily activities and contacts	Justice
Existential Care	Enhancing experience of life as valuable	Autonomy

This model provides an ethical framework for balancing recovery-oriented care with palliative approaches, ensuring dignity and respect for this vulnerable population [26]. By adapting the environment to the patient rather than forcing the patient to adapt to the environment, the model offers a promising approach to reducing the use of restrictive or coercive measures while maintaining ethical integrity [26].

Barriers to Equitable Access: A Multi-Level Analysis

Structural and Systemic Barriers

Equitable access to quality EOL care for persons experiencing SPMI is compromised by numerous structural and systemic barriers. Research indicates that fragmented care systems create significant obstacles, with poor continuity between mental health services, primary care, and specialized palliative care [31] [32]. This fragmentation is exacerbated by the divide between child and adult psychiatric services, which often fails to ensure continuity of care during critical transition periods when young adults with SPMI may be particularly vulnerable [32].

Geographic disparities in access to palliative care significantly impact equity. Decentralized inpatient palliative and EOL care services from urban centers creates particular challenges for rural populations [31] [33]. Studies show that individuals outside major cities are substantially underrepresented in care provided by specialist palliative services, reflecting widespread geographic access barriers [31]. Resource allocation issues at both organizational and societal levels further compound these structural barriers, creating ethical tensions between individualized care and institutional policies [19] [26].

Clinical and Diagnostic Barriers

At the clinical level, diagnostic overshadowing represents a significant barrier to equitable EOL care. This phenomenon occurs when physical symptoms are misattributed to mental health conditions, leading to under-treatment of somatic issues [26]. Persons experiencing SPMI frequently have co-occurring somatic conditions that often go unaddressed, contributing to their reduced life expectancy [26]. The "survival imperative" in acute care settings further complicates appropriate referral to palliative care, with intensivists often focusing on life-prolonging treatments even when aligned with patient goals would suggest a palliative approach [31] [34].

Assessment challenges include difficulties in identifying patients nearing end of life and accurately evaluating symptoms in persons with communication limitations or atypical presentations [31]. Research reveals prolonged delays in initiating palliative care for persons experiencing SPMI, suggesting systemic failures in recognizing palliative care needs in this population [19] [26]. Additionally, communication barriers may exist between patients with SPMI and healthcare providers, particularly when cognitive symptoms impair the patient's ability to articulate physical discomfort or express care preferences [19].

Stigma and Discrimination

Stigma represents perhaps the most profound barrier to equitable EOL care for persons experiencing SPMI. Clinical stigma manifests through unconscious biases among healthcare providers who may de-prioritize pain and symptom management for those with mental health conditions [35]. The National Association of Social Workers notes that social workers must advocate for clients' needs in EOL care, particularly challenging stigmatizing assumptions that may affect care quality [35].

Structural stigma is embedded in healthcare systems through inadequate training in both mental health and palliative care, creating providers who lack confidence and competence in addressing the complex needs of this population [31] [35]. Additionally, social stigma impacts persons experiencing SPMI through limited social networks and support systems, which reduces advocacy on their behalf and decreases the likelihood that care preferences will be known and respected [19] [26]. Research indicates that racial and ethnic discrimination further compounds these barriers, with minority populations facing additional obstacles in accessing appropriate palliative and EOL care [31] [33].

Table 2: Barriers to Equitable End-of-Life Care for Persons with SPMI

Barrier Category	Specific Challenges	Impact on Care Equity
Structural Barriers	Fragmented care systems, Geographic disparities, Resource allocation issues	Limited access to specialized services, Service discontinuity
Clinical Barriers	Diagnostic overshadowing, Communication difficulties, Assessment challenges	Delayed palliative care referral, Inadequate symptom management
Stigma-Related Barriers	Clinical bias, Structural stigma, Social isolation	Under-treatment of pain, Less advocacy, Unaddressed needs

Methodological Approaches for Research and Clinical Practice

Qualitative Research Methodologies

Investigating equity in EOL care for persons experiencing SPMI requires robust qualitative methodologies that capture nuanced experiences across stakeholder groups. The Flemish qualitative study on ethical issues in EOL care for persons experiencing SPMI provides an exemplary methodological framework [19] [26]. This research conducted 73 in-depth qualitative interviews with care users, family members, caregivers, care managers, and ethics experts, employing purposive sampling across seven mental health care organizations representing diverse care settings [26].

The methodology included semi-structured interviews following a pre-constructed topic guide covering care approaches, EOL care needs, ethical considerations, and existential questions [26]. Interviews ranged from 30 minutes to over two hours, averaging approximately one hour, and were conducted in locations chosen by participants to ensure comfort and authenticity of responses [26]. Data analysis employed content analysis to identify recurring themes and reflect on ethical practices, with particular attention to representing the voices of vulnerable persons experiencing SPMI despite additional methodological challenges [19] [26].

For researchers replicating this approach, key methodological considerations include: ensuring appropriate support for participants with SPMI during potentially distressing discussions; managing power differentials in interviewer-interviewee relationships; and developing accessible interview guides that accommodate varying cognitive and communication abilities [26].

Clinical Assessment Tools and Protocols

Effective integration of palliative care for persons experiencing SPMI requires standardized assessment protocols. The Needs at the End-of-Life Screening Tool (NEST) represents a validated 13-item questionnaire that assesses needs across multiple domains of palliative care quality: physical and psychological symptoms, social support, EOL care, and spiritual and cultural aspects of care [34]. This tool can be particularly valuable for identifying unmet palliative care needs in populations with communication challenges.

For ICU settings where persons with SPMI may receive care, the electronic poor outcome screening (ePOS) score provides a 14-variable prediction model that can be automatically extracted from electronic medical records to identify patients at high risk for poor outcomes and potential palliative care needs [34]. This tool enables early identification of patients who might benefit from palliative care integration, potentially overcoming triggers based solely on mortality predictions that may not adequately reflect palliative care needs [34].

Advanced care planning protocols for persons experiencing SPMI should include adapted communication strategies, supported decision-making frameworks, and regular capacity assessments that account for fluctuating mental status. These protocols should specifically address psychiatric advance directives alongside traditional medical directives, clarifying preferences for both psychiatric and medical care during periods of decisional incapacity [25] [26].

Visualizing Ethical Decision-Making Frameworks

Ethical Analysis Workflow

The complex ethical decision-making required in EOL care for persons experiencing SPMI benefits from structured approaches. The following diagram illustrates a systematic workflow for addressing ethical challenges in this context:

Interdisciplinary Collaboration Model

Effective EOL care for persons experiencing SPMI requires robust interdisciplinary collaboration. The following diagram maps the essential components and relationships within an integrated care team:

Research Reagents and Methodological Tools

Table 3: Essential Research Tools for Studying EOL Care in SPMI Populations

Tool/Instrument	Primary Application	Key Features	Validation Context
NEST (Needs at End-of-Life Screening Tool)	Identifying unmet palliative care needs	13-item questionnaire assessing physical, psychological, social, spiritual domains	Developed for diverse seriously ill populations [34]
ePOS (electronic Poor Outcome Screening)	Predicting palliative care needs in ICU	14-variable model from electronic health records	Validated for 6-month mortality prediction [34]
Semi-structured Interview Guide	Qualitative research on experiences and needs	Covers care approaches, EOL needs, ethical considerations	Developed for SPMI population in Flanders study [26]
CHARMS (Clinical High At Risk Mental State)	Identifying youth at risk of severe mental disorder	Assesses multiple risk domains including depressive symptoms	Validated for predicting transition to severe disorders [32]

Implementation Strategies and Recommendations

Clinical Practice Interventions

Implementing equitable EOL care for persons experiencing SPMI requires targeted clinical interventions. Early integrated palliative care models that combine psychiatric and palliative expertise show promise in addressing the complex needs of this population [34]. The ProPACC trial, comparing integrated specialty palliative care versus usual care by ICU physicians, represents an important efficacy study that may guide future implementation strategies [34].

Advance care planning adaptations for persons experiencing SPMI should include specialized approaches to support decision-making during periods of stable mental health. These include: (1) psychiatric advance directives that specify preferences for both psychiatric and medical care during incapacity; (2) facilitated decision-making supports involving trusted caregivers; and (3) periodic review of preferences that accounts for fluctuating capacity [25] [26]. Research demonstrates that advance directives improve quality of EOL care and reduce care burden without increasing mortality [25].

Staff education and training must address both unconscious bias and clinical skills deficits. Training should focus on developing cultural humility—understanding and respecting unique cultural, social, and linguistic backgrounds of patients and families [33]. Additionally, communication skills training specifically designed for discussions with persons experiencing SPMI can improve capacity assessment, symptom evaluation, and care preference clarification [26] [35].

System-Level Reforms

Addressing structural barriers requires comprehensive system-level reforms. Care model redesign should re-envision palliative approaches to engage individuals in their communities through non-institutionalized services such as hospice-at-home programs and technology-enhanced care options including telehealth [33]. Decentralizing inpatient palliative services from urban centers can alleviate geographic access challenges, particularly for rural populations [31] [33].

Policy interventions must create supportive environments for equity-focused care. This includes developing and promoting policies that address treatment-related financial hardships and extend optimal support to individuals requiring temporary or long-term care, along with their families and caregivers [33]. Additionally, workforce development should incorporate palliative care training for all mental health professionals and mental health training for palliative care providers, breaking down historical silos between these specialties [35] [33].

Research investment should prioritize examining structural vulnerabilities and addressing existing inequities. Funding should support collection and analysis of data on disparities in EOL care, identification of research gaps, and evaluation of interventions aimed at reducing these disparities [33]. Community-based participatory research methods that actively involve persons with lived experience of SPMI can ensure that research questions and interventions address real-world needs and priorities [26].

Achieving equity in EOL care for persons experiencing SPMI represents a complex ethical imperative requiring committed action at clinical, organizational, and policy levels. The significant disparities in access to quality care stem from multifaceted barriers including structural fragmentation, clinical challenges, and profound stigma. Addressing these disparities demands tailored approaches that balance recovery-oriented care with palliative approaches, ensuring dignity and respect for this vulnerable population.

Researchers and clinicians play critical roles in advancing this agenda through rigorous investigation of disparities, development of adapted assessment tools and care models, and implementation of evidence-based interventions that address both individual and structural factors. By centering the voices of persons with lived experience, challenging stigmatizing assumptions, and advocating for system-level reforms, the healthcare community can move toward a more just future where all persons, regardless of mental health status, receive quality EOL care that honors their dignity and autonomy.

From Theory to Practice: Methodologies and Applied Frameworks for Clinical and Research Settings

Advance Care Planning (ACP) for persons with Severe and Persistent Mental Illness (SPMI) represents a critical intersection of clinical ethics, palliative care, and mental health. This technical guide synthesizes current evidence and protocols for implementing supported decision-making (SDM) frameworks within ACP for the SPMI population. Evidence indicates that while structured ACP interventions significantly increase documentation of end-of-life preferences (12% vs. 6.6% in control groups), they can also produce complex outcomes including potential increases in burdensome care at end-of-life (28.8% vs. 20.9%) [36]. This underscores the necessity of tailored approaches that address the unique ethical and communicative challenges in this population. The Oyster Care Model emerges as a promising framework, applying palliative principles through four pillars—physical, psychological, social, and existential care—while emphasizing environmental adaptation over coercive measures [26] [20]. Successful implementation requires multidisciplinary collaboration, systematic capacity assessment, and ethical support structures accessible to frontline clinicians.

Persons experiencing SPMI, characterized by the "3 D's"—disease, duration, and disability—constitute approximately 1% of the population and face a life expectancy reduction of up to 15 years compared to the general population [26] [20]. This mortality gap, driven by severe co-occurring somatic conditions, creates an urgent imperative for ethical ACP protocols. The Belgian context, with its legal framework permitting euthanasia for unbearable psychiatric suffering since 2002, provides a salient backdrop for examining these complex ethical dimensions [26]. Research reveals that ethical dilemmas in SPMI care frequently involve tensions between autonomy and paternalism, resource allocation challenges, and difficulties in assessing decision-making capacity during fluctuating mental states [26]. These complexities are compounded by insufficient access to ethical support systems, with many frontline staff reporting that existing ethics committees are not well-known or easily accessible [26].

Advance Care Planning: Core Concepts and Evidence Base

Theoretical Framework and Definitions

Advance Care Planning is defined as "the process of thinking about, discussing and making plans for future health and social care" in anticipation of potential capacity loss [37]. For SPMI populations, this process extends beyond traditional medical decisions to encompass psychological, social, and existential dimensions. The conceptual framework for ACP in SPMI integrates several complementary approaches:

• Palliative Psychiatry: An emerging paradigm applying palliative principles to psychiatric care for treatment-refractory conditions [26] [20]
• Palliative Care Approach: A philosophical orientation focusing on quality of life rather than solely curative interventions [26]
• Oyster Care Model: A specific model using the metaphor of a shell to represent a protective, adaptive approach with four pillars: physical, psychological, social, and existential care [26] [20]

Quantitative Evidence Base for ACP Efficacy

Recent meta-analyses and large-scale studies provide evidence for ACP effectiveness across multiple domains:

Table 1: Advance Care Planning Outcomes from Recent Meta-Reviews

Outcome Category	Findings from Meta-Reviews	Number of Reviews Supporting Finding
Healthcare Utilization	Significantly decreased hospital utilization aligned with preferences [38]	15 reviews
Goal-Concordant Care	Significant increases in patients receiving care consistent with goals [38]	14 reviews
Documentation	Significant increases in patients documenting preferences [38]	12 reviews
Decisional Conflict	Mixed evidence: decreased conflict in some studies, no effect in others [38]	8 reviews decreased, 5 no effect

Table 2: ACP Conversation Rates by Diagnostic Group (Primary Care Study)

Diagnostic Group	Incidence Rate Ratio (IRR) of First ACP Conversation	95% Confidence Interval
Cancer	1.75 [39]	1.68 to 1.83
Organ Failure	0.70 [39]	0.68 to 0.73
Dementia with Comorbid Cancer	Increased probability [39]	Not specified
Organ Failure with Comorbid Dementia	Decreased probability [39]	Not specified

The SHARING Choices trial (2021-2022, N=64,915) demonstrated that structured ACP interventions can significantly increase documentation of end-of-life preferences (12% intervention vs. 6.6% control) but also revealed potential unintended consequences, including increased burdensome care among seriously ill patients who died during the observation period (28.8% intervention vs. 20.9% control) [36]. This highlights the complex relationship between ACP documentation and actual care outcomes.

Supported Decision-Making Framework for SPMI

Conceptual Foundation and Legal Context

Supported Decision-Making (SDM) represents an alternative to guardianship that preserves autonomy by providing persons with disabilities the necessary support to make their own decisions [40] [41]. Within ACP, SDM involves collaborative processes where individuals with SPMI identify trusted supporters, access information in accessible formats, and articulate preferences through iterative conversations. The SDM approach aligns with the Oyster Care Model's emphasis on adapting the environment to the care user rather than forcing conformity [26]. Legal frameworks for SDM vary, but typically include instruments like healthcare proxies, powers of attorney, and advance directives [41]. The SDM process distinguishes itself from shared decision-making by centering the individual as the ultimate decision-maker rather than as a participant in a clinical negotiation [40].

Capacity Assessment in SPMI: A Dynamic Protocol

Decision-making capacity assessment in SPMI requires a disorder-specific approach that acknowledges fluctuating mental states and disorder-specific challenges. The following protocol provides a structured methodology:

Table 3: Decision-Making Capacity Assessment Protocol for SPMI

Assessment Domain	SPMI-Specific Considerations	Assessment Methods
Understanding	Ability to comprehend information about psychiatric condition, treatment options, and potential outcomes [26]	Teach-back method; simplified visual aids; repeated assessments across clinical states
Appreciation	Ability to recognize how information applies to one's own situation, including insight into mental illness [26]	Exploratory questions about beliefs; discussion of previous experiences with treatment
Reasoning	Ability to compare options and consequences, even if conclusions differ from clinical recommendations [26]	Process tracing; identifying factors influencing decisions; values-based discussion
Expression	Ability to communicate a choice consistently, acknowledging fluctuations due to psychiatric symptoms [26]	Multiple assessments over time; accommodations for communication challenges

Implementation Protocols and Clinical Workflows

Structured ACP Conversation Framework

Implementing effective ACP for SPMI populations requires standardized yet flexible approaches. The following protocol synthesizes elements from successful interventions:

Pre-Conversation Preparation

• Review clinical history, including psychiatric symptom trajectory and previous treatment responses
• Identify potential supporters designated by the individual
• Schedule sessions during optimal functioning periods based on symptom patterns
• Prepare accessible educational materials tailored to cognitive and psychiatric needs

Conversation Architecture

• Initiate with values exploration before specific treatment decisions
• Use open-ended questions: "What makes life meaningful for you?" "What fears do you have about your future healthcare?"
• Discuss psychiatric and somatic treatment preferences separately but integratively
• Frame discussions within recovery-oriented principles while acknowledging potential deterioration

Documentation and Integration

• Record preferences using standardized templates that capture psychiatric-specific scenarios
• Designate a healthcare proxy with understanding of SPMI complexities
• Distribute documentation to all treating clinicians across psychiatric and medical settings
• Establish review intervals (e.g., annually or with significant clinical change)

Research Reagents and Methodological Tools

Table 4: Essential Research and Implementation Resources

Tool Category	Specific Instruments	Application in SPMI ACP Research
Capacity Assessment	MacCAT-T (MacArthur Competence Assessment Tool for Treatment) [26]	Structured evaluation of decision-making abilities with psychiatric adaptations
ACP Documentation	ACP document templates, POLST/MOLST forms [42]	Standardized recording of psychiatric and medical care preferences
Outcome Measurement	ACP Engagement Survey, Decisional Conflict Scale [38]	Quantification of ACP participation and decision-making quality
Fidelity Assessment	ACP Conversation Quality coding scheme [36]	Standardized evaluation of conversation completeness and quality
Ethics Support	Moral Case Deliberation protocols [26]	Structured approach to resolving ethical dilemmas in clinical care

Ethical Considerations and Implementation Challenges

Navigating Complex Ethical Terrain

The integration of ACP within SPMI care raises distinctive ethical challenges that require specialized frameworks:

Euthanasia and Medical Assistance in Dying (MAID) In jurisdictions where psychiatric euthanasia is legal, ACP conversations require exceptional sensitivity. Research identifies euthanasia as the most frequently mentioned ethical issue in SPMI end-of-life care [26]. Particular challenges include assessing whether psychiatric conditions can be considered "irremediable" and determining the influence of psychiatric symptoms on decision-making capacity for MAID requests [26]. The Oyster Care Model was specifically developed within this context to provide "a full-fledged alternative equivalent to palliative care" [26].

Autonomy and Paternalism Ethical tensions emerge between respecting autonomy through SDM and implementing protective measures when capacity is compromised. Qualitative research reveals that caregivers describe "tensions between creative, individualized care and institutional policies" [26]. The Oyster Care Model addresses this by aiming to "reduce the use of restrictive or coercive measures" while maintaining safety [26].

Implementation Barriers and Equity Considerations

Significant disparities persist in ACP implementation across diagnostic groups and demographic populations. Evidence indicates patients with organ failure have significantly lower rates of ACP conversations (IRR 0.70) compared to those with cancer (IRR 1.75) [39]. The SHARING Choices trial demonstrated that while specialized equity training for facilitators improved engagement among Black patients and those with dementia, documentation rates remained lower for these subgroups [36]. This reflects persistent disparities in healthcare access and decision-making support.

Structural barriers include limited ACP conversation uptake (approximately 5% in intervention studies) despite systematic outreach efforts [36]. Additionally, ethical support structures, while often available, are "not well known or not perceived as easily accessible to frontline staff" [26]. Successful implementations have employed "ethics pubs" or peer support mechanisms for challenging situations [26].

Advance Care Planning for persons with SPMI requires specialized protocols that integrate supported decision-making, psychiatric-specific capacity assessment, and ethical frameworks that balance autonomy with protection. The Oyster Care Model provides a promising structure for applying palliative approaches to severe mental illness through its four-pillar framework. Future research should prioritize:

• Standardized outcome measures specific to ACP in SPMI populations
• Implementation strategies for improving equity in ACP access and documentation
• Educational protocols for clinicians navigating euthanasia requests in SPMI
• Longitudinal studies examining the concordance between documented preferences and actual care received

As evidence evolves, ACP protocols for SPMI must remain dynamic, respecting the dignity and self-determination of persons with severe mental illness while providing robust ethical and clinical safeguards.

Palliative psychiatry represents a paradigm shift in the care of individuals with Severe and Persistent Mental Illness (SPMI), moving from an exclusive focus on cure and symptom reduction toward the relief of suffering and improvement of quality of life [43] [44]. This approach is particularly relevant for a specific patient population: those with prolonged, intense, and evidence-based treatment efforts who remain experiencing severe psychological suffering, impaired psychosocial functioning, and reduced quality of life [45] [46]. For these individuals, traditional therapeutic interventions aimed at cure often prove ineffective, leading caregivers to either persist with futile therapeutic approaches or discontinue care altogether [47]. Within this challenging clinical landscape, the Oyster Care model has emerged as an innovative, structured application of palliative philosophy tailored specifically to SPMI patients [45] [48].

Developed initially in Flanders, Belgium, the model originated from caregivers' search for quality care solutions in a complex context marked by two significant factors: the implementation of psychosocial rehabilitation that paradoxically increased pressure on SPMI care, and the background of legal regulation of euthanasia for unbearable psychiatric suffering since 2002 [45] [20] [26]. The name "Oyster Care" derives from the Dutch "schelpzorg" or "crustatieve zorg" ("crustative care"), intentionally chosen to avoid negative connotations associated with "palliative care" while emphasizing the specificity and novelty of the approach [45]. The model uses the powerful metaphor of a shell: caregivers create an "exoskeleton" or "shell" in which SPMI patients can "come to life," functioning primarily through the external structure provided rather than relying on their diminished internal capacities [45] [48].

Table 1: Key Characteristics of Severe and Persistent Mental Illness (SPMI)

Characteristic Dimension	Description	Common Diagnoses
Diagnosis	One or more severe psychiatric disorders as defined in diagnostic systems	Schizophrenia, bipolar disorder, major depression, anorexia nervosa, severe personality disorders [45] [20]
Duration	Chronic course with prolonged or recurrent symptoms and treatment	Typically long-term illness lasting years or decades with persistent symptoms [20] [46]
Disability	Serious limitations in psychosocial functioning and daily activities	Impaired activities of daily living, reduced quality of life, need for long-term support [45] [9]

The fundamental premise of Oyster Care is that it provides a dynamic approach responsive to the needs, possibilities, and pace of each patient: within the safety of the "shell," individuals can either fold back or take new steps toward recovery and improved functioning [45]. As a holistic care approach, it complements potentially useful treatment options while focusing primarily on daily quality of life, representing a significant departure from traditional psychiatric rehabilitation models that may insufficiently address the needs of this specific population [45] [47].

The Conceptual Framework and Foundations of Oyster Care

Theoretical Underpinnings: Between Curative Efforts and Therapeutic Nihilism

The development of Oyster Care emerged from the tension between two problematic extremes in SPMI care: therapeutic stubbornness (persisting with ineffective curative treatments) and therapeutic nihilism (abandoning active care efforts) [45]. This clinical challenge mirrors the historical situation in 20th-century oncology, where a similar tension between aggressive treatment with detrimental side effects and therapeutic abandonment led to the development of palliative medicine [45]. For SPMI patients with therapy-resistant conditions, caregivers often risk either continuing the same unsuccessful treatments or resorting to underinvestment in therapeutic support [45].

Oyster Care positions itself as a palliative approach that is distinct from both end-of-life care and recovery-oriented models, while integrating compatible elements from each [45] [43]. It does not necessitate discontinuing all treatments but involves a transition where the focus gradually shifts more toward care instead of cure [45]. The model specifically addresses the reality that SPMI patients face a significantly reduced life expectancy—up to 10-20 years shorter than the general population—due to factors including higher suicide risk, side effects of long-term psychotropic medication, comorbid somatic conditions, and late detection of serious illnesses due to care-avoiding behavior [20] [9].

The Shell Metaphor: Creating a Protective Exoskeleton

The central metaphor of the oyster shell provides a powerful conceptual framework for understanding the model's operational logic [45]. The shell functions as an exoskeleton that protects and supports patients who lack sufficient internal structure to function autonomously [45] [48]. This external structure enables them to "come to life" despite their significant internal limitations [45]. The shell is not static but dynamically responsive, scaling care up or down according to the patient's rhythm and current capabilities [20] [26].

This approach prioritizes environmental adaptation rather than attempting to force the patient to adapt to environmental demands [20] [26]. For example, a care recipient's hoarding tendencies might be tolerated or sublimated rather than confronted, representing a significant departure from traditional behavioral approaches [20] [26]. The shell also aims to reduce the use of restrictive or coercive measures while maintaining safety, representing an ethical commitment to minimal restraint consistent with palliative philosophy [20] [26].

The Four Pillars of Oyster Care: A Holistic Framework

Oyster Care operates through four interconnected pillars that collectively address the multidimensional needs of SPMI patients. These pillars adapt the traditional framework of palliative care to the specific requirements of severe psychiatric illness, creating a comprehensive approach to wellbeing.

Physical Care: Addressing Somatic Health Needs

The physical care pillar focuses on responding adequately to the significant somatic impairments commonly experienced by SPMI patients [45] [47]. This population faces substantial physical health challenges, including higher rates of obesity, metabolic syndrome, cardiovascular disease, and other conditions exacerbated by psychotropic medications, poor lifestyle factors, and disparities in healthcare access [9] [47]. The physical care component emphasizes regular somatic assessments, management of medication side effects, and attention to basic physical comforts that contribute to overall quality of life [45] [47].

Within the Oyster Care framework, physical care extends beyond traditional medical interventions to include comfort-oriented measures and attention to bodily wellbeing as fundamental elements of psychiatric care [47]. This approach recognizes that physical discomfort and somatic complaints can exacerbate psychiatric symptoms, and that attending to the body represents an essential foundation for psychological wellbeing [45].

Psychological Care: Shifting from Cure to Comfort

The psychological care pillar involves a fundamental reorientation of therapeutic goals from symptom reduction and functional improvement to mental comfort and wellbeing [45] [20]. This represents a significant departure from conventional psychiatric approaches that prioritize the reduction of core psychiatric symptoms [43]. Instead, Oyster Care focuses on alleviating psychological suffering and enhancing emotional comfort, even in the presence of persistent symptoms [45].

This pillar emphasizes the therapeutic relationship as central to care, prioritizing connection and understanding over technique-driven interventions [45] [43]. It acknowledges that for some patients with long-standing, treatment-refractory conditions, the relentless pursuit of symptom reduction may itself become a source of suffering, and that acceptance of persistent symptoms coupled with attention to quality of life may represent a more ethical and effective approach [44].

Social Care: Providing Structure and Connection

Social care focuses on establishing a reliable structure of daily activities and social contacts that provides rhythm, meaning, and connection for patients who often experience profound social isolation and disrupted daily functioning [45] [20]. This pillar addresses the profound social disability that often accompanies SPMI, including strained family relationships, limited social networks, and difficulties with occupational and community engagement [9].

The social care component creates a supportive social ecology around the patient, including structured activities, facilitated social interactions, and attention to the patient's role within their community [45] [47]. This approach recognizes that social connection and meaningful activity constitute fundamental human needs that contribute significantly to quality of life, even for those with severe functional impairments [45].

Existential Care: Enhancing Meaning and Value

Existential care focuses on enhancing the patient's experience of life as valuable and meaningful despite persistent suffering and limitations [45] [20]. This pillar addresses spiritual and existential dimensions of suffering that are particularly salient for individuals facing severe, chronic mental illness [45] [46]. It involves supporting patients in their search for meaning, purpose, and value in life as they experience it, which may differ significantly from conventional notions of recovery or success [45].

This component requires caregivers to develop existential and spiritual competencies that enable them to help patients identify and undertake meaningful activities, as well as to cope with their own existential distress when facing the limitations of their therapeutic efforts [45] [46]. The existential pillar acknowledges that questions of meaning, purpose, and value are particularly pressing for individuals facing severe, persistent psychological suffering, and that addressing these dimensions constitutes an essential aspect of comprehensive care [45].

Table 2: The Four Pillars of Oyster Care with Specific Interventions and Outcomes

Pillar	Core Objective	Representative Interventions	Targeted Outcomes
Physical Care	Address somatic comorbidities and enhance bodily comfort	Regular somatic assessments; management of medication side effects; attention to nutrition, sleep, and physical comfort [45] [47]	Reduced physical suffering; improved management of comorbid conditions; enhanced bodily wellbeing [45]
Psychological Care	Shift focus from symptom reduction to mental comfort	Therapeutic relationship as central intervention; acceptance-based approaches; emotional support; comfort-focused strategies [45] [43]	Enhanced psychological comfort; reduced suffering; improved emotional regulation [45] [44]
Social Care	Provide structure for daily activities and social connection	Facilitated social interactions; structured daily activities; supported community engagement; relationship maintenance [45] [20]	Reduced isolation; enhanced social connectedness; improved daily functioning [45]
Existential Care	Enhance experience of life as meaningful and valuable	Exploration of meaning and purpose; values clarification; spiritual support; meaningful activities [45] [46]	Enhanced sense of meaning and purpose; reduced existential distress; clarified values [45]

Implementation and Methodological Framework

Operationalizing the Model: Structural and Process Elements

Successful implementation of Oyster Care requires specific structural elements and care processes. Research has identified 79 indicators of high-quality Oyster Care, grouped into 24 sub-themes and eight overarching themes that provide a framework for implementation [47]. These include:

• The care process - emphasizing personalized, flexible approaches
• The four pillars - operationalizing each pillar into specific practices
• End-of-life care - addressing terminal care needs when they arise
• Team vision, culture, and development - ensuring staff alignment with model philosophy
• The living environment - creating physical spaces conducive to the approach [47]

The implementation occurs through a dynamic process that responds to the fluctuating needs, capabilities, and rhythms of each patient [45] [20]. Within the safety of the therapeutic "shell," patients can either "fold back" during periods of increased vulnerability or "take new steps" when capable, with the level of support adjusted accordingly [45]. This dynamic adjustment represents a fundamental shift from standardized treatment protocols toward highly individualized care processes.

The Oyster Care Workflow: A Dynamic Process

The following diagram illustrates the operational workflow of the Oyster Care model, showing how the four pillars function within the protective shell structure:

Quality Monitoring and Fidelity Assessment

Implementation of Oyster Care requires systematic monitoring to ensure fidelity to the model and evaluate outcomes. A recently developed quality monitoring tool comprises 79 validated indicators across the eight thematic areas, demonstrating high scores for clarity (97%) and relevance (93%) in empirical testing [47]. This tool enables care teams to:

• Assess implementation fidelity to the Oyster Care model
• Identify areas for improvement in care delivery
• Evaluate the relationship between model fidelity and patient outcomes
• Guide resource allocation and staff development [47]

The monitoring tool represents a crucial advancement in operationalizing the somewhat abstract principles of Oyster Care into measurable practices, supporting the translation of theoretical framework into clinical reality [47].

Ethical Dimensions in the Context of SPMI End-of-Life Care

Ethical Challenges and Principles

The application of palliative approaches to SPMI care raises significant ethical considerations, particularly within the broader context of end-of-life care and medical assistance in dying (MAID) [9] [26]. The four principles of biomedical ethics manifest in specific ways within this population:

• Autonomy: Questions regarding decision-making capacity, authenticity of choices influenced by pathology, and communication difficulties create challenges in respecting patient self-determination [9]. The classic dilemma between respecting autonomy and paternalistic approaches resurfaces, particularly regarding treatment refusal or requests for MAID [9].

• Justice: Issues of equity in access to quality care, stigma associated with mental illness, and resource allocation at organizational and societal levels represent significant concerns [9] [26]. SPMI patients often face disparities in healthcare access, including palliative care services [9].

• Non-maleficence and Beneficence: The ongoing debate regarding the benefits and obstacles in applying palliative care approaches in psychiatry engages these principles, particularly regarding concepts of futility and the risk-benefit ratio of continued aggressive treatment [9] [43].

Oyster Care as Ethical Response

The Oyster Care model positions itself as an ethical response to unbearable psychological suffering, particularly in jurisdictions where euthanasia for psychiatric suffering is legally available [45] [20] [26]. By providing a comprehensive alternative focused on quality of life and meaning, it offers a full-fledged equivalent to palliative care in somatic medicine [20] [26]. However, the approach also raises ethical concerns, including the risk of paternalism or insufficient recovery-orientation [20] [26].

The model emphasizes personal virtues and attitudes in care professionals, such as compassion, non-abandonment, and upholding dignity, positioning caregivers as essential advocates for patients who often lack extensive social networks [9]. This virtue-based ethical framework complements principle-based approaches, emphasizing the character and moral commitments of caregivers as fundamental to quality care [9].

Research Implications and Future Directions

Evidence Base and Knowledge Gaps

While initial feedback on Oyster Care from both caregivers and care users has been positive, with caregivers reporting heightened sense of wellbeing and care users experiencing reduced symptom burden and enhanced quality of life, the evidence base remains limited [47]. Most publications to date have been conceptual analyses, case studies, or descriptions of model development, with limited controlled research on outcomes [45] [47]. Significant knowledge gaps include:

• Long-term outcomes of Oyster Care compared to traditional approaches
• Cost-effectiveness and resource utilization implications
• Optimal implementation strategies across different care settings
• Specific interventions most effective within each pillar [47] [43]

Priority Research Areas

Future research should prioritize several key areas to advance the field of palliative psychiatry and Oyster Care specifically:

• Intervention Development: Creating and testing specific interventions within each pillar of care, with particular attention to existential and spiritual approaches [43].

• Outcome Measurement: Developing and validating patient-centered outcome measures that capture dimensions of quality of life, meaning, and wellbeing relevant to SPMI populations [47] [43].

• Implementation Science: Studying strategies for effectively implementing Oyster Care across diverse settings, including staffing models, training requirements, and organizational supports [47].

• Ethical Analysis: Continued ethical analysis of palliative approaches in psychiatry, including their relationship with MAID, concepts of futility, and decision-making capacity assessment [9] [26].

Table 3: Essential Methodological Resources for Oyster Care Research

Research Tool Category	Specific Instrument/Approach	Application in Oyster Care Research
Quality Monitoring Tools	Oyster Care quality monitor (79 indicators across 8 themes) [47]	Assessing implementation fidelity; evaluating care quality; guiding quality improvement
Ethical Analysis Frameworks	Biomedical ethical principles (autonomy, justice, beneficence, non-maleficence) [9]	Analyzing ethical dilemmas; guiding clinical decision-making; policy development
Outcome Assessment Methods	Patient-reported outcome measures for quality of life and meaning [43]	Evaluating intervention effectiveness; capturing patient perspectives; assessing wellbeing
Implementation Science Methods	Mixed-methods approaches; stakeholder engagement [47]	Studying implementation processes; identifying barriers and facilitators; adapting models

The Oyster Care model represents a significant innovation in the care of individuals with Severe and Persistent Mental Illness, applying palliative principles within a structured framework focused on quality of life rather than cure. Its four-pillar approach—addressing physical, psychological, social, and existential dimensions of care—provides a comprehensive methodology for addressing the complex needs of this vulnerable population. While preliminary reports are promising, substantial research remains necessary to establish its efficacy, refine its implementation, and understand its broader implications for psychiatric care. As palliative psychiatry continues to develop as a field, Oyster Care offers a tangible clinical model that balances recovery-oriented approaches with realistic acknowledgment of persistent suffering, potentially filling a crucial gap in mental healthcare systems worldwide.

Severe and Persistent Mental Illness (SPMI) represents a small but critically vulnerable population within mental healthcare, characterized by chronic psychiatric disorders that result in significant functional disability and profound suffering [26]. Individuals with SPMI experience a life expectancy reduced by 10-20 years compared to the general population, creating an urgent need to develop sophisticated frameworks for assessing treatment futility within ethical end-of-life contexts [9]. The concept of "futility" in psychiatry remains particularly challenging, requiring careful operationalization to balance therapeutic optimism with realistic appraisal of clinical progress [49].

Treatment-resistant schizophrenia (TRS) represents a paradigmatic condition within SPMI where futility assessments become clinically and ethically relevant. Well over three decades after Kane's seminal clozapine study established the foundation for understanding TRS, approximately one-third of persons with schizophrenia still fail to respond to conventional treatments [50] [51]. This analysis develops operational criteria for identifying futility in SPMI, framed within the ethical imperative to provide dignified care when curative paradigms may no longer apply.

Operationalizing Treatment Resistance in SPMI

Defining Treatment-Resistant Schizophrenia (TRS)

The Treatment Response and Resistance in Psychosis (TRRIP) working group has established consensus criteria for TRS that provide a foundational framework for assessing treatment resistance across SPMI conditions. These criteria encompass four essential domains: symptom severity, functional impairment, treatment history, and adherence verification [50].

Table 1: TRRIP Consensus Criteria for Treatment-Resistant Schizophrenia

Domain	Minimum Requirements	Optimal Assessment
Symptom Duration & Severity	Active and persistent symptoms for ≥12 weeks with impaired functioning	Measurement with validated scales (PANSS, BPRS); distinct symptom domains elicited
Previous Treatment Failures	Documented failure of ≥2 antipsychotic trials	Multiple measures including pill counts, electronic monitoring, or plasma levels
Treatment Adequacy	≥6 weeks at doses equivalent to ≥600 mg chlorpromazine daily	6-week trial with long-acting injectable antipsychotic; two antipsychotics from different pharmacologic profiles
Adherence Verification	Clinical assessment	Documented ≥80% compliance with oral medications, LAI antipsychotic trial, antipsychotic blood levels, or combination

The seminal Kane study established that TRS requires failure to respond to at least three antipsychotic trials from two different classes over five years, with persistent poor functioning and cross-sectional symptom severity marked by BPRS scores ≥45 and specific item scores ≥4 on conceptual disorganization, suspiciousness, hallucinatory behavior, and unusual thought content [50]. Contemporary definitions have refined these criteria while maintaining their fundamental rigor.

Clozapine Resistance and Ultra-Treatment Resistance

A critical distinction in operationalizing futility emerges with the concept of ultra-treatment resistance, which the TRRIP group defines as persistent illness despite an adequate clozapine trial [50]. Clozapine remains the gold standard for TRS, with demonstrated superiority over first-generation antipsychotics (30% response rate versus 4% with chlorpromazine) [50]. Treatment resistance extends to clozapine non-response in approximately 30-40% of TRS cases, creating a population with ultra-treatment-resistant illness [51].

For clozapine resistance to be established, specific parameters must be met:

• Adequate dosage: Clozapine titrated to therapeutic levels (typically 300-900 mg/day)
• Therapeutic serum levels: Plasma concentrations ≥350 ng/mL
• Sufficient duration: Minimum trial of 6-12 weeks at therapeutic levels
• Adherence verification: Regular plasma level monitoring and administration oversight

Failure to respond despite meeting these parameters defines the ultra-treatment-resistant subgroup for whom futility considerations become clinically relevant [50] [51].

Quantitative Assessment Frameworks and Clinical Trial Data

Standardized Symptom Measurement Tools

Operational criteria for treatment resistance depend on validated, quantifiable assessment instruments. Clinical trials in schizophrenia predominantly utilize structured scales with demonstrated reliability and sensitivity to change.

Table 2: Standardized Assessment Tools for Treatment Resistance and Futility

Assessment Tool	Domains Measured	Score Range & Interpretation	Clinically Significant Change
PANSS (Positive and Negative Syndrome Scale)	Positive symptoms (7 items), Negative symptoms (7 items), General psychopathology (16 items)	30-210; higher scores indicate greater severity	20-30% reduction from baseline considered clinically meaningful [52]
BPRS (Brief Psychiatric Rating Scale)	Overall psychiatric symptoms (18-24 items)	0-126; higher scores indicate greater severity	20% reduction from baseline; score ≤35 indicates response [50]
NSA-16 (Negative Symptom Assessment)	5 domains: communication, emotion/affect, social involvement, motivation, retardation	16 items scored 1-6; higher scores indicate greater severity	Primary endpoint for negative symptom-specific trials [53]
CGI (Clinical Global Impression)	Global severity and improvement	1-7 scale; higher scores indicate greater severity	Score ≤3 indicates clinical response [50]

Recent analyses of 32 randomized clinical trials involving 14,219 participants support using modified versions of the PANSS to streamline assessment without sacrificing validity. The overall concordance rate between change from baseline in the modified PANSS score and change from baseline in the total PANSS score was 93.0% at week 4 and 97.7% at week 6 [52]. This suggests that focused assessment tools can maintain accuracy while improving efficiency in futility determinations.

Temporal Parameters for Treatment Trials

Determining treatment resistance requires strict adherence to evidence-based temporal frameworks. Clinical trial data demonstrate that statistically significant separation between active treatment and placebo emerges as early as 1 week after treatment initiation [52]. However, adequate trial duration remains essential for accurate futility assessment.

Table 3: Evidence-Based Temporal Parameters for Treatment Trials

Treatment Type	Minimum Trial Duration	Assessment Timepoints	Evidence Source
First-line Antipsychotics	6 weeks at therapeutic dose	Baseline, weeks 1, 2, 4, 6	TRRIP Consensus [50]
Clozapine Monotherapy	6-12 weeks at therapeutic plasma levels	Baseline, weeks 2, 4, 6, 8, 12	BAP Guidelines [50]
Augmentation Strategies	4-8 weeks after optimization of base therapy	Baseline, weeks 2, 4, 6, 8	Expert Opinion [51]

Concordance analyses reveal that trial outcomes at week 4 show 93.0% agreement with outcomes at week 6, suggesting that abbreviated trials may be sufficient for detecting non-response patterns [52]. For individuals with ultra-treatment resistance, the TRRIP group recommends confirming that clozapine serum levels reach ≥350 ng/mL before declaring treatment failure [50].

Ethical Frameworks for Assessing Futility in SPMI

Biomedical Ethical Principles in Futility Assessment

End-of-life care for persons with SPMI involves complex ethical considerations that directly inform futility assessments. The four principles of biomedical ethics provide a structured framework for navigating these challenges [9] [25].

Autonomy principles raise fundamental questions about decision-making capacity in persons with SPMI. Assessment must distinguish between authentic patient preferences and those influenced by psychiatric pathology, with particular attention to how long-term care dependency may impact choices [9]. Beneficence requires careful evaluation of whether continued aggressive treatment provides meaningful benefit relative to burden. Non-maleficence necessitates avoiding interventions that cause harm without compensatory benefit, including iatrogenic effects from persistent aggressive treatment. Justice considerations address fair resource allocation and equitable access to palliative approaches for persons with SPMI [9] [25].

The Palliative Care Approach and Psychiatric Futility

A growing consensus supports applying palliative care approaches to SPMI when treatment resistance persists despite optimized interventions [26]. The emerging concept of "palliative psychiatry" recognizes that for some individuals with ultra-treatment-resistant illness, a shift in therapeutic goals from cure to comfort may represent the most ethical approach [49].

The Oyster Care model provides a structured framework for implementing palliative approaches in SPMI. This model complements recovery-oriented care and uses the metaphor of a shell to represent a palliative approach focusing on quality of life, creativity, and holistic personhood [26]. The model's four pillars include:

• Physical care: Adequately responding to somatic comorbidities and medication side effects
• Psychological care: Shifting focus from symptom elimination to mental comfort and well-being
• Social care: Providing structure for daily activities and social connections
• Existential care: Enhancing the experience of life as valuable and meaningful

This approach aims to adapt the care environment to the individual rather than forcing the individual to conform to treatment demands, representing a fundamental shift from curative to comfort-focused paradigms [26].

Methodological Protocols for Futility Research

Experimental Design for Futility Studies

Research on futility in SPMI requires rigorous methodological approaches that account for the complexity of treatment resistance and the subjective nature of quality of life assessments. The following workflow outlines a comprehensive protocol for futility assessment in clinical research settings.

Key methodological considerations include:

• Stratification: Participants should be stratified by specific SPMI diagnosis, treatment history, and comorbidity profile
• Standardized measures: Primary outcomes should include both symptom reduction (PANSS, BPRS) and functional/quality of life measures
• Blinding: Double-blind assessment is essential given the subjective components of improvement evaluation
• Timeframes: Adequate trial duration with predefined assessment points aligned with evidence-based parameters

Conducting rigorous research on futility in SPMI requires specific assessment tools, biological measures, and methodological resources.

Table 4: Essential Research Resources for Futility Studies in SPMI

Resource Category	Specific Tools/Measures	Application in Futility Research
Symptom Assessment	PANSS-30, PANSS-19 modified version, BPRS, NSA-16	Quantifying treatment response using validated instruments with established psychometric properties [52] [53]
Functional Assessment	WHO Disability Assessment Schedule (WHODAS), Specific Level of Functioning Scale (SLOF)	Measuring real-world functional capacity and disability
Biological Assays	Clozapine serum level testing, pharmacogenetic panels	Verifying adherence, optimizing dosing, identifying pharmacokinetic failures [50] [51]
Quality of Life Measures	Quality of Life Scale (QLS), WHOQOL-BREF	Assessing subjective well-being and life satisfaction beyond symptom reduction
Capacity Assessment	MacArthur Competence Assessment Tool for Treatment (MacCAT-T)	Evaluating decision-making capacity for care transitions [9]
Ethical Analysis Frameworks	Four-principles approach, ethics consultation protocols	Structuring ethical deliberation around futility determinations [9] [25]

Recent research indicates that the modified 19-item PANSS shows 93.0% concordance with the full 30-item PANSS at week 4 and 97.7% concordance at week 6, supporting its use as a streamlined assessment tool in futility research [52]. Additionally, therapeutic drug monitoring represents an essential methodological component to distinguish true pharmacodynamic resistance from pharmacokinetic failures.

Developing operational criteria for treatment-resistant SPMI requires balancing rigorous assessment of treatment response with compassionate recognition of therapeutic limitations. The TRRIP criteria provide a validated foundation for identifying true treatment resistance, while emerging concepts like psychiatric futility and palliative psychiatry offer ethical frameworks for transitioning care goals when curative approaches have been exhausted.

Future research should focus on validating specific biomarkers of treatment resistance, refining quality of life assessment in severe mental illness, and developing standardized protocols for implementing palliative approaches in psychiatry. By integrating operationalized diagnostic criteria with patient-centered ethical frameworks, clinicians and researchers can advance care for this vulnerable population while maintaining scientific rigor and compassionate innovation.

Engaging care users and their families as stakeholders in health research is critical for developing interventions that are both meaningful and effective, particularly in ethically complex fields like end-of-life care for persons experiencing Severe and Persistent Mental Illness (SPMI) [26] [54]. This paradigm shifts the research process from a traditionally investigator-led model to a collaborative, co-creative partnership that actively values the lived experience of those the research intends to serve [54]. Such participatory approaches are an ethical imperative, helping to uphold the autonomy and dignity of vulnerable populations and ensuring that research outcomes are relevant and readily translatable into practice [55] [26]. This guide provides researchers and drug development professionals with methodologies, metrics, and ethical frameworks for implementing robust stakeholder-inclusive research.

Quantitative Measures of Stakeholder Engagement

Systematic evaluation is essential for moving beyond tokenistic involvement and demonstrating the tangible impact of engagement. A systematic review identified quantitative measures for assessing stakeholder engagement, though the field is characterized by a lack of standardized tools [56].

Table 1: Categories of Quantitative Engagement Measures

Measure Category	Description	Example Metrics	Relationship to Outcomes
Participant-Reported	Data collected directly from stakeholders on their level of involvement [56].	Self-reported surveys on engagement levels; perceived influence and satisfaction [56].	100% of studies assessing this relationship found a significant link to positive outcomes [56].
Observational Methods	Variables quantified by researchers observing engagement-related behaviors [56].	Attendance records at meetings or events; frequency of stakeholder contributions [56].	Limited reporting on the relationship between observational metrics and final research outcomes [56].
Utilization & Referrals	Metrics tracking the practical use of resources or the effectiveness of stakeholder-driven recruitment [56].	Use of interactive research tools; number of participant referrals from community members [56].	Use of tools and community messaging associated with increased abstinence rates in a health intervention [56].

A significant finding from the review is that while 47% of participant-reported measures were tested for a relationship to outcomes, none of the identified studies used the same standardized measure, and only 13% reported any psychometric data such as reliability coefficients [56]. This highlights a critical gap and opportunity for the development and validation of robust, standardized quantitative instruments.

Methodological Protocols for Engagement

Implementing stakeholder-inclusive research requires deliberate planning and the use of specific methodological protocols tailored to the context and population.

The Health Social Laboratory (HSL) Model

The EU-funded Hereditary project developed the Health Social Laboratory (HSL) as a participatory model for multimodal data integration in neurodegenerative diseases [55]. The implementation involves a structured, two-phase approach:

• Phase 1: Foundational Analysis. This initial stage combines a comprehensive literature review with an exploratory context analysis [55]. The context analysis is conducted via semi-structured interviews with key project partners (e.g., clinicians, researchers) to map the existing stakeholder network, clinical processes, technology infrastructure, and communication patterns [55]. Interviews are transcribed verbatim and subjected to thematic analysis to identify recurring patterns and insights [55].
• Phase 2: Prospective Laboratory Methodology. Findings from the foundational analysis are translated into a prospective methodology for the HSLs. These laboratories facilitate multi-stakeholder dialog through opportunities for discussion, comparison, and feedback, actively involving patients, citizens, and experts in co-designing the project's architecture [55].

Co-Design and Participatory Methods in Dementia Research

Research in dementia care provides powerful, transferable models for engaging vulnerable populations with cognitive and communicative challenges.

• Co-Creation of Research Instruments: Research advisory groups comprising people with Lewy body dementia and their supporters have been successfully involved in co-designing surveys. This collaboration leads to tangible improvements, such as clearer attribute descriptions and more user-friendly presentation formats, enhancing the tool's accessibility and relevance [54].
• Flexible Engagement Techniques: A hybrid method combining elements of focus groups and interviews within a single event has been used to capture valuable feedback from people with dementia while managing resource constraints [54]. This demonstrates a pragmatic and adaptive approach to participation.
• Evaluating the Engagement Process: Tools like the PEIRS-22 (Public and Patient Engagement Evaluation Tool) are used to track the quality of involvement [54]. Furthermore, exploring the psychosocial outcomes for stakeholders—such as enhanced self-perception, joy, and social engagement, alongside acknowledging potential sadness—is crucial for understanding the full impact of engagement [54].

Qualitative Exploration of Ethical Issues in SPMI Care

For SPMI end-of-life research, a deep understanding of the ethical landscape is a prerequisite for ethical engagement. A qualitative study in Flanders, Belgium, provides a methodological blueprint [26] [19].

• Participant Sampling: Conduct in-depth qualitative interviews with a wide range of stakeholders, including care users experiencing SPMI, family members, caregivers, care managers, and ethics experts. A representative study engaged 73 participants across these groups [26].
• Data Collection: Use a piloted, semi-structured interview guide to ensure consistency while allowing for flexibility to explore emergent themes. Interviews, averaging one hour, should be conducted in a location chosen by the participant to ensure comfort [26].
• Data Analysis: Employ content analysis to identify recurring ethical themes and reflect on existing ethical practices. This process helps illuminate issues such as euthanasia, autonomy, resource allocation, and delays in palliative care initiation from multiple perspectives [26].

Ethical Frameworks and Considerations

Engaging individuals with SPMI in end-of-life research demands navigating a complex web of ethical challenges. Key considerations include:

• Autonomy and Decision-Making Capacity: Tensions often arise between fostering creative, individualized care and adhering to institutional policies [26]. A core ethical challenge is maintaining patient autonomy while acknowledging potential fluctuations in decision-making capacity [26].
• Access to Ethical Support: While many facilities have ethics committees or guidelines, these are often not well-known or perceived as inaccessible by frontline staff [26]. Ethical dilemmas are frequently addressed at the team level using mechanisms like "ethics pubs" or peer support [26].
• Balancing Care Approaches: Ethical care requires a delicate balance between recovery-oriented care and a palliative care approach [26]. Models like the Oyster Care model, which focuses on quality of life, creativity, and adapting the environment to the care user, offer a framework but require vigilance to avoid paternalism [26].
• Informed Consent and Epistemic Injustice: Tailoring consent processes with lived-experience insight is critical, especially with emerging technologies like AI [54]. Researchers must actively work to avoid epistemic injustice—the discrediting of a person's knowledge based on their identity or condition—by fully recognizing people with severe illnesses as persons with human rights and valuable experiential knowledge [54].

The Scientist's Toolkit: Essential Reagents for Engagement

Table 2: Key Research Reagent Solutions for Stakeholder-Inclusive Research

Item/Tool	Function in Engagement Research
Semi-Structured Interview Guides	Ensures consistent data collection across participants while allowing flexibility to explore unique perspectives and emergent themes [55] [26].
Thematic Analysis Framework	A systematic method for analyzing qualitative data (interview transcripts) to identify, analyze, and report patterns (themes) within the data [55].
Co-Design Advisory Group	A panel of care users and family members convened to partner with researchers in designing studies, tools, and dissemination strategies [54].
Public and Patient Engagement Evaluation Tool (PEIRS-22)	A quantitative instrument used to measure the quality and impact of the engagement process itself from the stakeholder perspective [54].
Ethical Advisory Structure	Frameworks such as ethics committees, "ethics pubs," or designated reference persons to provide accessible support for navigating moral dilemmas [26].

Workflow and Signaling Pathways

The following diagram illustrates the integrated workflow for designing and implementing a stakeholder-inclusive research project, from foundational analysis to translation and impact.

Stakeholder-inclusive research is a rigorous and ethically sound methodology essential for addressing complex challenges in end-of-life care for persons experiencing SPMI. Success hinges on moving beyond consultation to meaningful co-creation, utilizing structured protocols like Health Social Laboratories and co-design advisory groups. Researchers must employ mixed-method evaluations—combining quantitative metrics and qualitative insights—to measure engagement quality and impact. Furthermore, a steadfast commitment to ethical principles is required to navigate issues of autonomy, capacity, and justice. By systematically integrating the lived expertise of care users and families, researchers can ensure their work is not only scientifically valid but also relevant, respectful, and transformative for the populations it aims to serve.

Ethics support structures have become essential components of modern healthcare systems, providing crucial frameworks for navigating complex moral challenges in clinical practice. This technical guide examines the implementation of two primary forms of ethics support: Moral Case Deliberation (MCD) and ethics consultation, with specific focus on their application in end-of-life care for persons experiencing Severe and Persistent Mental Illness (SPMI). These structured approaches enable healthcare professionals, researchers, and clinical teams to manage ethically difficult situations that frequently arise when providing care for vulnerable populations [9] [26].

The significance of robust ethics support is particularly pronounced in SPMI end-of-life contexts, where patients often present with complex care needs compounded by impaired decision-making capacity, communication challenges, and limited social networks [9] [26]. Research indicates that individuals with SPMI have a life expectancy 10-20 years shorter than the general population, making ethical end-of-life care a pressing concern [9]. Within these sensitive scenarios, ethics support structures serve to balance fundamental principles of autonomy, beneficence, and justice while addressing specific challenges such as assessment of decision-making capacity, requests for euthanasia, and the application of palliative approaches in psychiatric care [9] [26].

Theoretical Foundations and Definitions

Moral Case Deliberation (MCD)

Moral Case Deliberation constitutes a specific, facilitated approach to clinical ethics support characterized by its structured, bottom-up methodology. MCD is defined as "a facilitator-led collective moral inquiry by health care providers into a concrete moral question connected to a real case in their practice" [57]. Unlike expert-driven consultation models, MCD emphasizes collective reflection and shared moral reasoning among healthcare professionals using structured conversation methods such as the dilemma method or Socratic dialogue [58] [59].

The fundamental principles underlying MCD include:

• Collective Inquiry: Joint reflection on concrete moral questions by interdisciplinary teams
• Structured Dialogue: Use of specific conversation methods facilitated by trained moderators
• Process Orientation: Focus on reflective reasoning rather than definitive solutions
• Bottom-Up Approach: Prioritization of perspectives from direct care providers [58] [57] [59]

Ethics Consultation

Ethics consultation represents a more formalized, top-down approach to clinical ethics support, typically provided by ethics committees or individual ethics consultants [58] [26]. These services often operate with an expert model where ethicists or ethics committees provide recommendations or guidance on ethically complex cases [58]. In many countries, including Belgium, hospitals are legally required to have ethics committees that provide guidance on ethical aspects of hospital care, evaluate experiments involving human participants, and offer advice on individual cases where ethical questions arise [26].

Comparative Analysis

Table 1: Key Characteristics of MCD Versus Ethics Consultation

Feature	Moral Case Deliberation (MCD)	Ethics Consultation
Approach	Bottom-up, participatory	Top-down, expert-driven
Primary Focus	Reflection process and moral reasoning	Decision-making and case resolution
Facilitator Role	Process guide without advisory role	Content expert with advisory role
Outcome	Enhanced moral competence and team cohesion	Specific recommendations or decisions
Participant Dynamic	Collaborative exploration among equals	Consultant-client relationship
Typical Structure	Regular scheduled sessions	Case-by-case consultation

Implementation Frameworks

Prerequisites for Effective MCD Implementation

Successful implementation of Moral Case Deliberation requires careful attention to organizational, structural, and human factors. Evidence indicates that specific facilitators are critical for establishing effective MCD programs [58] [60] [59]:

• Organizational Commitment: Securing dedicated time, resources, and institutional support for regular MCD sessions is fundamental. Organizations must recognize MCD as a valuable investment in ethical quality rather than an optional extra [58] [60].

• Trained Facilitators: Effective facilitation requires specialized training in both conversation methods and moral reasoning. Facilitators must cultivate "a safe and respectful atmosphere" while acting as an "attentive authority" to guide reflection without imposing solutions [59].

• Participant Readiness: Healthcare professionals should be prepared for what participation in MCD entails, including openness to reflection, willingness to consider multiple perspectives, and commitment to collaborative inquiry [59].

• Appropriate Physical Space: Conducting MCD in a neutral, comfortable environment that promotes open dialogue and minimizes interruptions [59].

MCD Implementation Process

The implementation process for MCD involves several clearly defined stages, each requiring specific attention and resources:

• Preparation Phase:

  • Conduct organizational needs assessment
  • Identify potential facilitators for specialized training
  • Secure management commitment and resources
  • Develop implementation plan with clear objectives

• Facilitator Training:

  • Provide comprehensive training in MCD methods and facilitation skills
  • Include theoretical foundations, practical exercises, and supervised sessions
  • Establish criteria for facilitator competence and certification

• Pilot Implementation:

  • Begin with volunteer teams or units
  • Schedule regular sessions with case selection from participants
  • Establish evaluation mechanisms for continuous improvement

• Organization-Wide Rollout:

  • Scale successful pilot programs across departments
  • Develop internal trainer capacity for sustainability
  • Integrate MCD into regular clinical routines and quality systems [60] [59]

The implementation experience at a psychiatric hospital demonstrated that a 4-year MCD project resulted in sessions that were consistently evaluated as "(very) positive" and "useful" by healthcare professionals, who reported improved moral competencies including knowledge, attitude, and skills [60].

Workflow Visualization

MCD Process Flow - This workflow illustrates the sequential stages of Moral Case Deliberation from case identification through practice integration.

Outcomes and Evaluation

Domains of MCD Impact

Research has identified six primary domains in which MCD generates measurable outcomes for healthcare professionals and organizations [57]:

• Enhanced Emotional Support: Reduction of moral distress, feelings of relief, and increased confidence in handling ethical challenges
• Enhanced Collaboration: Improved understanding of colleagues' perspectives, better communication, and strengthened team relationships
• Improved Moral Reflexivity: Increased awareness of moral dimensions of care, better moral reasoning skills, and recognition of multiple perspectives
• Improved Moral Attitude: Development of moral virtues including courage, humility, and perseverance in ethical practice
• Organizational Improvements: Positive changes in procedures, protocols, and ethical climate within healthcare settings
• Concrete Results: Specific actions and decisions implemented following MCD sessions [58] [57]

Quantitative Assessment Instruments

The development of standardized evaluation instruments has advanced the empirical measurement of MCD outcomes. The European Moral Case Deliberation Outcomes Instrument (Euro-MCD) represents a rigorously validated tool for assessing MCD impact across different contexts and countries [57].

Table 2: Euro-MCD Outcome Domains and Measurement Items

Domain	Sample Measurement Items	Contextual Factors
Emotional Support	- Feelings of relief- Reduced moral distress- Increased confidence	Influenced by workplace culture, facilitator competence, and group dynamics
Collaboration	- Understanding colleagues' views- Improved communication- Team cohesion	Affected by interdisciplinary participation and organizational support structures
Moral Reflexivity	- Moral awareness- Reasoning skills- Perspective recognition	Varies with facilitator approach and conversation method used
Moral Attitude	- Moral courage- Professional humility- Ethical perseverance	Influenced by participant engagement and session frequency
Organizational Impact	- Procedure changes- Ethical climate- Policy development	Dependent on management engagement and implementation support
Concrete Actions	- Case-specific decisions- Practice modifications- Follow-up initiatives	Related to action planning and accountability mechanisms

The Euro-MCD instrument has demonstrated utility across diverse healthcare settings in multiple European countries, capturing both the perceived importance and experienced outcomes of MCD participation [57].

Application in SPMI End-of-Life Care

Ethical Challenges in SPMI End-of-Life Context

End-of-life care for persons with Severe and Persistent Mental Illness presents distinctive ethical challenges that necessitate specialized ethics support [9] [26]:

• Autonomy and Decision-Making Capacity: Assessing and respecting patient preferences while navigating fluctuations in decision-making capacity due to mental illness
• Paternalism vs. Respect for Choices: Balancing protective interventions with respect for patient self-determination, particularly regarding treatment refusals
• Euthanasia Requests: Addressing requests for medical assistance in dying within jurisdictions where this is legally permitted for psychiatric suffering
• Palliative Care Approach: Determining the appropriateness and timing of palliative approaches within psychiatric care contexts
• Resource Allocation: Ensuring equitable access to quality end-of-life care for a historically marginalized population [9] [26]

Structured Approach to Ethical Dilemmas

MCD provides a structured framework for addressing these complex challenges through methodical analysis and collective reasoning. The following protocol outlines a systematic approach:

Ethical Analysis Framework - This structured approach enables systematic analysis of complex ethical dilemmas in SPMI end-of-life care.

Core Ethical Principles and Applications

Table 3: Ethical Principles in SPMI End-of-Life Care

Principle	Application in SPMI End-of-Life Care	Common Tensions
Autonomy	- Support for advance care planning- Assessment of decision-making capacity- Respect for current and past preferences	Between respecting "pure" patient autonomy and providing optimal care; between authentic choice and psychopathology influence [9]
Beneficence	- Advocacy for appropriate pain management- Ensuring access to palliative care services- Promotion of quality of life	Between life-saving interventions and quality-of-life focus; between paternalistic protection and respect for risk-taking [9] [25]
Non-Maleficence	- Avoidance of unnecessary coercive measures- Prevention of abandonment- Mitigation of therapeutic futility	Between safety concerns and freedom restrictions; between risk prevention and dignity preservation [9] [25]
Justice	- Equitable access to end-of-life resources- Addressing stigma and discrimination- Fair allocation of specialized services	Between individual needs and resource constraints; between SPMI population and general population entitlements [9] [26]
Fidelity	- Truthful communication about prognosis- Consistency in care relationships- Honesty about limitations of treatment	Between hope and realism; between full disclosure and emotional protection [25]

Research and Evaluation Instruments

Implementation of effective ethics support requires specific tools for assessment and evaluation:

• Euro-MCD Instrument: A validated 26-item questionnaire measuring six domains of MCD outcomes, available in multiple languages for cross-cultural application [57]
• Maastricht Moral Deliberation Evaluation Questionnaire: A process evaluation tool specific to MCD implementation in healthcare settings [57]
• Content Analysis Frameworks: Qualitative instruments for analyzing conversation protocols and session recordings to assess depth of moral reflection [58]

Facilitator Competency Framework

High-quality MCD facilitation requires development of specific competencies across multiple domains:

• Methodological Competence: Proficiency in structured conversation methods and ability to select appropriate approaches for different contexts
• Moral Reasoning Competence: Understanding of ethical theories and principles and ability to guide moral reflection without imposing solutions
• Interpersonal Competence: Creation of psychological safety and management of group dynamics and conflict
• Contextual Competence: Navigation of organizational structures and adaptation to specific care settings [59]

Implementation of robust ethics support structures through Moral Case Deliberation and ethics consultation provides essential frameworks for addressing complex ethical challenges in healthcare, particularly in the sensitive domain of end-of-life care for persons with Severe and Persistent Mental Illness. Evidence indicates that well-implemented MCD programs generate significant positive outcomes across multiple domains, including enhanced emotional support, improved collaboration, strengthened moral competencies, and concrete practice improvements [58] [57].

The effectiveness of these ethics support structures depends on careful attention to implementation factors, including organizational commitment, facilitator competence, participant readiness, and appropriate methodological application. When properly implemented, these approaches facilitate nuanced navigation of the distinctive ethical challenges presented by SPMI end-of-life care, including tensions between autonomy and protection, debates regarding euthanasia requests, and equitable resource allocation [9] [26].

Future development of ethics support services would benefit from continued refinement of evaluation instruments, expansion of facilitator training programs, and further research into context-specific adaptations for specialized populations. Through systematic implementation of these ethics support structures, healthcare organizations can significantly enhance their capacity to provide ethically grounded, person-centered care for vulnerable populations at the end of life.

Navigating Complexities: Troubleshooting Common Challenges and Optimizing Care Delivery

Within end-of-life care for persons with severe and persistent mental illness (SPMI), the ethical tension between respecting patient autonomy and acting beneficently represents a critical challenge. This technical guide examines the management of treatment refusals through a systematic analysis of ethical principles, capacity assessment methodologies, and clinical protocols. By synthesizing current research and empirical data, we provide a structured framework for navigating these complex decisions while upholding both ethical obligations and clinical rigor. The integration of specialized tools and interventions aims to ensure that care for this vulnerable population remains both compassionate and scientifically grounded.

Patients with severe and persistent mental illness (SPMI) experience significantly reduced life expectancy—up to 10-20 years shorter than the general population—creating urgent imperatives for specialized end-of-life care approaches [14]. This mortality gap, combined with the complex interplay of psychiatric symptoms and somatic conditions, generates profound ethical tensions when patients refuse life-sustaining treatments. The core challenge lies in navigating the delicate balance between two fundamental bioethical principles: respect for patient autonomy (the right to self-determination) and beneficence (the obligation to act in the patient's best interest) [61] [62].

Clinical encounters with this population frequently present scenarios where patients refuse essential medical interventions despite potentially grave consequences. These refusals may stem from various factors including psychiatric symptomatology, medication side effects, misperceptions of treatment, or deeply held personal values [61] [14]. Research indicates that the ethical dilemmas arising in these contexts are predominantly addressed at the clinical team level, often without adequate access to structured ethical support systems [26]. This whitepaper examines the nuanced application of ethical frameworks to these challenging scenarios, providing evidence-based methodologies for maintaining this balance while ensuring dignified care.

Ethical Foundations and Theoretical Framework

The management of treatment refusals in SPMI end-of-life care rests upon four core bioethical principles, each requiring specific consideration within this unique clinical context.

The Principle of Autonomy in SPMI

Autonomy in patients with SPMI necessitates a nuanced approach that acknowledges potential fluctuations in decision-making capacity while resisting unfounded assumptions about capability based solely on psychiatric diagnosis. Studies demonstrate that simply carrying a diagnosis of schizophrenia or other serious mental illness does not automatically preclude patients from having capacity [63]. The ethical obligation involves distinguishing between authentic refusals consistent with longstanding values versus those driven primarily by psychiatric symptomatology [14]. This distinction requires careful assessment rather than presumption, with particular attention to maintaining patient dignity throughout the decision-making process.

The Principle of Beneficence and Non-Maleficence

Beneficence obliges clinicians to provide care that genuinely benefits the patient, while non-maleficence requires avoiding unnecessary harm. In cases of treatment refusal, these principles may appear to conflict with autonomy when clinicians perceive that refusal would lead to preventable suffering or premature death [61] [62]. The application of these principles requires careful consideration of treatment futility—recognizing that interventions with minimal benefit and significant burden may not constitute beneficent care, even when life-sustaining [62]. This is particularly relevant when considering that forced treatment can itself cause psychological harm and erode therapeutic trust.

The Concept of Futility in Life-Sustaining Treatments

A critical consideration in balancing these principles is determining when life-sustaining treatment becomes medically futile. From an ethical perspective, the default position should be "do not treat" unless two necessary conditions are met: (1) the treatment is medically indicated with a reasonable chance of benefitting the patient, and (2) informed consent has been obtained from the patient or appropriate surrogate [62]. When either condition is not met, clinicians are not morally obligated to provide treatment, and in some cases, doing so may constitute battery if it causes harm against the patient's will.

Table 1: Ethical Principles in Treatment Refusal Contexts

Ethical Principle	Application in SPMI Treatment Refusal	Potential Pitfalls
Autonomy	Respecting authentic choices based on patient values and preferences	Misattuning refusal solely to psychiatric symptoms without assessment
Beneficence	Providing treatments with favorable benefit-burden ratio	Overemphasizing biological life extension over quality of life
Non-maleficence	Avoiding coercive interventions that cause psychological harm	Underestimating the trauma of forced treatment
Justice	Ensuring equitable access to palliative care resources	Disparities in care quality based on psychiatric diagnosis

Assessing Decision-Making Capacity in SPMI

Systematic capacity assessment forms the cornerstone of ethical management when patients with SPMI refuse life-sustaining treatments. Clinicians must employ standardized approaches to evaluate decision-making abilities without relying on diagnostic assumptions.

Capacity Assessment Methodology

Capacity evaluation must address four distinct components through targeted clinical assessment, which can be guided by structured tools or careful interview techniques [63]:

• Understanding: Ability to comprehend the medical situation, proposed treatments, and potential outcomes
• Appreciation: Ability to apply this understanding to one's own circumstances
• Reasoning: Ability to compare options through rational consideration of consequences
• Expression of Choice: Ability to communicate a consistent decision

Validated assessment tools include the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) and the Assessment of Capacity for Everyday Decisions (ACED), which provide structured approaches to these evaluations [63]. These instruments help standardize assessments while providing documentation of the evaluation process.

Capacity Assessment Protocol

The following protocol provides a systematic approach to capacity evaluation in clinical settings:

• Contextual Assessment: Conduct the evaluation in a quiet, private setting when the patient is least affected by medication side effects or acute agitation.
• Structured Interview: Utilize open-ended questions targeting each capacity domain:
  • Understanding: "Can you tell me in your own words what you understand about your current medical condition?"
  • Appreciation: "What do you believe will happen if you refuse this treatment?"
  • Reasoning: "What factors have you considered in making this decision?"
  • Expression of Choice: "Can you tell me clearly what you decide about this treatment?"
• Psychiatric Symptom Evaluation: Specifically assess how current symptoms might influence decision-making, including paranoid ideation, depressive hopelessness, or disruptive thought processes.
• Documentation: Thoroughly document the assessment process, including specific questions, patient responses, and clinical observations.
• Time-Limited Reassessment: Establish a plan for reevaluation, particularly for patients with fluctuating capacity.

Table 2: Capacity Assessment Components with Clinical Indicators

Capacity Component	Clinical Assessment Approach	Indicators of Intact Capacity	Red Flags for Impaired Capacity
Understanding	Ask patient to explain condition, treatment, risks/benefits in own words	Able to accurately describe diagnosis, proposed treatment, and potential outcomes	Significant factual errors or inability to retain information despite repetition
Appreciation	Inquire how information applies to personal situation	Recognizes personal diagnosis and believes treatment recommendations apply to self	Denial of diagnosis or belief that treatment recommendations don't apply to them
Reasoning	Explore how patient compares alternatives and consequences	Able to describe logical connection between choice and anticipated outcomes	Illogical explanations or inability to consider consequences of choices
Expression of Choice	Observe consistency in communicated decision	Clear, consistent choice maintained over time	Frequent flipping between options without new information

Clinical Interventions and Management Protocols

Effective management of treatment refusals requires multifaceted approaches that address both immediate clinical concerns and longer-term care planning.

Psychiatric Advance Directives (PADs) and Peer Support

Psychiatric Advance Directives (PADs) represent a crucial intervention for preserving autonomy during periods of impaired capacity. These legal documents allow patients to specify treatment preferences and appoint surrogate decision-makers during psychiatric crises. Despite their utility, PAD completion rates remain low (4-13% across multiple U.S. sites), though 66-77% of patients express interest in completing them with assistance [64].

Peer-support facilitation models have demonstrated significant effectiveness in increasing PAD completion and quality. Studies show that peer-facilitated PADs are more likely to be prescriptive and result in decreased compulsory hospital admissions while improving self-perceived symptoms, empowerment, and recovery outcomes [64]. This approach effectively addresses barriers at multiple levels:

• System-level: Reduces time burden on clinical staff
• Provider-level: Mitigates concerns about bias in facilitation
• Patient-level: Builds trust through shared lived experience

Communication Approaches in End-of-Life Discussions

Language and framing significantly influence end-of-life decision-making. Research comparing "Do Not Resuscitate" (DNR) with "Allow Natural Death" (AND) terminology demonstrates that AND framing increases preference for comfort-focused care among both healthcare providers and surrogate decision-makers [65]. In quantitative studies, participants offered AND orders were more likely to endorse them (77.19%) compared to DNR orders (69.15%) [65].

Healthcare providers identify AND as promoting family-centered communication through several mechanisms: changing focus to comfort, increasing ease of approaching families, promoting discussion, being proactive, and supporting family healing [65]. This evidence supports the adoption of carefully considered terminology in end-of-life discussions with patients with SPMI and their families.

The Oyster Care Model for SPMI Populations

The Oyster Care Model provides a structured approach specifically designed for persons with SPMI, operating parallel to palliative care with four foundational pillars [26] [20]:

• Physical Care: Addressing somatic comorbidities and treatment side effects
• Psychological Care: Shifting focus toward mental comfort and well-being
• Social Care: Providing structure through daily activities and contacts
• Existential Care: Enhancing experience of life as valuable and meaningful

This model emphasizes environmental adaptation rather than attempting to change the patient, dynamically scaling care intensity according to the patient's rhythm while reducing restrictive or coercive measures [20].

Specialized Assessment Tools and Research Reagents

The ethical management of treatment refusals in SPMI populations benefits from specialized assessment tools and structured approaches that standardize evaluation and intervention.

Table 3: Essential Assessment Tools for Treatment Refusal Evaluation

Tool/Instrument	Primary Function	Application Context	Administration Time	Psychometric Properties
MacCAT-T	Assesses four capacity domains through structured interview	Evaluation of treatment decision capacity	15-20 minutes	Well-validated with strong reliability
ACED	Point-based system for decision-specific capacity assessment	Clinical settings requiring standardized assessment	10-15 minutes	Good inter-rater reliability
PAD Template	Structured psychiatric advance directive documentation	Advance care planning with SPMI patients	30-60 minutes (with facilitation)	Legally valid in authorizing states
AND/DNR Decision Aid	Visual and narrative aids comparing care options	End-of-life decision-making with patients/surrogates	15-30 minutes	Shown to reduce decisional conflict

Cultural and Systemic Considerations

The management of treatment refusals occurs within broader cultural and healthcare contexts that significantly influence implementation. Cross-cultural studies demonstrate substantial variation in end-of-life awareness and preferences across healthcare settings [66]. In Bangladesh, for example, research documented profound disparities in palliative care awareness between private hospitals (70%), public settings (31%), and community settings (7.1%) [66].

Cultural norms significantly influence decision-making processes, with some cultures favoring family-centered approaches over individual autonomy. These variations highlight the necessity of culturally adapted approaches that respect diverse values while maintaining ethical rigor [66]. Systemic barriers, including resource limitations and access to specialized palliative care, further complicate consistent application of optimal practices across settings.

The ethical management of treatment refusals in patients with severe and persistent mental illness requires nuanced application of bioethical principles within a structured clinical framework. By integrating systematic capacity assessment, evidence-based communication strategies, peer-supported advance care planning, and specialized care models like the Oyster Care approach, clinicians can navigate these complex scenarios while respecting both patient autonomy and beneficent care obligations. Future research should focus on refining assessment protocols, evaluating implementation strategies across diverse cultural contexts, and developing more sophisticated decision-support tools tailored to this vulnerable population. Through continued scientific rigor and ethical commitment, the field can advance toward more equitable, compassionate, and effective end-of-life care for persons with SPMI.

Medical Assistance in Dying (MAID) for individuals with mental disorders as the sole underlying medical condition (MAID-MD) represents one of the most complex and ethically challenging frontiers in end-of-life care. Within the context of persistent mental illness, the evaluation of MAID requests forces a critical examination of fundamental bioethical principles, including autonomy, beneficence, and justice. The legalization of MAID-MD in a growing number of jurisdictions, including Belgium, the Netherlands, Luxembourg, Spain, and potentially Canada, has created an urgent need for rigorous research frameworks and standardized clinical protocols [67]. This technical guide examines the current landscape of MAID in psychiatric contexts, focusing on empirical evidence, methodological approaches, and ethical considerations relevant to researchers and clinicians working at this intersection.

The fundamental ethical tension lies in balancing respect for patient autonomy with the obligation to protect vulnerable individuals from irreversible decisions made amid potentially treatable psychiatric symptoms. Emerging data suggests that psychiatric comorbidity is prevalent among MAID requesters, with one Canadian study documenting psychiatric conditions in 39% of patients requesting MAID, including 6.5% with severe mental illness [68]. This reality necessitates sophisticated assessment protocols that acknowledge psychiatric suffering while ensuring decisions are made with adequate decision-making capacity and absence of external pressure.

Clinical and Epidemiological Landscape

Prevalence and Demographic Trends

Understanding the epidemiological profile of MAID-MD requesters is essential for developing appropriate clinical resources and research protocols. Current data reveals distinct patterns in psychiatric versus somatic MAID requests, with significant implications for service delivery and assessment models.

Table 1: MAID-MD Epidemiological Profile Across Jurisdictions

Jurisdiction	Reported Cases	Notable Trends	Key Patient Characteristics
Netherlands (2002-2023)	900 MAID-PG cases (<1.5% of total MAID) [69]	Surge in young requesters (<30 years): 781 requests in 2022, 895 in 2023 [69]	Multiple persistent psychiatric disorders: major depression, personality disorders, autism spectrum disorder [69]
Belgium (2002-2023)	457 MAID-PG cases [69]	Increase in patients <30: from ~4/year (2015-16) to 20/year (2018-21) [69]	Similar diagnostic profile to Netherlands; chronic course with little improvement despite interventions [20]
Canada (Institutional study)	39% of MAID requesters had psychiatric comorbidity [68]	Severe mental illness present in 6.5% of total sample [68]	Depression most common (73% of those with psychiatric comorbidity) [68]

The increasing proportion of young MAID-MD requesters warrants particular research attention. Dutch data demonstrates a dramatic surge in requests from individuals under 30, while Belgian reports note the emergence of requests from minors (though ineligible under current law) [69]. This trend raises important questions about developmental considerations in capacity assessment and the potential influence of social contagion effects mediated through media coverage.

Clinical Characteristics and Comorbidity Patterns

MAID-MD requesters typically present with complex, treatment-resistant conditions characterized by extensive mental healthcare histories. Research indicates that the majority have undergone numerous treatment attempts without meaningful improvement in quality of life or reduction of suffering [70]. Specific clinical features include:

• Multimorbidity: Most requesters present with multiple co-occurring psychiatric conditions, commonly including major depressive disorders, personality disorders (particularly borderline personality disorder), and autism spectrum disorder [69].

• Treatment Resistance: Patients typically have long histories of unsuccessful interventions across multiple treatment modalities, including psychotherapy, pharmacotherapy, and in some cases, neuromodulation therapies [70].

• Somatic Comorbidity: Despite psychiatric conditions being the primary indication, many patients have co-occurring somatic conditions that may contribute to overall suffering [68].

Assessment Methodologies and Protocols

Standardized MAID-MD Assessment Framework

The evaluation of MAID-MD requests requires a multidimensional approach that addresses both general MAID criteria and considerations specific to psychiatric contexts. The following workflow illustrates the complex assessment pathway:

Due Care Criteria: Legal and Clinical Requirements

Jurisdictions permitting MAID-MD have established specific due care criteria that must be rigorously evaluated. These criteria form the foundation of assessment protocols:

Table 2: Standard Due Care Criteria for MAID-MD Assessment

Criterion	Operational Definition	Assessment Methods
Voluntary & Well-Considered Request	Request free from external pressure; consistent over time [71]	Longitudinal assessment; exploration of potential coercion sources; evaluation of request stability amid symptom fluctuation
Unbearable Suffering	Subjective experience of suffering without prospect of improvement [71]	Qualitative assessment of suffering dimensions; functional impact evaluation; quality of life measures
Decision-Making Capacity	Ability to understand, appreciate, and reason with relevant information [71]	Standardized capacity assessment tools; cognitive evaluation; psychiatric symptom assessment
Informed Consent	Understanding of diagnosis, prognosis, alternatives, and MAID procedure [71]	Structured disclosure with verification of comprehension; assessment of appreciation of consequences
No Reasonable Alternatives	Exhaustion of available acceptable treatments or persistent refusal [71]	Documentation of treatment history; evaluation of treatment refractoriness; exploration of palliative approaches
Consultation	Independent review by qualified professional(s) [71]	Review by psychiatrist not involved in treatment; second independent physician consultation

Specialized Methodological Approaches

Prospective Longitudinal Observational Design

Recent research initiatives have implemented sophisticated methodological approaches to address key questions in MAID-MD. The following protocol exemplifies current best practices in studying this population:

Study Protocol: "Suicidality and needs among people seeking medical assistance in dying based on psychological suffering" [70]

Objective: To characterize clinical/demographic characteristics, psychological processes, and help needs among psychiatric MAID applicants, tracking evolution of death wishes and suicidality.

Design: Prospective longitudinal observational study with repeated measures.

Population: Individuals aged ≥16 years requesting MAID at Dutch Expertise Centre (EE) based on psychological suffering.

Sample Size Calculation:

• Expected consent rate: 80% of applicants
• Initial questionnaire response: 50% of those approached
• Follow-up response: 50% of initial respondents
• Final expected sample: 160-200 for longitudinal analysis [70]

Data Collection Points:

• T1: Within one week after registration with EE
• T2: 180 days after T1 measurement

Measures:

• Validated scales (51 items total)
• Study-specific items (27 items, 14 conditional)
• Domains: psychiatric history, MAID request details, suicidality, death wish characteristics, unmet help needs [70]

Analytical Approach: Mixed methods combining quantitative analysis of scale scores with qualitative analysis of open-ended responses to capture nuanced experiences.

Qualitative Exploration of Stakeholder Perspectives

Comprehensive understanding of MAID-MD requires incorporation of diverse stakeholder viewpoints. One Flemish study exemplifies this approach:

Method: Qualitative study using semi-structured interviews [20]

Participants: 73 total participants (17 care users, 12 next-of-kin, 24 caregivers, 20 managers/experts)

Recruitment: Purposive sampling across seven mental healthcare organizations in Flanders

Analysis: Combination of deductive and inductive thematic content analysis using Qualicoder software [20]

Key Themes Identified:

• Advance care planning and end-of-life discussions
• Suicide risk and prevention strategies
• Palliative care provision in psychiatric settings
• Euthanasia considerations and decision-making
• Bereavement care needs

This methodological approach captures nuanced perspectives often missed in purely quantitative studies, particularly regarding relational and systemic factors influencing MAID-MD decisions.

Ethical Framework and Considerations

Moral Concerns in MAID-MD Implementation

A systematic review of moral concerns identified five primary contexts in which ethical challenges emerge, each with corresponding potential solutions:

Special Ethical Considerations in Psychiatric Contexts

Decision-Making Capacity and Vulnerability

The assessment of decision-making capacity in MAID-MD requires particular rigor due to the potential influence of psychiatric symptoms on reasoning and judgment. Key considerations include:

• Cognitive vs. Affective Influences: Evaluation must distinguish between stable, reasoned decisions and those driven by transient emotional states or psychiatric symptoms [71].

• Appreciation of Consequences: Assessment must verify genuine understanding of the irreversibility of MAID and alternatives [71].

• External Pressure: Particular vigilance required regarding real or perceived coercion, including family burden or resource limitations [71].

• Disorder-Specific Considerations: Different psychiatric conditions may impact decision-making in distinct ways, requiring tailored assessment approaches [71].

Organ Donation After MAID-MD

A particularly complex ethical intersection emerges regarding organ donation following MAID on psychiatric grounds. Dutch data indicates that patients with psychiatric conditions donate organs at a substantially higher rate than other MAID requesters (28.9% of all MAID organ donation cases) [71]. Ethical analysis must consider:

• Motivation Assessment: Rigorous evaluation of whether donation decision arises from altruism or perceived self-worth issues related to psychiatric condition.

• Timing of Discussion: Strict separation between MAID approval and organ donation discussion to prevent perceived linkage [71].

• Capacity Specificity: Separate assessment of capacity for organ donation decision distinct from MAID decision [71].

Research Gaps and Methodological Challenges

Critical Knowledge Gaps

Current research reveals significant limitations in understanding MAID-MD, presenting opportunities for scholarly investigation:

• Trajectory Studies: Limited longitudinal data on evolution of decision-making and suffering in MAID-MD requesters, particularly those whose requests are denied or withdrawn [70].

• Capacity Assessment Tools: Absence of validated, disorder-specific capacity assessment instruments for MAID-MD contexts [71].

• Treatment Refractoriness Criteria: Lack of operationalized, standardized criteria for determining when psychiatric conditions are truly irremediable [67].

• Demographic Disparities: Insufficient understanding of factors driving increased MAID-MD requests among young adults [69].

• Suicide Prevention Integration: Need for development of targeted suicide prevention strategies for MAID-MD applicants, particularly given documented suicide risk while awaiting assessment [70].

Table 3: Research Reagent Solutions for MAID-MD Investigation

Research Tool Category	Specific Instruments/Approaches	Application in MAID-MD Context
Qualitative Methodologies	Semi-structured interviews; Thematic content analysis [20]	Exploration of stakeholder perspectives; understanding subjective experiences of suffering
Longitudinal Designs	Prospective cohort studies with repeated measures [70]	Tracking evolution of decision-making, suffering experience, and help needs over time
Capacity Assessment Tools	MacCAT-T; SICIATRI; disorder-specific evaluations [71]	Standardized evaluation of decision-making capacity components: understanding, appreciation, reasoning
Suffering and Quality of Life Measures	Quantitative scales combined with qualitative assessment	Multidimensional evaluation of suffering experience; treatment outcome measurement
Mixed-Methods Approaches	Integrated quantitative-qualitative analysis [20]	Comprehensive understanding of complex phenomenological experiences
Stakeholder Engagement Frameworks	Deliberative dialogues; participatory research models [67]	Inclusion of diverse perspectives: patients, families, clinicians, ethicists

MAID in psychiatric contexts represents a clinically and ethically complex domain requiring sophisticated research approaches and carefully implemented clinical protocols. The growing international experience with MAID-MD highlights both the profound importance of respecting patient autonomy in irremediable psychiatric suffering and the critical obligation to protect vulnerable individuals through rigorous assessment and comprehensive care alternatives.

Future research must prioritize longitudinal studies of decision trajectories, development of validated assessment tools, and examination of demographic trends, particularly the concerning increase in young MAID-MD requesters. Simultaneously, clinical protocols must integrate robust capacity assessment, evaluation of irremediability, and connection to appropriate psychiatric care throughout the MAID-MD process.

The ethical imperative for researchers and clinicians lies in balancing compassionate response to profound suffering with rigorous protection of vulnerable individuals, all while acknowledging the considerable limitations in current evidence regarding long-term outcomes for treatment-refractory psychiatric conditions. As jurisdictions continue to grapple with MAID-MD implementation, ongoing research using methodologically sophisticated approaches will be essential to inform evidence-based policy and clinical practice.

Persons with Severe and Persistent Mental Illness (SPMI) represent a vulnerable population within healthcare systems, characterized by significant functional impairment, chronic courses of serious mental disorders, and a life expectancy 10-20 years shorter than the general population [9] [17] [14]. The lower life expectancy, combined with complex care needs and heightened vulnerability, creates substantial ethical challenges in providing appropriate end-of-life care [9]. This technical guide examines the communication barriers that impede effective discussions about death and dying with SPMI patients, framed within the ethical dilemmas prominent in current research. Despite documented benefits of advance care planning (ACP) and palliative care, uptake remains low among SPMI populations due to multifaceted communication challenges that operate at consumer, provider, and system levels [72] [17]. Understanding these barriers and implementing evidence-based strategies is essential for researchers and clinicians aiming to improve equitable end-of-life care for this marginalized population.

Understanding Communication Barriers in SPMI Populations

Multilevel Barrier Framework

Research identifies communication barriers occurring across three distinct levels, each requiring tailored intervention approaches. The table below synthesizes these barriers from recent empirical studies.

Table 1: Multilevel Communication Barriers in End-of-Life Discussions with SPMI Patients

Level	Barrier Category	Specific Manifestations
Consumer-Level	Psychological Resistance	Patient hesitation, fear of death, denial of prognosis, association of ACP with imminent death [72]
	Knowledge & Understanding Deficits	Lack of awareness about ACP documents, misunderstanding of care options, belief that family members already know their wishes [72]
	Clinical & Social Factors	Cognitive decline, lack of social support for decision-making, cultural and language barriers [72] [9]
Provider-Level	Discomfort & Skill Deficits	Provider fear of patient/family reactions, discomfort with serious illness discussions, lack of training in palliative approaches [72] [20]
	Therapeutic Orientation & Attitudes	Physician resistance, "sugar-coating" prognoses, curative-focused mindset, perceived futility of discussions [72] [24]
	Assessment Challenges	Difficulty determining decision-making capacity, distinguishing psychiatric symptoms from authentic preferences [9] [14]
System-Level	Policy & Resource Limitations	Lack of integrated care policies, insufficient staff training, limited palliative care access, regional policy variations [72] [17]
	Care Fragmentation	Poor coordination between mental and physical healthcare services, difficult follow-up, inadequate communication protocols [20] [17]
	Temporal Factors	Discussions occurring too late in illness trajectory, crisis-driven rather than planned conversations [72]

Ethical Dimensions of Communication Barriers

Within the context of SPMI end-of-life research, these communication barriers create significant ethical dilemmas that can be analyzed through the four principles of biomedical ethics.

Autonomy and Decision-Making Capacity The principle of autonomy is particularly challenging in SPMI end-of-life care. Tensions arise between respecting patient self-determination and determining whether choices are authentic or influenced by psychiatric pathology [9] [14]. Assessing decision-making capacity becomes complicated by communication difficulties, with care professionals sometimes defaulting to paternalistic approaches that undermine autonomy [9]. The drafting and implementation of advance care planning documents is similarly fraught with questions about authenticity and timing [9] [14].

Beneficence, Non-Maleficence, and Futility Care providers experience ethical conflicts between respecting patient autonomy and acting beneficently to provide optimal care [9] [14]. This is particularly evident in debates about applying palliative care approaches in psychiatry and determining when further curative treatments may be futile [24] [14]. Psychiatrists trained in suicide prevention may experience moral distress when faced with end-of-life decisions that challenge this life-sustaining orientation [9].

Justice and Equity SPMI populations face substantial disparities in access to quality palliative care due to stigma, diagnostic overshadowing, and fragmented care systems [17] [14]. Research indicates that people with SPMI are at risk of suboptimal end-of-life care, partly due to stigma among healthcare professionals and lack of integrated care policies [17].

Methodological Approaches for SPMI End-of-Life Research

Experimental Protocols and Assessment Tools

Conducting rigorous research on communication in SPMI end-of-life care requires specialized methodologies that account for population vulnerability and topic sensitivity.

Qualitative Interview Protocols Research with SPMI populations necessitates adapted qualitative approaches. Successful protocols include:

• Semi-structured interviews with simplified language and limited questions to reduce participant burden [73]
• Single-point interviews conducted by researchers with both qualitative expertise and experience working with SPMI populations [73]
• Flexible location selection allowing interviews in familiar environments like wards or residences where participants have lived for extended periods [20]
• Topic guides covering care approaches, end-of-life needs, ethical considerations, and existential questions, pilot-tested for appropriateness [20]

Capacity Assessment Methodologies Determining decision-making capacity for research participation and healthcare decisions requires rigorous protocols:

• Multi-stage consent processes with additional time to explain documents and assess understanding [73]
• Verbal agreement recording as an alternative to formal signed consent for participants hesitant about legal documents [73]
• Involvement of legal representatives with adequate advance notice when capacity concerns exist [73]
• Ongoing capacity assessment throughout research participation rather than single-point evaluation [73]

Table 2: Standardized Assessment Tools in SPMI End-of-Life Research

Assessment Domain	Instrument	Application in SPMI Populations
Decision-Making Capacity	MacCAT-CR, MacCAT-T	Adapted with simplified language, repeated assessments, focus on appreciation rather than just understanding [73]
Communication Quality	QUAL-EC, ACEND	Modified to account for communication fluctuations, proxy reporting when needed [20]
Palliative Care Needs	POS, IPOS	Integrated with mental health symptom assessment, longer assessment windows [24]
Ethical Distress	MDS, EIS	Adapted for interdisciplinary teams, including moral distress around futility decisions [74]

Research Reagent Solutions: Methodological Tools

Table 3: Essential Methodological Tools for SPMI End-of-Life Communication Research

Research Tool	Function	Application Considerations
Adapted Consent Materials	Ensure ethical participation while maintaining validity	Simplified language, visual aids, verbal consent options, extended process [73]
Case Vignettes	Standardize responses to clinical scenarios	Development based on published material, advisory group review, diagnostic variety [24]
Stakeholder Topic Guides	Facilitate semi-structured interviews	Separate guides for care users, relatives, caregivers, experts; pilot testing [20]
Cross-Sectoral Education Frameworks	Train researchers in SPMI-specific methods	Combine mental health communication skills with palliative care approaches [20] [14]

Evidence-Based Communication Strategies and Models

Structured Communication Frameworks

Research supports specific communication approaches that can overcome barriers in SPMI end-of-life discussions.

The Talking About Dying (TAD) Model This evidence-based communication model provides structure for conversations about approaching death, emphasizing:

• Three-phase structure following clinical recognition of dying [75]
• Dual attention to both content and relational dimensions of communication [75]
• Provider self-awareness and self-care as central components [75]
• Practical communication aids for navigating challenging conversations [75]

The Oyster Care Model A specific approach for SPMI populations using the metaphor of a shell to represent a palliative approach focusing on:

• Four pillars: physical, psychological, social, and existential care [20]
• Environmental adaptation rather than requiring patient adaptation [20]
• Dynamic care intensity scaled according to patient rhythm rather than fixed protocols [20]
• Tolerance for symptomatic behaviors such as hoarding, within safety limits [20]

The following diagram illustrates the workflow for implementing these communication strategies in clinical practice and research contexts.

Implementation Framework

Successful implementation of communication strategies requires attention to both content and process elements across multiple system levels.

Content Modifications for SPMI Populations

• Simplified vocabulary avoiding complex medical terminology [73]
• Concrete examples rather than abstract concepts [20]
• Visual aids to support verbal explanations [73]
• Repetition and summarization to enhance understanding [20]

Process Adaptations

• Extended timeframes for discussions, allowing multiple sessions [73] [20]
• Support person involvement with patient consent [20]
• Familiar environments rather than clinical settings when possible [20]
• Integration with ongoing care rather than isolated conversations [20]

Addressing communication barriers in end-of-life care for SPMI patients requires multifaceted approaches that target consumer, provider, and system levels simultaneously. The ethical complexity of these communications demands careful attention to autonomy, beneficence, and justice principles within research and clinical practice. Evidence supports structured communication models like TAD and Oyster Care, implemented through adapted protocols that account for the unique needs of SPMI populations.

Significant research gaps remain, particularly regarding palliative sedation in SPMI, longitudinal outcomes of communication interventions, and effective knowledge translation strategies. Future research should prioritize inclusive methodologies that amplify the voices of SPMI patients themselves, develop validated assessment tools specific to this population, and test implementation strategies for scaling effective communication approaches across diverse care settings. As evidence grows, researchers and clinicians have an ethical imperative to ensure that communication about death and dying is accessible, respectful, and effective for all patients, regardless of mental health status.

Caring for persons with Severe and Persistent Mental Illness (SPMI) at the end of life presents a critical nexus of ethical challenges, particularly concerning resource allocation within constrained healthcare systems. Individuals with SPMI—diagnosed with conditions such as schizophrenia, bipolar disorder, or severe depression that follow a chronic course and cause significant disability—experience a life expectancy 10-20 years shorter than the general population [14]. This mortality gap, combined with their complex clinical needs, creates profound ethical tensions for healthcare systems striving to balance equitable resource distribution with individualized care. This paper examines the ethical dimensions of resource triage in SPMI end-of-life care, analyzing how systemic constraints impact care quality and decision-making processes for this vulnerable population.

The concept of SPMI is often described using the "3 D's"—disease, duration, and disability [26]. These individuals experience severe suffering and challenges in daily functioning, with approximately 1% of the global population living with SPMI [26]. Their reduced life expectancy stems from multiple factors: high rates of suicide, co-occurring somatic conditions, side effects of long-term psychotropic medication, and late detection of serious illnesses like cancer due to care-avoiding behavior and communication difficulties [14]. This complex clinical picture necessitates sophisticated care approaches that often compete for limited healthcare resources.

Ethical Frameworks and Triage Principles in SPMI Care

Core Ethical Principles in SPMI Resource Allocation

Resource allocation decisions for SPMI end-of-life care occur within a framework of competing ethical principles that must be carefully balanced:

• Autonomy versus Beneficence: Tensions arise between respecting patient choices and providing optimal care, particularly when patients refuse life-extending treatments or when decision-making capacity is fluctuating due to mental illness [14]. This is especially complex in SPMI care where assessments of "authentic choice" must account for how pathology may influence decision-making [14].

• Justice and Equity: Persons with SPMI face significant disparities in accessing quality palliative care [14]. Studies from Australia, New Zealand, and Canada indicate that patients with serious mental illness are 2 to 4 times less likely to access palliative care services in their final months of life compared to the general population [76]. Stigma and diagnostic overshadowing (where physical symptoms are misattributed to mental illness) further exacerbate these inequities.

• Non-abandonment and Dignity Upholding: Care professionals serving SPMI populations emphasize virtues of compassion and non-abandonment, becoming main advocates for patients who often lack extensive social networks [14]. This commitment must be balanced against systemic constraints that limit resource availability.

Triage Decision-Making in Practice Settings

Table 1: Resource Allocation Challenges Across Care Settings

Care Setting	Key Resource Constraints	Ethical Triage Challenges
Emergency Medicine	Time, rapid decision-making protocols, limited patient history	Decisions characterized by rapid, protocol-driven processes constrained by time and workload; limited incorporation of patient values and preferences [77]
Family Medicine	Longitudinal relationship knowledge, clinical judgment time	Relies on patient relationships and clinical judgment but lacks formalized guidelines for treatment limitation decisions; family physicians rarely included in emergency care decisions despite potential to align care with patient preferences [77]
Psychiatric Care Facilities	Specialized palliative care knowledge, ethics support access	While many facilities have ethical guidelines or advisory structures, these are often not well known or perceived as inaccessible to frontline staff; ethical dilemmas predominantly addressed at team level [26]
Palliative Care Services	Capacity for complex SPMI cases, staff training resources	Patients with psychiatric disorders are less likely to receive palliative or hospice care and more likely to die alone or in nursing homes [76]

Methodologies for Studying Resource Allocation Ethics

Qualitative Investigation of Stakeholder Perspectives

Understanding resource allocation ethics requires robust methodological approaches that capture diverse stakeholder experiences. The following experimental protocol outlines a comprehensive qualitative research design:

Protocol Title: Multi-stakeholder Qualitative Investigation of Resource Allocation Ethics in SPMI End-of-Life Care

Objective: To explore experiences, needs, and expectations of care users, relatives, caregivers, managers, and ethics experts regarding resource allocation and ethical triage in SPMI end-of-life care.

Participant Recruitment:

• Purposive sampling from multiple mental healthcare organizations representing varied care settings (residential care, assisted living, ambulatory services)
• Target sample: 70-80 participants including care users with SPMI (n=17), family members (n=12), frontline caregivers (n=24), care managers and ethics experts (n=20) [26]
• Ensure representative socio-demographic distribution across all target groups

Data Collection:

• Conduct in-depth, semi-structured interviews using a pre-constructed topic guide
• Interviews range from 30 minutes to over two hours, averaging approximately one hour
• Conduct in preferred locations chosen by participants, typically their care facility or residence
• Pilot-test interview guides and refine based on initial feedback [20]

Data Analysis:

• Audio-record, transcribe verbatim, and pseudonymize interviews
• Employ combination of deductive and inductive thematic content analysis using qualitative data analysis software
• Have multiple researchers independently analyze and code transcripts
• Discuss differences in interpretation and resolve disagreements through consensus with senior researcher input
• Continue data collection until thematic saturation is reached while ensuring diversity in age, gender, and professional background [20]

Ethical Considerations:

• Obtain approval from institutional ethics committee
• Secure informed consent from all participants
• Demonstrate flexibility in scheduling and allocate extra time to review information documents with care users
• Allow care users to have a trustee present during interviews if preferred [20]

Systematic Evidence Synthesis Protocols

For comprehensive understanding of resource allocation ethics, systematic reviews of existing literature provide crucial evidence synthesis:

Systematic Review Protocol: Ethical Aspects of Treatment Limitation Decisions in Primary Care

Search Strategy:

• Search electronic databases (PubMed, Embase) using tailored search strings
• Include studies published between 2004-2024 focusing on ethical aspects of limiting treatment in end-of-life care in family and emergency medicine
• Apply PICOS framework for study selection

Study Selection:

• Include primary empirical research articles reporting on decisional tools, influencing factors, decision-making processes, and ethical considerations
• Focus on physicians' views of decision-making processes
• Exclude studies conducted in secondary or tertiary hospitals, long-term care facilities, and those focused exclusively on DNR orders [77]

Quality Assessment and Data Synthesis:

• Use adapted Critical Appraisal Skills Programme (CASP) checklists for quality assessment
• Perform narrative synthesis of included studies
• Compare findings between family medicine and emergency medicine settings [77]

Visualization of Ethical Decision-Making in Resource Allocation

The diagram below illustrates the complex ethical decision-making workflow for resource allocation in SPMI end-of-life care, highlighting key tension points and stakeholder interactions:

Diagram 1: Ethical Decision-Making Workflow for SPMI Care Resource Allocation. This flowchart illustrates the complex balance between ethical principles and systemic constraints in SPMI end-of-life care.

Research Reagents and Tools for SPMI Ethics Investigation

Table 2: Essential Research Tools for Investigating Resource Allocation Ethics

Research Tool/Reagent	Function/Purpose	Application in SPMI Research
Semi-Structured Interview Guides	Elicit rich qualitative data on experiences and perspectives	Explore lived experiences of care users, families, and clinicians regarding resource allocation dilemmas [26]
Thematic Content Analysis Software	Systematically code and analyze qualitative data	Identify emergent themes and patterns across multiple stakeholder groups [20]
Critical Appraisal Skills Programme (CASP) Checklists	Assess methodological quality of included studies	Evaluate rigor of empirical studies in systematic reviews of treatment limitation ethics [77]
PRISMA-ScR Guidelines	Ensure comprehensive reporting of scoping reviews	Map ethical aspects of end-of-life care for persons with SPMI [14]
Ethical Advisory Committee Structures	Provide formal ethics consultation and support	Address complex moral dilemmas in clinical care; though often underutilized in SPMI care settings [26]

Discussion: Navigating Systemic Constraints Through Ethical Innovation

Promising Models for Ethical Resource Allocation

Several innovative care models demonstrate potential for optimizing resources while maintaining ethical integrity in SPMI end-of-life care:

• The Oyster Care Model: This approach complements recovery-oriented care using a palliative framework focused on quality of life, creativity, and holistic personhood. The model operates on four pillars: physical care responding to somatic impairments; psychological care focusing on mental comfort; social care providing daily structure; and existential care enhancing life meaning [26]. The model's mission adapts the environment to the care user rather than vice versa, potentially reducing costly coercive measures and hospitalizations while respecting patient autonomy.

• Cross-Sectoral Education and Collaboration: Enhancing collaboration between family and emergency physicians could improve primary end-of-life care while optimizing resource use [77]. Family physicians possess crucial knowledge about patient preferences often absent in emergency decisions about treatment limitations.

• Structured Ethics Support Mechanisms: While many facilities have ethics committees, these are often underutilized. Frontline staff benefit from more accessible supports like "ethics reference persons" in units, "ethics pubs," or peer support mechanisms for challenging situations [26]. These approaches bring ethical deliberation directly to care teams rather than requiring formal committee processes.

Future Research Directions

Significant knowledge gaps persist in understanding and optimizing resource allocation for SPMI end-of-life care. Priority research areas include:

• Economic evaluations of innovative care models like the Oyster Care approach to quantify potential resource savings alongside quality metrics
• Implementation studies examining optimal strategies for integrating palliative care principles into standard SPMI treatment
• Intervention research developing and testing staff training programs for ethical decision-making in resource-constrained environments
• Methodological innovation creating participatory action research models that include persons with SPMI in developing allocation frameworks

Resource allocation and systemic constraints present profound ethical challenges in end-of-life care for persons with SPMI. These challenges demand attention to autonomy, collaboration, and distributive justice within healthcare systems. Current evidence indicates that persons with SPMI frequently experience inequitable access to quality end-of-life care, often resulting in "death with indignity" rather than dignified endings [76]. Ethical triage in this context requires balancing multiple competing principles while developing creative solutions to systemic constraints.

Moving forward, healthcare systems must prioritize greater accessibility to ethical support systems and tailored approaches that balance recovery-oriented care with palliative approaches. This includes developing clearer guidelines for treatment limitation decisions in primary care settings [77], enhancing collaboration between care sectors, and implementing comprehensive training for caregivers in ethical decision-making under constraints. By addressing these challenges proactively, healthcare systems can move closer to ensuring dignity and respect for this vulnerable population at the end of life, even within necessarily constrained resources.

Managing Disruptive Behavior and Countertransference in End-of-Life Settings

Caring for persons with Severe and Persistent Mental Illness (SPMI) at the end of life presents a complex clinical landscape marked by unique ethical challenges and interpersonal dynamics. Individuals with SPMI—characterized by chronic, serious psychiatric disorders resulting in significant functional impairment—experience mortality rates 10-20 years higher than the general population and often face considerable barriers to receiving quality end-of-life care [9]. This clinical context creates a fertile ground for disruptive behaviors and clinician countertransference reactions that can significantly impact care quality and ethical decision-making.

Within this specialized care context, transference and countertransference dynamics frequently emerge. Transference represents the unconscious redirection of a patient's feelings, attitudes, and desires from significant past relationships onto clinicians [78] [79]. Countertransference constitutes the clinician's unconscious emotional response to the patient, often shaped by both the current clinical relationship and the clinician's personal history [80]. These phenomena are not inherently pathological but require conscious recognition and management to prevent detrimental effects on care. When unaddressed, they can contribute to avoidance behaviors, inappropriate treatment decisions, and the perpetuation of patient mistrust within healthcare systems [79].

This technical guide examines the management of disruptive behavior and countertransference within the broader ethical framework of end-of-life care for persons with SPMI, addressing the critical intersection of mental health care, palliative medicine, and clinical ethics.

Understanding the Clinical Population: Persons with SPMI at End of Life

Defining Characteristics and Vulnerabilities

SPMI encompasses conditions such as schizophrenia, bipolar disorder, and severe depression that follow a chronic course with substantial disability [9] [26]. The "3 D's" framework—disease, duration, and disability—captures the essential characteristics of this population [26]. Beyond their psychiatric conditions, persons with SPMI experience multiple vulnerabilities that complicate end-of-life care, including limited social networks, communication difficulties, impaired decision-making capacity, self-stigma, and often disruptive behaviors [9] [26].

Table 1: Vulnerability Factors in End-of-Life Care for Persons with SPMI

Vulnerability Factor	Impact on End-of-Life Care	Ethical Consideration
Early Mortality (10-20 years reduced life expectancy) [9]	Requires earlier palliative care integration	Justice in resource allocation
Complex Comorbidity (physical and psychiatric) [81]	Complicates symptom management	Holistic care approach necessity
Communication Difficulties [9]	Impedes assessment of symptoms and preferences	Adaptation of communication strategies
Limited Social Networks [9]	Often lack advocacy support	Role of clinicians as advocates
Decision-Making Capacity Challenges [9]	Complicates informed consent	Balancing autonomy with protection
Self-Stigma & Care-Avoiding Behavior [9]	Delays diagnosis and treatment	Need for trauma-informed approaches

Disruptive Behaviors: Manifestations and Underlying Etiologies

Disruptive behaviors in this population may include treatment refusal, non-adherence to medication regimens, aggression, or oppositional attitudes toward care providers. These behaviors often represent manifestations of the underlying psychiatric condition, untreated physical symptoms, psychological distress, or historical trauma within healthcare systems [9] [26]. For example, patients with histories of substance use disorder may respond with anger to appropriate opioid tapers, reacting to prior experiences of stigmatization rather than the current clinical recommendation [79].

Understanding these behaviors as communication rather than intentional opposition is fundamental to effective management. Such behaviors often signal unmet needs, existential distress, or reflections of the patient's unique psychological framework developed through years of living with severe mental illness [9] [26].

Ethical Frameworks in End-of-Life Care for SPMI

The provision of end-of-life care to persons with SPMI activates complex ethical considerations that extend standard biomedical ethical principles. Research mapping ethical aspects in end-of-life care for this population identifies how the four principles of biomedical ethics require specific application in this context [9].

Application of Core Ethical Principles

Autonomy and Decision-Making Capacity: Respecting autonomy in this population requires careful assessment of decision-making capacity, which may fluctuate based on psychiatric symptoms, medication effects, or disease progression [9] [25]. The fundamental question involves determining whether patient choices are authentic or primarily manifestations of psychiatric pathology [9]. This assessment must avoid both the premature assumption of incapacity and the uncritical acceptance of potentially harmful decisions.

Beneficence and Nonmaleficence: These principles require clinicians to balance the duty to provide benefit while avoiding harm, particularly when considering the application or withdrawal of life-sustaining treatments [25]. In SPMI populations, this balance becomes increasingly complex when considering the potential benefits and drawbacks of applying palliative care approaches within psychiatric contexts [9].

Justice: Persons with SPMI frequently experience disparities in access to quality palliative care [9] [26]. Ensuring equitable resource distribution and combating stigma become ethical imperatives for clinicians and healthcare systems serving this population [9] [25].

Table 2: Ethical Challenges in End-of-Life Care for Persons with SPMI

Ethical Challenge	Clinical Manifestation	Potential Consequences
Autonomy Assessment	Questions regarding authenticity of choices influenced by psychiatric symptoms [9]	Overly paternalistic approaches or uncritical acceptance of harmful decisions
Futility Determination	Debate regarding benefits/obstacles of palliative approaches in psychiatry [9]	Either premature care limitation or prolonged, inappropriate curative efforts
Resource Allocation	Limited access to specialist palliative care services [26]	Disparities in pain/symptom management quality
Euthanasia Requests	Requests for medical assistance in dying for psychiatric suffering [26]	Moral distress among clinicians, complex capacity assessments
Communication Barriers	Difficulty discussing end-of-life preferences [9]	Default to life-prolonging treatments without consideration of patient values

Countertransference: Recognition, Management, and Ethical Implications

Understanding Countertransference Dynamics

Countertransference represents the clinician's unconscious emotional response to a patient, shaped by both the current clinical relationship and the clinician's personal history [78] [80]. In palliative care settings, where clinicians regularly confront mortality, suffering, and existential concerns, these reactions are particularly common and intense [78]. Countertransference is not inherently negative; when recognized and managed effectively, it can provide valuable diagnostic information and enhance therapeutic understanding [78] [80].

However, unexamined countertransference can manifest in various detrimental ways, including avoidance of certain patients, shortened visits, excessive focus on physical symptoms to the exclusion of psychological concerns, or over-identification with particular patients [78] [79]. For example, a clinician who unconsciously avoids a patient with borderline personality disorder may miss critical symptoms, while a clinician who over-identifies with a young dying patient may unrealistically optimistic prognosis estimates [80].

Countertransference in SPMI End-of-Life Care

Working with persons with SPMI at the end of life can trigger specific countertransference reactions. Clinicians may experience feelings of frustration, helplessness, or aversion when faced with patients whose behaviors disrupt standard palliative care delivery [9] [26]. Conversely, clinicians with personal histories involving mental illness may experience over-identification that clouds clinical judgment [78].

The literature documents several common countertransference patterns in this context:

• Rescue Fantasies: Attempting to compensate for patients' limited social networks through boundary-violating behaviors [78]
• Avoidance Behaviors: Shortening visits or focusing exclusively on physical symptoms to minimize psychological distress exposure [79]
• Paternalistic Reactions: Overriding patient preferences based on assumptions about decision-making capacity [9]
• Moral Distress: Experiencing conflict when organizational constraints or ethical dilemmas prevent what the clinician believes to be right care [78] [26]

Management Strategies for Countertransference

Effective management of countertransference requires systematic approaches that enhance self-awareness and promote reflective practice:

Diagram 1: Countertransference Management Protocol

Recognition and Naming: The initial step involves recognizing intense emotional responses during clinical encounters and consciously naming these feelings [79] [80]. This act of recognition transforms unconscious processes into manageable conscious experiences.

Normalization: Clinicians should normalize these emotional responses as expected aspects of working with profound suffering rather than personal failures [79]. Normalization reduces the shame and guilt that often accompany "negative" emotions toward patients.

Behavioral Awareness: Following emotional recognition, clinicians should reflect on how these feelings impact their clinical behaviors, enabling corrective adjustments [79]. For instance, recognizing inner helplessness might prompt more systematic screening for patient depression rather than avoidance.

Interdisciplinary Collaboration: Regular consultation with trusted colleagues, particularly those with mental health expertise, provides external perspectives on challenging cases [79] [80]. Structured forums like Schwartz Center Rounds offer safe spaces for discussing emotional aspects of care [79].

Personal Reflection and Therapy: Some clinicians benefit from personal therapy to understand the origins of their countertransference reactions and develop more adaptive responses [80].

Intervention Framework: Managing Disruptive Behavior

Assessment and Differential Diagnosis

Effective management of disruptive behavior begins with comprehensive assessment to identify underlying causes, which may include:

• Uncontrolled physical symptoms (pain, dyspnea, nausea)
• Psychiatric symptom exacerbation
• Medication side effects
• Cognitive impairment/delirium
• Psychological/existential distress
• Communication difficulties
• Historical trauma or stigmatization within healthcare systems [9] [26]

Diagram 2: Behavioral Assessment and Intervention Workflow

Communication Strategies

Effective communication approaches include:

• Adapted Information Sharing: Adjusting the amount and complexity of information to match the patient's cognitive and emotional capacity [26]
• Systematic Assessment of Preferences: Using structured tools to understand patient values and care preferences, even outside formal advance care planning [81]
• Validation Techniques: Acknowledging the patient's emotional experience without necessarily agreeing with the behavioral expression [26]
• Clear Limit Setting: Establishing and consistently maintaining appropriate behavioral boundaries while preserving therapeutic alliance [9]

Pharmacological and Non-Pharmacological Approaches

Medication management requires special consideration in this population due to potential drug interactions, altered pharmacokinetics, and increased sensitivity to side effects [82]. Collaboration between palliative care and psychiatric specialists optimizes symptom control while minimizing adverse effects [82].

Non-pharmacological approaches may include:

• Environmental modifications to reduce sensory overload or under-stimulation
• Structured routines that provide predictability and reduce anxiety
• Integration of meaningful activities adapted to functional capacity
• Simple, distraction-based techniques for managing distress episodes [26]

Research Gaps and Methodological Considerations

Current Research Limitations

The evidence base for managing disruptive behavior and countertransference in end-of-life care for persons with SPMI remains limited by several factors:

• Exclusion of persons with SPMI from many palliative care studies [26]
• Predominant focus on clinician and caregiver perspectives rather than patient experiences [81] [26]
• Geographical concentration of research in countries with specific legal frameworks for euthanasia/assisted dying [26]
• Lack of standardized outcome measures for evaluating interventions in this population [81]

Recommended Research Methodologies

Table 3: Research Approaches for Studying SPMI End-of-Life Care

Methodology	Application	Considerations
Qualitative Interviews [26]	Exploring experiences of patients, families, and clinicians	Requires adaptation for cognitive and communication limitations
Medical Record Review [81]	Analyzing documented goals of care and treatment decisions	Limited by documentation quality and implicit biases
Ethnographic Observation	Understanding clinical interactions and decision-making processes	Addresses observer effect on sensitive clinical encounters
Mixed-Methods Studies	Combining quantitative outcomes with qualitative experiences	Provides comprehensive understanding of complex phenomena
Longitudinal Cohort Studies	Tracking care experiences and outcomes over time	Challenging due to high mortality and attrition rates

Table 4: Research Tools for SPMI End-of-Life Studies

Research Tool	Function	Application Notes
Semi-Structured Interview Guides [26]	Eliciting experiences while maintaining focus	Requires flexibility for participant cognitive variability
Good Death Inventory (GDI) [83]	Measuring quality of death outcomes	May need adaptation for SPMI population values
Care Evaluation Scale (CES) [83]	Assessing perceived quality of care	Validated in bereaved family members
Mental Health Recovery Measures	Assessing psychiatric outcome dimensions	May conflict with palliative approach in advanced illness
Ethical Dilemma Analysis Frameworks [9]	Structuring complex value conflicts	Based on four-principles approach with SPMI modifications

Managing disruptive behavior and countertransference in end-of-life care for persons with SPMI requires integration of clinical expertise, ethical sensitivity, and profound self-awareness. This population's unique vulnerabilities demand adapted approaches that respect autonomy while providing appropriate protection, that acknowledge the legitimacy of suffering while avoiding therapeutic nihilism, and that honor the dignity of persons whose lives have been marked by severe mental illness.

Effective care in this domain necessitates organizational support, interdisciplinary collaboration, and ongoing clinician reflection. The development of specific care models, such as the Oyster Care approach with its focus on creative adaptation to patient needs rather than coercive measures, shows promise in balancing recovery-oriented perspectives with palliative philosophy [26]. Further research centered on the experiences of persons with SPMI is essential to developing evidence-based approaches that ensure quality care while respecting the profound humanity of this vulnerable population at life's end.

Evaluating Evidence and Models: Validation, Comparative Analysis, and Outcome Measures

Medical Assistance in Dying (MAID) for individuals suffering solely from psychiatric disorders represents one of the most ethically and legally complex frontiers in end-of-life care. As jurisdictions worldwide grapple with expanding access to assisted dying, the application of these laws to psychiatric suffering raises fundamental questions about capacity assessment, therapeutic futility, and the very definition of irremediable suffering. This technical analysis examines the comparative legal frameworks governing psychiatric MAID across international jurisdictions, with particular attention to the implications for research on severe and persistent mental illness (SPMI). The evolving legal landscape presents significant challenges for clinicians, researchers, and policymakers seeking to balance patient autonomy against protection for vulnerable populations within ethically sustainable parameters [84] [85].

Comparative Analysis of International MAID Frameworks

Jurisdictional Approaches to Psychiatric MAID

Table 1: International Legal Status of MAID for Psychiatric Suffering

Jurisdiction	Legal Status	Key Eligibility Criteria	Special Safeguards for Psychiatric Cases	Data Availability
Belgium	Legal since 2002	"Unbearable and irreversible" psychological suffering; no requirement of terminal illness	Mandatory psychiatric consultation; 1-month reflection period for non-terminal cases	Comprehensive national registry (2002-present) [86]
Netherlands	Legal since 2002	"Unbearable suffering with no prospect of improvement"	"Great diligence" requirement; independent psychiatrist assessment mandatory [85]	Annual reports including psychiatric cases [87]
Switzerland	Permitted under specific conditions	No requirement for terminal illness; focus on decision-making capacity	No specific legal safeguards, but medical guidelines emphasize capacity assessment [85]	Limited official statistics; research-based data
Canada	Under consideration (planned 2027)	Currently limited to "reasonably foreseeable natural death" (excluding most psychiatric cases)	Proposed: assessment by multiple specialists; demonstrated treatment resistance [87]	Tracking current MAID cases excluding psychiatric suffering
United States	Generally prohibited	Restricted to terminal physical illness with 6-month prognosis [88]	Mental health evaluation only if capacity questioned [88]	State-level reporting with psychiatric cases excluded

The comparative analysis reveals three distinct regulatory models for psychiatric MAID: the permissive model (Belgium, Netherlands, Switzerland) which allows psychiatric suffering as primary basis for MAID; the restrictive model (most U.S. states) which limits MAID to terminal physical illness; and the transitional model (Canada) which is actively considering expansion to include psychiatric suffering [87] [85].

Belgium and the Netherlands have the most established frameworks, with Belgium reporting 427 cases of euthanasia for psychiatric disorders between 2002-2023, representing 1.27% of all euthanasia cases [86]. The Netherlands has seen a gradual increase in such cases, from 68 (1.1% of total) in 2019 to 219 (2.2%) in 2024 [87]. These jurisdictions employ reinforced procedures for non-terminal cases, including mandatory psychiatric consultation and extended reflection periods [86].

Regional Variations in Implementation

Significant regional variations exist even within permissive jurisdictions. Belgium demonstrates notable differences between Dutch-speaking Flanders and French-speaking regions, with higher overall euthanasia rates in Flanders but faster increases in French-speaking populations in recent years [86]. Gender disparities are also evident, with psychiatric MAID cases initially higher among women but increasing among men over time [86].

Switzerland's unique decriminalized approach (under Article 115 of the Swiss Penal Code) emphasizes altruistic motives rather than medical oversight, resulting in a more diverse set of practice guidelines compared to the clinically-integrated Dutch model [85]. This has implications for research standardization and data collection across jurisdictions.

Ethical Dimensions in SPMI End-of-Life Care

Core Ethical Dilemmas

The extension of MAID to psychiatric contexts introduces profound ethical challenges, particularly for individuals with Severe and Persistent Mental Illness (SPMI). Research indicates that persons with SPMI face life expectancies 10-20 years shorter than the general population, creating complex intersections between mental healthcare and end-of-life decision-making [14].

Table 2: Ethical Principles and Applications in Psychiatric MAID

Ethical Principle	Manifestation in Psychiatric MAID	Key Challenges
Autonomy	Respect for patient's assessment of unbearable suffering	Determining authenticity of request versus symptomatology; communication barriers [14]
Beneficence	Relief of refractory psychological suffering	Defining "irremediability" in psychiatric conditions; balancing life-saving psychiatric ethos [19] [14]
Non-maleficence	Protection of vulnerable populations	Avoiding coercion subtle or overt; preventing "slippery slope" expansion [84] [14]
Justice	Equitable access to end-of-life options	Socioeconomic disparities in access; variable regional implementation [20] [14]

Qualitative research from Flanders, Belgium reveals that ethical dilemmas in SPMI end-of-life care frequently involve tensions between creative, individualized care and institutional policies, with resource allocation emerging as a significant concern [19]. Frontline staff often lack familiarity with or access to ethics committees and support structures, leading to ethical dilemmas being addressed primarily at the team level rather than through formal mechanisms [19].

Capacity Assessment Challenges

The assessment of decision-making capacity represents the cornerstone of ethical psychiatric MAID implementation. Unlike physical illnesses where capacity may be more readily ascertained, psychiatric conditions by their nature can impair the very cognitive and emotional faculties necessary for informed consent [84]. Research indicates that fluctuating capacity, ambivalence, and the influence of psychopathology on perceived suffering complicate these determinations [14].

Clinical experience suggests that suicidal ideation as a symptom of depression must be distinguished from a sustained, rational desire for death, though this distinction poses significant challenges [88] [84]. The American Psychological Association notes that "desire for hastened death is not the same thing as suicidal ideation," highlighting the need for psychological expertise in these assessments [88].

Methodological Framework for Psychiatric MAID Assessment

Capacity Evaluation Protocol

Diagram 1: MAID Capacity Assessment Workflow

The assessment of MAID requests for psychiatric suffering requires a rigorous, multidisciplinary approach with specific attention to decision-making capacity and treatment history. The workflow above outlines a comprehensive evaluation protocol based on practices in jurisdictions with experience in psychiatric MAID [84] [85].

Suffering Assessment Methodology

A critical component of psychiatric MAID evaluation involves comprehensive suffering assessment. Research indicates that suffering in SPMI encompasses multiple dimensions beyond symptomatic distress:

• Physical suffering: Often related to side effects of long-term psychotropic medication or co-occurring conditions [14]
• Psychological suffering: Includes loss of meaning, hopelessness, and emotional pain [89]
• Social suffering: Encompasses stigma, isolation, and loss of social roles [87] [89]
• Existential suffering: Concerns loss of dignity, autonomy, and personhood [87] [89]

A scoping review of clinical practice guidelines revealed a notable absence of standardized approaches to addressing these multidimensional aspects of suffering, highlighting the need for more comprehensive assessment tools [88]. Recent initiatives like the Delphi Study in Canada have proposed recommendations for integrating social determinants of health into MAID evaluations and introducing psychosocial care services early in the disease trajectory [88].

Research Gaps and Methodological Challenges

Key Research Reagents and Tools

Table 3: Essential Research Methodologies for Psychiatric MAID Studies

Research Domain	Recommended Methodologies	Application in Psychiatric MAID
Capacity Assessment	MacCAT-T (MacArthur Competence Assessment Tool for Treatment); SICIATRI (Structured Interview for Competence/Incompetence Assessment Test for Rating Intelligence)	Standardized evaluation of decision-making capacity in psychiatric populations [84]
Suffering Metrics	QUALID (Quality of Life in Late-Stage Dementia); SDS (Suffering Dimensions Scale); phenomenological interviews	Multidimensional assessment of suffering encompassing physical, psychological, social and existential domains [88] [89]
Longitudinal Tracking	Mixed-methods designs; prospective cohort studies; qualitative follow-up	Documenting trajectory of suffering and decision stability over time [20] [86]
Ethical Analysis	Qualitative content analysis; deliberative consultation methods; case-based ethics rounds	Identifying and addressing ethical dilemmas in clinical practice [19] [14]

Significant Evidence Gaps

Current research on psychiatric MAID faces several methodological limitations and evidence gaps:

• Limited long-term studies: Most available data track initial outcomes rather than long-term effects on families, clinicians, or healthcare systems [20] [86]
• Inconsistent outcome measures: Lack of standardized metrics for "irremediability" and "unbearable suffering" across jurisdictions [89]
• Selection bias: Research participants may not represent the full spectrum of psychiatric suffering, particularly less articulate or more marginalized individuals [20]
• Cultural considerations: Most data comes from Western European contexts, limiting generalizability to other cultural frameworks [90] [14]

A critical methodological challenge involves distinguishing rational, sustained requests for death from symptoms of mental illness itself. Case analyses from Belgium illustrate this complexity, revealing instances where detailed clinical documentation, potential unresolved trauma, and lack of psychodynamic assessment raised questions about evaluation robustness and informed consent validity [84].

The comparative analysis of MAID policies for psychiatric suffering reveals an evolving landscape characterized by significant jurisdictional variation and ongoing ethical deliberation. Permissive frameworks in Belgium, the Netherlands, and Switzerland demonstrate that psychiatric MAID can be implemented with specific safeguards, though questions remain about consistent application and vulnerability protection. Core challenges include establishing clear protocols for capacity assessment, defining irremediable psychiatric suffering, and ensuring equitable access while preventing coercion. The expansion of MAID to psychiatric contexts necessitates rigorous methodological approaches in both clinical practice and research, particularly through standardized assessment tools, multidisciplinary evaluation, and longitudinal tracking. As more jurisdictions consider legalizing psychiatric MAID, evidence-based frameworks that balance respect for autonomy with protection of vulnerable individuals remain essential for ethical implementation. Future research should prioritize prospective studies, culturally sensitive methodologies, and meaningful inclusion of persons with lived experience of SPMI to ensure policies reflect the complex realities of severe psychiatric suffering.

Palliative psychiatry is an emerging approach for patients with severe and persistent mental illness (SPMI) that shifts focus from curative intent to improving quality of life and relieving suffering. It has recently been defined as "an approach that improves the quality of life of patients and their families in facing the problems associated with life-threatening severe persistent mental illness (SPMI) through the prevention and relief of suffering by means of a timely assessment and treatment of associated physical, mental, social, and spiritual needs" [91]. This model focuses on "harm reduction and on avoidance of burdensome psychiatric interventions with questionable impact," particularly when consecutive ineffective medication trials have diminished the probability of achieving full symptom reduction while increasing side effect burden [91]. The approach becomes relevant when a curative approach is either unrealistic or impossible in the face of significant treatment resistance and side effects [91].

This paradigm emerges within a critical context: persons with SPMI experience significantly reduced life expectancy—up to 10-20 years shorter than the general population—due to higher suicide risk, side effects of long-term psychotropic medication, and poor detection of co-occurring somatic conditions [14]. The ethical framework for this approach is complex, navigating tensions between recovery-oriented care and acknowledging persistent, treatment-refractory suffering [14]. This technical guide examines the available efficacy data, outcome measures, and methodological approaches for validating palliative psychiatry interventions, with particular attention to the ethical dimensions of end-of-life care for this vulnerable population.

Efficacy Data and Current Evidence Base

Quantitative Evidence for Palliative Approaches

The evidence base for palliative psychiatry is currently limited, with a notable scarcity of standardized quality indicators (QIs) and patient outcome measures (POMs) specific to this population [92]. A systematic review of palliative care for non-communicable diseases found that only 26.8% of studies focused on QIs, while 73.2% used POMs, with over 90% of research occurring in high-income settings [92]. The review noted that evidence is "limited, patchy and heterogenous in quality" across palliative care domains, with outcome of care being most studied while structure and process of care remain understudied [92].

Table 1: Available Efficacy Data for Palliative Psychiatry Approaches

Domain	Current Evidence	Limitations	Data Sources
Symptom Reduction	Focus on distress reduction rather than symptom elimination; decreased use of polypharmacy	Lack of randomized controlled trials; heterogeneous patient populations	Qualitative studies, case reports [91]
Quality of Life	Improvements in patient-reported well-being; increased sense of dignity	Limited validated SPMI-specific palliative QoL measures	Patient interviews, stakeholder reports [26]
Caregiver Burden	Reduced conflict over treatment goals; improved communication	Few studies include caregiver-reported outcomes	Family member interviews, care team reports [20]
Service Utilization	Potential reduction in aggressive interventions at end-of-life	No long-term health economic analyses	Institutional practice reviews [14]

Mental Health Trajectories in Palliative Care

A six-month longitudinal study of palliative care professionals provides relevant data on mental health trajectories in populations frequently exposed to death and suffering. This research identified two primary trajectories: a resilience trajectory (63.21-68.93% of participants) and a chronic distress trajectory (approximately 31.07-36.79% of participants) [93]. Chronic stress from ongoing end-of-life care was the strongest predictor of mental health outcomes between timepoints. Higher psychological flexibility significantly increased the odds of a resilience trajectory, with mindfulness and self-compassion serving as resilience factors for anxiety and depression scores [93]. These findings suggest potential mechanisms that might be targeted in palliative psychiatry interventions.

Emerging Outcome Measures and Assessment Protocols

Patient-Centered Outcome Measures

The validation of palliative psychiatry requires outcome measures that capture patient-valued benefits beyond symptom reduction. The Feeling Heard and Understood (HU) measure, developed for ambulatory palliative care, represents one such approach [94]. This multi-item survey assesses four critical domains through patient reporting:

• Feeling Heard and Understood: "I felt heard and understood by this provider and team"
• Best Interests Prioritization: "I felt this provider and team put my best interests first when making recommendations about my care"
• Person-Centered Identification: "I felt this provider and team saw me as a person, not just someone with a medical problem"
• Values Understanding: "I felt this provider and team understood what is important to me in my life" [94]

The survey uses a "top-box" scoring system, counting the most positive response ("Completely True") as successful performance. Administration occurs within 60 days of an ambulatory palliative care visit, with minimum sample sizes of 12 surveys for individual clinicians or 38 for groups to ensure reliability [94].

Ethical Outcome Assessment

Ethical dimensions of care require specific assessment approaches. Research using the four principles of biomedical ethics (autonomy, justice, beneficence, and non-maleficence) provides a framework for evaluating palliative psychiatry outcomes [14]. Autonomy assessment must include evaluation of decision-making capacity and authenticity of patient choices, particularly given the pathology of SPMI which may influence decision-making [14]. Justice measures should address equity in access to quality care and reduction of stigma, while beneficence and non-maleficence require assessment of the balance between benefits and obstacles in applying palliative approaches [14].

Table 2: Core Outcome Domains and Assessment Methods for Palliative Psychiatry

Domain	Specific Constructs	Assessment Methods	Frequency
Clinical Outcomes	Symptom distress, treatment burden, side effect profile	Standardized rating scales, medication inventories, laboratory monitoring	Monthly to quarterly
Quality of Life	Physical comfort, psychological well-being, social connectedness, existential peace	HU survey, QUAL-E, FACIT-Sp, customized SPMI instruments	Quarterly
Ethical Outcomes	Autonomy support, decision-making quality, goal concordance	Capacity assessments, goal concordance measures, ethical case reviews	As needed for care decisions
Process Outcomes	Care continuity, communication quality, interdisciplinary collaboration	Chart reviews, care team surveys, family feedback	Continuous

Experimental Protocols and Methodological Approaches

The validation of palliative psychiatry interventions requires innovative study designs that accommodate ethical concerns and patient vulnerability. Qualitative methodologies have proven essential for understanding the experiences of all stakeholders. The Flemish study on end-of-life care for persons with SPMI employed in-depth qualitative interviews with 73 participants (care users, family members, caregivers, care managers, and experts) using a semi-structured topic guide [26] [20]. Interviews ranged from 30 minutes to over two hours, were audio-recorded, transcribed verbatim, and analyzed using a combination of deductive and inductive thematic content analysis [20]. This protocol ensured that the voices of vulnerable persons with SPMI were included despite methodological challenges [26].

Longitudinal designs tracking mental health trajectories over time, as demonstrated in the six-month study of palliative care professionals, provide another methodological template [93]. This approach assessed stressors, psychosocial factors, and mental health outcomes at two timepoints six months apart, allowing identification of resilience versus distress trajectories and their predictors [93].

Visualization of Palliative Psychiatry Approach

Table 3: Essential Research Tools for Palliative Psychiatry Investigation

Tool Category	Specific Instrument	Application in Palliative Psychiatry	Implementation Considerations
Qualitative Interview Guides	Semi-structured topic guides on care experiences, end-of-life needs, ethical concerns [26]	Eliciting stakeholder perspectives on care quality and outcomes	Require adaptation for cognitive and communication challenges in SPMI
Patient-Reported Outcome Measures	Feeling Heard and Understood (HU) survey [94]	Assessing core relational aspects of palliative care	May require proxy or assisted completion for some SPMI patients
Mental Health Trajectory Assessments	Resilience vs. distress trajectory mapping [93]	Tracking outcomes over time in intervention studies	Requires longitudinal design with multiple assessment points
Ethical Analysis Frameworks	Four principles approach (autonomy, justice, beneficence, non-maleficence) [14]	Evaluating ethical dimensions of care approaches	Should be complemented by virtue ethics and care ethics perspectives
Occupational Assessment Tools	Job Demand-Control model instruments [93]	Evaluating caregiver and provider experiences	Important for assessing implementation climate and sustainability

Ethical Dimensions and Implementation Challenges

The implementation of palliative psychiatry occurs within a complex ethical landscape, particularly in regions where medical assistance in dying (MAID) is legalized for psychiatric suffering [26] [20]. The Belgian context, where euthanasia based on unbearable psychiatric suffering has been legal since 2002, demonstrates how palliative psychiatry must navigate between "palliative care approach" and "euthanasia as an end-of-life option" [20]. This creates tension between developing robust palliative alternatives while respecting autonomous choice, requiring careful assessment of decision-making capacity and treatment futility [14].

The Oyster Care Model, developed in Flanders, exemplifies one approach to these ethical challenges [20]. This model "adapts the environment as much as possible to the care user rather than the other way around" and operates on four pillars parallel to palliative care: physical, psychological, social, and existential care [20]. While offering benefits, this approach also raises ethical concerns about potential paternalism or insufficient recovery-orientation [20]. Research indicates that ethical dilemmas in this field are predominantly addressed at the team level, with organizations employing "reference person ethics," "ethics pubs," or peer support mechanisms for challenging situations [26].

The validation of palliative psychiatry requires methodological innovation and ethical sensitivity. Future research should prioritize the development of SPMI-specific palliative outcome measures that capture the unique needs and treatment goals of this population. Mixed-methods designs that combine quantitative tracking of symptom trajectories with qualitative exploration of patient values and experiences will be essential to establish the evidence base for this approach.

The field must also address significant gaps in implementation science, including staff training needs, organizational readiness assessment, and resource allocation models [26]. As one study noted, "Greater accessibility to ethical support systems and tailored approaches are needed to balance recovery-oriented care with a palliative care approach, ensuring dignity and respect for this vulnerable group" [26]. Establishing valid, reliable, and ethically sound outcome measures remains a fundamental challenge and priority for advancing palliative psychiatry from theoretical concept to evidence-based practice.

Severe and Persistent Mental Illness (SPMI) represents a small yet clinically significant group within mental healthcare, characterized by one or more long-term psychiatric disorders that result in serious disability and functional impairment [26] [14]. The "3 D's" framework—disease, duration, and disability—is often used to conceptualize SPMI [26] [20]. This population experiences a significant mortality burden, with life expectancy reduced by 10-20 years compared to the general population [95] [14]. This stark reality necessitates a sophisticated examination of therapeutic approaches, particularly at the intersection of recovery-oriented models and emerging palliative psychiatry frameworks.

The clinical management of SPMI presents profound ethical challenges at the end of life, including assessing decision-making capacity, managing therapeutic futility, navigating fragmented care systems, and balancing autonomy with beneficence [26] [14]. This whitepaper provides a cross-model analysis contextualized within the ethical dilemmas persistent in mental illness end-of-life research, offering drug development professionals and researchers methodological frameworks and analytical tools to advance this critical field.

Quantitative Foundations: Empirical Evidence Supporting Paradigm Development

Recent empirical investigations provide crucial quantitative insights into psychiatrist perspectives on palliative approaches for SPMI. A 2019 cross-sectional survey of German-speaking psychiatrists in Switzerland (n=457, 34.9% response rate) revealed significant statistical support for paradigm evolution in SPMI care [95].

Table 1: Psychiatrist Perspectives on Palliative Approaches in SPMI Care

Survey Metric	Agreement/Endorsement Rate	Clinical Prioritization	Key Findings
SPMI as terminal	93.7% of psychiatrists	N/A	Recognition of potential fatality in certain SPMI forms
Palliative care appropriateness	>75% of psychiatrists	N/A	Support for integrated palliative approaches
Futility in anorexia nervosa case	72.4% of psychiatrists	N/A	Acknowledgment of treatment futility in specific contexts
Reduction of suffering	N/A	Highest priority	Primary focus in SPMI treatment
Maintaining daily functioning	N/A	High priority	Secondary focus in SPMI treatment
Curing underlying illness	N/A	Lower priority	Deprioritized versus quality-of-life measures

These quantitative findings demonstrate a significant paradigm shift among treating psychiatrists, who increasingly prioritize quality-of-life interventions over strictly curative models for appropriate SPMI cases [95]. This evidence base is essential for researchers and pharmaceutical developers working to align trial endpoints and therapeutic targets with evolving clinical priorities.

Conceptual Frameworks and Ethical Foundations

Recovery-Oriented Model: Principles and Applications

The recovery-oriented model represents the established paradigm in contemporary psychiatric care, emphasizing functional restoration, symptom remission, and personal recovery journeys. This approach operates on the principle that meaningful improvement and functional recovery are possible even in severe mental illness, focusing on person-centered care, hope, empowerment, and community integration. The model drives development of novel therapeutic interventions with curative or disease-modifying intent.

Palliative Psychiatry Model: Definition and Scope

Palliative psychiatry has been formally defined as "an approach that improves the quality of life of patients and their families in facing the problems associated with life-threatening severe persistent mental illness (SPMI) through the prevention and relief of suffering by means of a timely assessment and treatment of associated physical, mental, social, and spiritual needs" [91]. This model focuses on harm reduction and avoidance of burdensome psychiatric interventions with questionable impact, particularly when curative approaches prove unrealistic or impossible due to significant side effect burden [91].

The World Health Organization's broader definition of palliative care emphasizes improving quality of life for patients and families facing life-threatening illness through prevention and relief of suffering [95]. Within psychiatry, this translates to interventions that primarily enhance quality of life through adequate symptom control and disability focus rather than curing the underlying illness [95].

The Oyster Care Model: An Integrative Framework

The Oyster Care Model, developed in Flanders, Belgium, provides a structured implementation framework for palliative psychiatry, using the metaphor of a protective shell [26] [20]. This model complements recovery-oriented care and is organized around four central pillars:

• Physical care: Adequately responding to somatic comorbidities and impairments
• Psychological care: Shifting therapeutic focus toward mental comfort and well-being
• Social care: Providing structure for daily activities and social contacts
• Existential care: Enhancing experience of life as valuable and meaningful [26] [20]

The model's mission adapts the care environment to the user rather than forcing adjustment to institutional protocols, dynamically scaling care intensity according to individual rhythms and needs [26] [20].

Ethical Analysis and Dilemma Mapping

The care of persons with SPMI at the end of life generates complex ethical challenges that manifest differently across therapeutic approaches. A 2025 qualitative study conducted 73 interviews with care users, family members, caregivers, and experts in Flanders, Belgium, identifying predominant ethical concerns [26] [19].

Table 2: Predominant Ethical Concerns in SPMI End-of-Life Care

Ethical Issue	Frequency Mentioned	Manifestation in Recovery Model	Manifestation in Palliative Model
Euthanasia/MAID	Most frequent	Conflict with suicide prevention mandate	Potential alignment with relief of suffering
Care neglect	Common	Insufficient access to evidence-based treatments	Delayed palliative care initiation
Autonomy preservation	Common	Tension with therapeutic insistence	Risk of over-deference to potentially impaired decisions
Resource allocation	Common	Pressure for intensive, costly interventions	Equity in access to palliative resources
Futility assessment	Common	Continuing potentially ineffective treatments	Determining when transition is appropriate

Biomedical Ethical Principles Framework

Analysis through Beauchamp and Childress' principlism reveals distinctive ethical profiles for each approach [14]:

• Autonomy: Recovery models may inadvertently diminish autonomy through therapeutic persistence, while palliative approaches risk over-relying on potentially impaired decision-making capacity in SPMI patients [14].
• Non-maleficence: The risk of burdensome treatments with questionable benefit represents a significant harm in recovery approaches, while palliative models risk harm through potential undertreatment or the perception of "giving up" [95] [91].
• Beneficence: Recovery models express beneficence through hope and active intervention, while palliative approaches focus beneficence on quality of life and dignity preservation [14].
• Justice: Both models face justice concerns regarding equitable resource allocation, with recovery models emphasizing access to active treatments and palliative approaches highlighting access to quality end-of-life care [14].

Methodological Protocols for SPMI Research

Research Objective: To quantify psychiatrist attitudes toward palliative care approaches and treatment goal prioritization in SPMI.

Participant Recruitment:

• Target population: All German-speaking members of professional psychiatric society (N=1311)
• Sampling frame: Professional organization membership registry
• Response rate: 34.9% (n=457)

Instrument Development:

• Format: 18-item survey with 7-point Likert scales (-3 to +3)
• Components: Demographic items, treatment goal prioritization (0-6 scale), case vignette evaluations
• Validation: Expert panel review for content validity including psychiatric practitioners, researchers, and biostatisticians

Case Vignette Structure:

• Three detailed clinical vignettes (anorexia nervosa, schizophrenia, major depressive disorder)
• Each vignette includes: diagnosis history, treatment resistance documentation, current clinical presentation, quality of life impact, and determination of decision-making capacity
• Seven evaluation questions per vignette using consistent Likert scale format

Data Collection Protocol:

• Mixed-mode administration: Primary paper-pencil format with prepaid return envelopes
• Timeline: February-March 2017
• Follow-up: Single reminder postcard at 4-week interval
• Incentives: None provided

Analytical Plan:

• Descriptive statistics for agreement rates and prioritization scores
• Comparative analysis across diagnostic vignettes
• Subgroup analyses based on psychiatrist demographics

Research Objective: To explore ethical themes and care experiences in end-of-life care for persons with SPMI from multiple stakeholder perspectives.

Participant Recruitment and Sampling:

• Total participants: 73 individuals
• Stakeholder categories: Care users (n=17), family members (n=12), caregivers (n=24), care managers and experts (n=20)
• Recruitment strategy: Purposive sampling from seven mental healthcare organizations across five geographic regions
• Settings: Residential care, assisted living, and ambulatory services
• Inclusion criteria: Direct experience with SPMI care (varied explicit experience with end-of-life issues)

Data Collection Protocol:

• Method: In-depth semi-structured interviews
• Duration: 30 minutes to >2 hours (average: 60 minutes)
• Period: July 2022 - May 2023
• Location: Participant-chosen settings (typically care facilities or workplaces)
• Instrument: Piloted interview guides tailored to stakeholder groups
• Documentation: Audio recording and verbatim transcription

Interview Content Domains:

• Care approaches and philosophies
• End-of-life care experiences and needs
• Ethical considerations and dilemmas
• Existential questions and meaning-making
• Advance care planning and decision-making

Analytical Framework:

• Approach: Thematic content analysis using combined deductive-inductive approach
• Software: Qualicoder for data management
• Coding process: Independent analysis by multiple researchers with consensus resolution
• Saturation: Continued sampling until thematic saturation with attention to demographic diversity

Ethical Considerations:

• Oversight: Central ethics committee approval (KU Leuven, Belgium)
• Consent: Written informed consent with pseudonymization
• Adaptation: Flexible scheduling and extended information review for care users

Conceptual Mapping of Care Models and Ethical Dimensions

Research Reagents and Methodological Toolkit

Table 3: Essential Research Instruments and Tools for SPMI Investigation

Research Tool	Application Context	Technical Function	Implementation Considerations
7-point Likert scales	Attitude assessment (-3 to +3)	Quantifies agreement/disagreement continuum	Neutral midpoint (0) reduces forced choice bias
Clinical vignettes	Case-based evaluation	Standardizes clinical presentation across respondents	Requires capacity assessment and treatment history
Semi-structured interview guides	Qualitative data collection	Ensures comprehensive topic coverage while allowing emergence	Must be piloted and stakeholder-adapted
Thematic content analysis framework	Qualitative data analysis	Identifies recurring themes and patterns	Requires multiple independent coders with consensus
WHO palliative care definition	Conceptual foundation	Standardizes approach understanding across respondents	Essential for terminological consistency
Ethical case deliberation protocols	Moral dilemma navigation	Structured discussion methodology for ethical issues	Facilitator-dependent; requires stakeholder inclusion

Discussion and Research Implications

Integration Challenges and Model Complementarity

The recovery and palliative approaches, while conceptually distinct, are not mutually exclusive paradigms. Evidence suggests that palliative psychiatry does not necessarily represent therapeutic abandonment but can function alongside recovery-oriented models, particularly for patients experiencing prolonged periods of significant distress despite intensive treatment [95] [91]. The critical clinical challenge lies in determining appropriate timing for model integration and establishing evidence-based criteria for assessing treatment futility in psychiatric contexts.

The futility debate remains particularly contentious in psychiatry, often linked to anecdotal reports in severe anorexia nervosa where palliative approaches may be considered [95]. In these circumstances, there is a risk that palliative psychiatry may be perceived as inevitably intertwined with 'giving up' rather than as complementary to recovery-oriented models [95]. This tension highlights the need for careful communication and explicit ethical framing when introducing palliative approaches in psychiatric care.

Implications for Pharmaceutical Development and Clinical Trials

For drug development professionals, this evolving paradigm has significant implications for clinical trial design and therapeutic target selection:

• Endpoint Selection: Trials for SPMI interventions should consider incorporating quality-of-life measures and functional assessments alongside traditional symptom reduction scales.
• Futility Considerations: Development programs should establish clear futility thresholds to avoid prolonged investment in interventions with minimal likelihood of success.
• Stratification Strategies: Patient stratification based on treatment resistance patterns and palliative indicators may enhance trial precision and clinical applicability.
• Ethical Oversight: Research protocols require robust ethical review processes specifically addressing SPMI vulnerability, decision-making capacity, and quality-of-life endpoints.

Future Research Directions

Significant knowledge gaps remain in several critical areas:

• Staging Models: Development of validated psychiatric staging systems to identify appropriate timing for palliative approaches [91]
• Capacity Assessment: Refinement of decision-making capacity evaluation tools specific to SPMI end-of-life decisions [14]
• Implementation Science: Research on effective integration of palliative approaches within existing recovery-oriented systems
• Outcome Measurement: Development and validation of SPMI-specific palliative care quality indicators and outcome measures
• Cross-Cultural Applications: Exploration of model applicability across diverse healthcare systems and cultural contexts

This cross-model analysis demonstrates that both recovery-oriented and palliative approaches offer distinct yet potentially complementary frameworks for addressing the complex needs of persons with SPMI. The emerging paradigm of palliative psychiatry represents a significant evolution in therapeutic philosophy, emphasizing quality of life and harm reduction when curative approaches prove futile or unacceptably burdensome [91].

The ethical dimensions of SPMI care necessitate ongoing dialogue, refined assessment tools, and careful implementation of integrated care models. For researchers and pharmaceutical developers, this analysis underscores the importance of aligning therapeutic development with evolving clinical priorities and ethical frameworks. Particularly critical is the development of more sophisticated approaches to assessing treatment futility, staging psychiatric illness, and integrating patient-valued outcomes into both research and clinical care.

As the field advances, the voices of persons with SPMI must be centered in both research and model development through inclusive methodologies that acknowledge their expertise and prioritize their values in care decision-making. The ultimate goal remains the same across both models: to provide compassionate, effective, and dignity-preserving care for some of the most vulnerable individuals in our healthcare systems.

End-of-life (EoL) care for persons experiencing severe and persistent mental illness (SPMI) represents one of the most ethically complex frontiers in modern healthcare. This in-depth technical guide examines the international perspectives on this issue, with particular focus on lessons from Belgium, where substantial clinical and ethical frameworks have been developed. The context of a broader thesis on ethical dilemmas in persistent mental illness end-of-life research frames this analysis, providing researchers, scientists, and drug development professionals with critical insights into the nuanced landscape of EoL decision-making for this vulnerable population.

Belgium's pioneering legal framework, which permits euthanasia based on unbearable psychiatric suffering, offers a unique natural laboratory for examining these complex issues [20]. Since the enactment of its euthanasia law in 2002, Belgium has accumulated significant data and clinical experience with EoL decisions in psychiatric contexts, providing valuable evidence for international comparison and policy development [86]. This analysis synthesizes quantitative trends, qualitative stakeholder experiences, and emerging care models that together form a comprehensive picture of current practices and their ethical implications.

Quantitative Landscape of EoL Decisions in Psychiatry

Epidemiological Trends in Psychiatric Euthanasia

Analysis of data from the Belgian Federal Commission for the Control and Evaluation of Euthanasia (FCCEE) from 2002 to 2023 reveals distinct patterns in euthanasia cases involving psychiatric conditions [86]. The comprehensive dataset encompassing 33,592 reported euthanasia cases during this period provides a robust foundation for understanding the scope and trajectory of this practice.

Table 1: Euthanasia Cases for Psychiatric Disorders and Dementia in Belgium (2002-2023)

Category	Number of Cases	Percentage of Total Euthanasia Cases	Trend Over Time	Rate of Change (per year)
Psychiatric Disorders	427	1.27%	Similar to other euthanasia types	Count: 1.00 (95%CI: 0.98; 1.03) Rate: 1.02 (95%CI: 0.99; 1.04)
Dementia	310	0.92%	Increased faster than other types	Count: 1.03 (95%CI: 1.00; 1.06) Rate: 1.04 (95%CI: 1.01; 1.07)
All Other Types	32,855	97.81%	Reference trend	Reference

The data reveal that euthanasia cases for psychiatric disorders, while representing a small proportion of total cases, have maintained a consistent trajectory similar to other types of euthanasia, with dementia cases showing a slightly accelerated growth pattern [86]. This trend persists even when accounting for demographic changes in the population.

Demographic Variations in EoL Patterns

Further analysis of the Belgian data reveals important demographic variations in euthanasia cases for psychiatric conditions [86]. Initial trends showed higher rates among women, but rates among men have been increasing over time. Significant regional variations are also evident, with higher overall euthanasia rates in the Dutch-speaking population, though the French-speaking population has experienced faster increases in recent years.

Table 2: Demographic Patterns in Psychiatric Euthanasia in Belgium

Demographic Factor	Historical Pattern	Recent Trends	Statistical Significance
Gender Distribution	Initially higher among women	Increasing rates among men	Rates converging over time
Regional Distribution	Higher in Dutch-speaking population	Faster increases in French-speaking population	Persistent but diminishing differences
Age Profile	Data not specified in research	Data not specified in research	Not available
Socio-economic Status	No data available	No data available	Major limitation noted

A critical limitation identified in current research is the lack of information on patients' socio-economic profiles, representing a significant gap in understanding potential disparities in access to or utilization of EoL options for psychiatric suffering [86].

Methodological Approaches in EoL Psychiatry Research

Qualitative Research Protocols

The complex nature of EoL decisions in psychiatry necessitates sophisticated qualitative methodologies to capture stakeholder experiences. Recent research in Belgium has employed comprehensive interview-based approaches with the following protocol [20]:

Research Objectives: To explore experiences, needs, and expectations of care users, relatives, and caregivers regarding EoL care for persons experiencing SPMI.

Participant Recruitment: Purposive sampling from seven mental healthcare organizations across all five Flemish provinces, representing varied care settings including residential care, assisted living, and ambulatory services [20].

Sample Characteristics: 73 participants including 17 care users, 12 next-of-kin, 24 caregivers, and 20 managers and experts [20]. Efforts were made to establish representative socio-demographic distribution among all target groups.

Data Collection: Semi-structured interviews conducted in Dutch from July 2022 to May 2023, ranging from 30 minutes to over two hours, averaging one hour [20]. Interviews followed a pre-constructed topic guide covering themes such as care approaches, EoL care needs, ethical considerations, and existential questions.

Ethical Considerations: Study approved by the central ethics committee of KU Leuven, Belgium (No. B3222021000688) [20]. Informed consent obtained from all participants. Extra flexibility demonstrated when scheduling interviews, with more time allocated to review information documents step-by-step with participants.

Data Analysis: Interviews audio-recorded, transcribed verbatim, and pseudonymized. Researchers independently analyzed and coded transcripts using a combination of deductive and inductive thematic content analysis in Qualicoder software [20]. Data collection continued until thematic saturation was reached.

Quantitative Research Methodologies

For quantitative analysis of euthanasia trends, researchers have employed rigorous statistical approaches [86]:

Data Source: Complete dataset of all cases of euthanasia reported to the FCCEE from 2002 to 2023 (N=33,592) [86].

Analytical Approach: Time-series zero-inflated negative binomial regression to model trends, examining interactions between euthanasia reasons and year, then extending to three-way interactions with patients' characteristics [86].

Rate Calculation: Models replicated with an offset to account for demographic changes and generate rates, not just raw counts [86].

Case Identification: Psychiatric disorder cases identified where psychiatric suffering was primary diagnosis, with reinforced procedure applied for cases where death not expected in foreseeable future (>12 months) [86].

The following diagram illustrates the complex ecosystem of stakeholders and their interactions in psychiatric EoL care, based on qualitative research findings:

EoL Care Models and Clinical Frameworks

The Oyster Care Model

A significant development in psychiatric EoL care in Flanders is the Oyster Care Model, which complements recovery-oriented care using the metaphor of a shell to represent a palliative approach for persons experiencing SPMI [20]. This model focuses on quality of life, creativity, and a holistic view of the person, operating parallel to palliative care based on four pillars:

• Physical Care: Adequately responding to the somatic impairments of patients
• Psychological Care: Focusing on mental comfort and wellbeing
• Social Care: Providing structure of daily activities and contacts
• Existential Care: Enhancing the experience of life as valuable and meaningful

The mission of this model is to adapt the environment as much as possible to the care user rather than the reverse [20]. For instance, a care recipient's hoarding tendencies may be tolerated or sublimated to a certain extent. This approach also aims to reduce the use of restrictive or coercive measures. The model is dynamic, with care being scaled up or down according to the care user's rhythm.

EoL Decision-Making Protocol

Based on analysis of Belgian practices, the following diagram outlines the complex decision-making pathway for psychiatric euthanasia requests:

Stakeholder Perspectives and Ethical Dimensions

Healthcare Professional Viewpoints

Research among healthcare workers in Belgium reveals that ethical perspectives on euthanasia in psychiatry are shaped by the interpretation and weighting of fundamental values across multiple tiers [96]. Participants identified three pivotal values and virtues:

• Religious Values: Personal faith perspectives influencing EoL decisions
• Professional Values: Training and professional identity considerations
• Fundamental Medical Values: Autonomy, beneficence, and non-maleficence, linked to compassion, quality care, and justice

These values interweave across four tiers: the patient, the patient's inner circle, the medical realm, and society at large [96]. Regardless of their euthanasia stance, participants generally displayed a blend of ethical values across these tiers, with their ultimate perspective shaped by value interpretation, significance allocation to key components, and tier weighting.

Relative and Caregiver Experiences

A qualitative exploration of close relatives involved in psychiatric euthanasia trajectories reveals complex and ambivalent emotional and cognitive experiences [97]. Research with 18 relatives conducted from March to May 2023 found that:

• Experiences with euthanasia trajectories varied from positive to negative, marked by shared feelings of surrealism and unreality
• The farewell process that relatives undergo occurs regardless of whether euthanasia is ultimately carried out
• While desired level of involvement varied, all relatives sought some degree of recognition and understanding for their complex position
• The level of actual involvement and support depended on the stage of the euthanasia request, their social network, and the reasons behind the request
• There was a significant demand for transparent communication, more emotional and practical support, and assistance in coping with the emotionally charged process

Research Reagents and Methodological Tools

Table 3: Essential Methodological Tools for EoL Psychiatric Research

Research Tool	Application in EoL Psychiatry Research	Key Functions	Examples from Literature
Semi-structured Interview Guides	Qualitative data collection from stakeholders	Explore experiences, needs, ethical considerations	Pre-constructed topic guides covering care approaches, EoL needs, ethical issues [20]
Thematic Content Analysis Software	Qualitative data analysis	Systematic coding and analysis of interview transcripts	Qualicoder software for deductive and inductive thematic analysis [20]
Time-Series Regression Models	Quantitative analysis of euthanasia trends	Model trends in euthanasia cases accounting for demographic changes	Zero-inflated negative binomial regression for euthanasia case analysis [86]
Stakeholder Mapping Frameworks	Identifying key actors in EoL decision-making	Clarify relationships and influences between stakeholders	Four-tier value framework (patient, inner circle, medical realm, society) [96]
Ethical Analysis Frameworks	Structured analysis of value conflicts	Identify and weigh competing ethical values	Analysis of autonomy, beneficence, non-maleficence, and justice in EoL decisions [96]

The Belgian experience with EoL decisions for persons with SPMI offers critical insights for the international community. Several key findings emerge from this analysis:

First, euthanasia for psychiatric disorders remains relatively rare (1.27% of all euthanasia cases) and follows trends similar to other types of euthanasia, suggesting a stable rather than expanding practice [86]. Second, the ethical landscape is characterized by complex weighing of competing values across multiple tiers of stakeholders, requiring nuanced approaches that resist simplistic categorization [96]. Third, the experiences of relatives and caregivers highlight the profound impact of these decisions beyond the individual patient, indicating a critical need for support systems throughout the decision-making process [97].

From a policy perspective, research suggests the need for: (1) investment in education and training for caregivers; (2) establishment of ethical support mechanisms; and (3) fostering collaboration with palliative care networks to ensure dignified and compassionate care for this vulnerable population [20]. The development of models like the Oyster Care Model represents promising approaches that adapt care environments to patient needs rather than the reverse [20].

For researchers, significant gaps remain, particularly regarding socio-economic determinants of EoL decisions, long-term impacts on healthcare systems, and cross-cultural comparisons that could illuminate alternative approaches. The methodologies and frameworks documented in this analysis provide foundation for further investigation into these complex ethical dilemmas at the intersection of mental healthcare and end-of-life decision-making.

Individuals with Severe and Persistent Mental Illness (SPMI), encompassing conditions such as schizophrenia, bipolar disorder, and recurrent major depressive disorder, represent a vulnerable population within healthcare systems. Research has consistently demonstrated that this group faces a significantly reduced life expectancy—from 10 to 20 years shorter than the general population—primarily due to a higher burden of somatic comorbidities such as cardiovascular disease, respiratory disease, and cancer [17] [14]. Despite this mortality gap, there remains a profound lack of evidence and clinical guidance on providing quality end-of-life (EoL) care for persons with SPMI, creating a critical area for ethical and clinical inquiry [17] [26] [20].

This whitepaper examines the principal gaps in the evidence base for EoL care in SPMI, framed within the ethical dilemmas that pervade this research domain. The existing literature reveals significant barriers to adequate care, including stigma among healthcare professionals, fragmented care systems, lack of advanced care planning, and insufficient training in palliative care among mental health specialists [17] [14]. By systematically identifying and prioritizing these research gaps, we aim to guide future clinical and translational research efforts toward areas with the greatest potential impact on the quality of EoL care for this marginalized population.

Mapping the Current Evidence Landscape and Methodological Gaps

Quantitative Evidence Shortfalls

Recent systematic and umbrella reviews have quantified the stark disparities in research attention and evidence quality concerning EoL care for SPMI populations. The table below summarizes key quantitative findings from recent literature analyses:

Table 1: Quantitative Evidence Gaps in SPMI End-of-Life Care Research

Evidence Domain	Current Status	Key Findings from Literature
Systematic Review Yield	Limited evidence base	An umbrella review (2025) identified only 10 systematic reviews meeting inclusion criteria, highlighting scarce synthesized evidence [17].
Palliative Sedation Evidence	Critical knowledge gap	No data were found regarding palliative sedation practices for people with SPMI and life-limiting illness [17].
Stakeholder Representation	Limited patient voices	A scoping review (2023) found ethical dialog mainly focused on professionals and relatives rather than persons with SPMI [14].
Geographical Distribution	Concentrated in high-income countries	Evidence primarily comes from a few countries (USA, Canada, UK, Netherlands, Belgium, Australia) [17] [14].

Qualitative Evidence Limitations

Qualitative research provides essential context for understanding the lived experiences of SPMI patients at the end of life, yet significant methodological and conceptual gaps persist:

Table 2: Qualitative and Methodological Research Gaps

Research Area	Current Gap	Research Implications
Inclusion of Patient Perspectives	Limited direct engagement with care users	Future studies must prioritize inclusion of persons with SPMI using adapted methodologies [26] [20].
Cross-Cultural Comparisons	Limited understanding of cultural variations	Research needed across diverse healthcare systems and cultural contexts [14].
Ethical Support Structures	Poor utilization of ethics committees	Studies needed on implementation and accessibility of ethics support for frontline staff [26].
Integrated Care Models	Limited evaluation of coordinated care	Research required on effectiveness of integrated mental and physical healthcare models [17].

Priority Research Domains: Clinical, Translational, and Ethical Dimensions

Palliative Psychiatry as an Emerging Paradigm

Palliative psychiatry represents a novel clinical approach that focuses on improving quality of life rather than symptom remission for individuals with SPMI. This approach "focuses on harm reduction and on avoidance of burdensome psychiatric interventions with questionable impact" [91]. Despite its potential value, significant knowledge gaps impede its implementation:

• Conceptual Clarity: Lack of consensus on defining 'futility' and 'terminal illness' in mental healthcare contexts [43]
• Clinical Models: No accepted clinical models of palliative care for individuals experiencing SPMI [43]
• Outcome Measures: Lack of validated metrics for measuring quality of life in SPMI palliative contexts [43] [98]
• Structural Barriers: Insufficient understanding of how to navigate medicolegal responsibilities and standards of practice [43]

Ethical Dilemmas as Research Priorities

The care of persons with SPMI at the end of life presents distinctive ethical challenges that demand rigorous investigation. These can be mapped using the Beauchamp and Childress principles of biomedical ethics:

Table 3: Key Ethical Dilemmas Requiring Research in SPMI End-of-Life Care

Ethical Principle	Research Questions	Current Evidence Status
Autonomy	How to assess decision-making capacity fluctuates with SPMI? How to implement advance care planning effectively?	Limited evidence on capacity assessment tools; advance directive implementation challenging [14].
Beneficence/Non-maleficence	When are psychiatric treatments futile? How to balance palliative sedation with risk assessment?	No data on palliative sedation; futility concept highly contested [17] [14].
Justice	How to address disparities in access to palliative care? How to reduce stigma among providers?	Clear evidence of care disparities; stigma identified as major barrier [17] [14].

The most frequently mentioned ethical issue in recent qualitative studies was euthanasia/medical assistance in dying (MAID), particularly in jurisdictions where it is legal [26] [20]. This highlights the urgent need for research on safeguards, assessment protocols, and alternatives for persons with SPMI requesting MAID.

Methodological Framework for Future Research

Proposed Experimental Protocols and Study Designs

To address the identified gaps, researchers should consider implementing the following methodological approaches:

Mixed-Methods Study Protocol for Palliative Psychiatry Outcomes

• Qualitative Component: Conduct in-depth interviews with care users, family members, and caregivers using piloted semi-structured guides [26] [20]
• Quantitative Component: Implement validated measures for quality of life, symptom burden, and healthcare utilization
• Integration Analysis: Use convergent design to identify discrepancies and connections between qualitative and quantitative findings

Cluster Randomized Trial for Integrated Care Models

• Intervention: Co-developed, cross-sectoral education programs for mental health and palliative care providers
• Control: Usual care with educational materials provided separately to each specialty
• Outcomes: Patient quality of life, caregiver burden, healthcare costs, place of death preferences

Longitudinal Cohort Study on Decision-Making Capacity

• Population: Persons with SPMI and life-limiting illness with varying levels of cognitive functioning
• Measures: Serial assessments of decision-making capacity using standardized tools
• Outcomes: Stability of treatment preferences, concordance with advance directives

Table 4: Key Research Reagent Solutions for SPMI End-of-Life Studies

Research Tool Category	Specific Instruments	Application in SPMI Population
Qualitative Data Collection	Semi-structured interview guides; topic guides covering care approaches, EoL needs, ethical considerations [26] [20]	Eliciting experiences and preferences from persons with SPMI using adapted communication approaches
Capacity Assessment Tools	MacArthur Competence Assessment Tool for Treatment (MacCAT-T); Decisional Capacity Assessment Tool (DCAT)	Evaluating decision-making capacity for medical decisions in context of psychiatric symptoms
Palliative Care Outcome Measures	POS-S; IPOS; QUAL-E; Integrated Palliative care Outcome Scale for people with dementia (IPOS-Dem) [98]	Assessing physical, psychological, and spiritual domains of palliative care needs
Suffering Assessment Instruments	SAVE protocol; Suffering Alleviation and Value of Experiential knowledge tools [98]	Systematically capturing lived experience of serious health-related suffering
Ethical Analysis Frameworks	Beauchamp and Childress four principles; Jonsen's four-box method	Structuring analysis of ethical dilemmas in clinical cases and research scenarios

Visualizing Research Prioritization: An Ethical Framework

The following diagram illustrates the logical relationships and prioritization framework for addressing ethical dilemmas in SPMI end-of-life research:

The evidence base for end-of-life care in severe and persistent mental illness remains critically underdeveloped, with significant gaps spanning clinical, ethical, and methodological domains. Future research must prioritize the development and evaluation of palliative psychiatry models, advance our understanding of decision-making capacity in SPMI, address disparities in care access, and establish ethical frameworks for complex issues such as medical assistance in dying.

This research agenda requires an integrated, interdisciplinary approach that centrally includes the perspectives of persons with lived experience of SPMI. By addressing these prioritised gaps through rigorous and ethically informed research, we can work toward ensuring that persons with SPMI receive end-of-life care that respects their dignity, autonomy, and unique needs.

Conclusion

The ethical provision of end-of-life care for individuals with SPMI demands a nuanced, multi-faceted approach that rigorously applies ethical principles while adapting to the unique vulnerabilities of this population. Key takeaways include the critical need to reconcile patient autonomy with impaired decision-making capacity, the potential of structured models like palliative psychiatry to improve quality of life, and the necessity of fair resource allocation and systemic support. For biomedical and clinical research, future directions must prioritize the development of validated criteria for determining psychiatric futility, robust outcome measures for palliative psychiatric interventions, and inclusive methodologies that integrate the first-hand accounts of persons with SPMI. Furthermore, drug development must address the complex pharmacokinetics and side-effect profiles in this comorbid and often treatment-resistant population. Ultimately, advancing this field requires a concerted effort to bridge the current gaps between somatic palliative care, psychiatry, and biomedical science to ensure dignified and ethical care throughout the life course.

References

• 1. Mortality gap and physical comorbidity of people with severe ... [https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-021-00374-y]
• 2. Mortality gap and physical comorbidity of people with ... [https://pubmed.ncbi.nlm.nih.gov/34903254/]
• 3. Dying Too Soon: Excess Mortality in Severe Mental Illness [https://pmc.ncbi.nlm.nih.gov/articles/PMC6918821/]
• 4. What is behind the 17-year life expectancy gap between ... [https://www.nature.com/articles/s41537-025-00667-1]
• 5. Mortality gap for people with severe mental illness is ... [https://slam.nhs.uk/pressreleases/mortality-gap-for-people-with-severe-mental-illness-is-hidden-health-crisis-study-finds-4890]
• 6. Cause-specific mortality in individuals with and without ... [https://www.sciencedirect.com/science/article/pii/S2666776225001899]
• 7. The association between area-level factors and mortality in ... [https://www.sciencedirect.com/science/article/pii/S0920996423004504]
• 8. Risk and Protective Factors in Relation to Early Mortality ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9822841/]
• 9. Mapping the ethical aspects in end-of-life care for persons ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10062453/]
• 10. End-of-Life Decision-Making Capacity in Older People With ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8492912/]
• 11. Evaluating Medical Decision-Making Capacity in Practice [https://www.aafp.org/pubs/afp/issues/2018/0701/p40.html]
• 12. Considerations for legal, ethical, and effective practice in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11231934/]
• 13. Informed Consent With People Who Have Dementia [https://www.physio-pedia.com/Informed_Consent_With_People_Who_Have_Dementia]
• 14. Mapping the ethical aspects in end-of-life care for persons ... [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1094038/full]
• 15. Palliative Psychiatry for Severe, Persistent Mental Illness [https://aapp.org/perspective/2025/08/202]
• 16. A Novel Tool to Assess the Capacity of People with ... [https://pubmed.ncbi.nlm.nih.gov/41269105/]
• 17. End-of-life care for people with severe and persistent ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12041735/]
• 18. Principles of Clinical Ethics and Their Application to Practice [https://pmc.ncbi.nlm.nih.gov/articles/PMC7923912/]
• 19. Mapping ethical issues encompassing end-of-life care for ... [https://pubmed.ncbi.nlm.nih.gov/40457393/]
• 20. Discussing end-of-life care for persons experiencing severe ... [https://apm.amegroups.org/article/view/136409/html]
• 21. Empirical research in bioethical journals. A quantitative ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2565792/]
• 22. StatiCAL: an interactive tool for statistical analysis of ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-024-05829-z]
• 23. Palliative psychiatry in a narrow and in a broad sense [https://pmc.ncbi.nlm.nih.gov/articles/PMC9679794/]
• 24. Acceptability of palliative care approaches for patients with ... [https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2091-x]
• 25. Ethical considerations at the end-of-life care - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7958189/]
• 26. Mapping ethical issues encompassing end-of-life care for ... [https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-025-01234-0]
• 27. Palliative psychiatry [https://tidsskriftet.no/en/2025/10/perspectives/palliative-psychiatry]
• 28. Goal-Concordant Palliative Psychiatry Needs Quality ... [https://hospicenews.com/2025/04/30/goal-concordant-palliative-psychiatry-needs-quality-framework/]
• 29. Integration of psychiatry into palliative care units [https://pmc.ncbi.nlm.nih.gov/articles/PMC12459452/]
• 30. Palliative Care Psychiatry: Update on an Emerging Dimension ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3762470/]
• 31. Equity of access to palliative care: a scoping review - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC11587758/]
• 32. Ten priorities that are shaping the future of mental health ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12484498/]
• 33. Equity of access to palliative care: a scoping review [https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-024-02321-1/tables/2]
• 34. Ethical issues in pain and palliation - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10911254/]
• 35. Standards for Palliative and End of Life Care [https://www.socialworkers.org/Practice/NASW-Practice-Standards-Guidelines/Standards-for-Palliative-and-End-of-Life-Care]
• 36. New Study Reveals Mixed Results in Advance Care Planning ... [https://publichealth.jhu.edu/2024/new-study-reveals-mixed-results-in-advance-care-planning-for-older-adults]
• 37. Advance care planning - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12273195/]
• 38. Evaluating outcomes of advance care planning interventions ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12405694/]
• 39. longitudinal analysis of data from health records linked with ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12496107/]
• 40. Supported Decision-Making in Health Care and Life Planning [https://nhfv.org/resources/supported-decision-making-in-health-care-and-life-planning/]
• 41. Your Right to Plan for the Future [https://acany.org/your-right-to-plan-for-the-future/]
• 42. 2025 MIPS Measure #047: Advance Care Plan [https://mdinteractive.com/mips_quality_measure/2025-mips-quality-measure-047]
• 43. Palliative psychiatry: research, clinical, and educational priorities [https://apm.amegroups.org/article/view/124435/html]
• 44. A palliative care approach in psychiatry: clinical implications [https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-020-00472-8]
• 45. Oyster Care: An Innovative Palliative Approach towards SPMI ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7294963/]
• 46. Editorial: Approaches for Severe and Persistent Mental ... [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.722496/full]
• 47. Ensuring high quality Oyster Care for people experiencing ... [https://www.researchsquare.com/article/rs-7545849/latest]
• 48. An Innovative Palliative Approach towards SPMI Patients [https://pubmed.ncbi.nlm.nih.gov/32581883/]
• 49. Psychiatric Futility and Palliative Care for a Patient With ... [https://pubmed.ncbi.nlm.nih.gov/35797693/]
• 50. Treatment-Resistant Schizophrenia - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7725152/]
• 51. Resistance is not futile: treatment-refractory schizophrenia [https://pubmed.ncbi.nlm.nih.gov/30407873/]
• 52. Association of End Point Definition and Randomized ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7330825/]
• 53. Schizophrenia: Four major clinical trials to watch in 2023 [https://www.clinicaltrialsarena.com/features/features-schizophrenia-trials-to-watch/]
• 54. Editorial: Methods of engagement of dementia care users ... [https://www.frontiersin.org/journals/dementia/articles/10.3389/frdem.2025.1692225/full]
• 55. Stakeholders' engagement for improved health outcomes [https://pmc.ncbi.nlm.nih.gov/articles/PMC11979262/]
• 56. Systematic Review of Quantitative Measures of Stakeholder ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5593160/]
• 57. Outcomes of Moral Case Deliberation - the development of an ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4234013/]
• 58. Impact of moral case deliberation in healthcare settings [https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-018-0325-y]
• 59. What is a High-Quality Moral Case Deliberation? [https://link.springer.com/article/10.1007/s10730-023-09519-w]
• 60. Implementing moral case deliberation in a psychiatric ... [https://pubmed.ncbi.nlm.nih.gov/18165908/]
• 61. Respecting Autonomy Promoting the Patient’s Good in the... and [https://pmc.ncbi.nlm.nih.gov/articles/PMC6913820/]
• 62. The ethics of forgoing life-sustaining treatment [https://mrmjournal.biomedcentral.com/articles/10.1186/2049-6958-9-14]
• 63. Refusal of Care - StatPearls - NCBI Bookshelf - NIH [https://www.ncbi.nlm.nih.gov/books/NBK560886/]
• 64. Protecting the Autonomy of Patients with Severe Mental ... Illness [https://journals.library.columbia.edu/index.php/bioethics/article/view/11800]
• 65. Allowing natural death in end-of-life decision-making [https://www.sciencedirect.com/science/article/abs/pii/S0197457225004689]
• 66. Choices and challenges in end-of-life care and decision-making [https://bmcpalliatcare.biomedcentral.com/articles/10.1186/s12904-025-01926-9]
• 67. Medical assistance in dying for people living with mental ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10594804/]
• 68. High rates of psychiatric comorbidity among requesters ... [https://www.sciencedirect.com/science/article/abs/pii/S0163834320301857]
• 69. Exploring the interplay of clinical, ethical and societal ... [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1463813/full]
• 70. Suicidality and needs among people seeking medical ... [https://www.medrxiv.org/content/10.1101/2025.05.08.25327143v1.full-text]
• 71. Organ donation after medically assisted death on ... [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1574900/full]
• 72. Barriers to Effective Communication about Advance Care ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10519725/]
• 73. Qualitative Research on the Topic of End-of-Life Care and a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11562099/]
• 74. Ethical issues in palliative care: nursing and quality of life [https://bmcnurs.biomedcentral.com/articles/10.1186/s12912-024-02530-7]
• 75. How to talk about dying? The development of an evidence ... [https://www.sciencedirect.com/science/article/pii/S2772628224000578]
• 76. End-of-Life Care for Patients With Psychiatric Disorders [https://www.psychiatrictimes.com/view/end-of-life-care-for-patients-with-psychiatric-disorders]
• 77. Ethical aspects of limiting end-of-Life treatment of adult ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12210583/]
• 78. Countertransference in Palliative Care Practice [https://www.capc.org/blog/countertransference-in-palliative-care-practice-whats-a-clinician-to-do/]
• 79. Transference and Countertransference in Palliative Care [https://www.mypcnow.org/fast-fact/transference-and-countertransference-in-palliative-care/]
• 80. Countertransference in Palliative Care [https://aahpm.org/publications/aahpm-quarterly/issue-archive/winter-2024/countertransference-in-palliative-care/]
• 81. Psychiatric Goals of Care at the End of Life: A Qualitative ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11623991/]
• 82. Palliative care: principles and pharmacy roles [https://pharmaceutical-journal.com/article/ld/palliative-care-principles-and-pharmacy-roles]
• 83. Effects of End-of-Life Discussions on the Mental Health ... [https://www.sciencedirect.com/science/article/pii/S0885392417301628]
• 84. Euthanasia in Mental Disorders: Clinical and Ethical Issues in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12385801/]
• 85. Differential treatment of individuals with mental health ... [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1616011/full]
• 86. Trends in assisted dying among patients with psychiatric ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12646481/]
• 87. Dying Gracefully – Legal, Ethical, and Insurance ... [https://www.genre.com/us/knowledge/publications/2025/september/uwfocus25-1-luckmann-ball-obrien-en]
• 88. Medical aid in dying brings a compassionate close to life [https://www.apa.org/monitor/2025/07-08/compassion-medical-aid-dying]
• 89. Exploring multiple levels of suffering and suicide ... [https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1589426/full]
• 90. Legislation on Medical Assistance in Dying (MAID) [https://pmc.ncbi.nlm.nih.gov/articles/PMC12071898/]
• 91. Palliative Psychiatry for Severe, Persistent Mental Illness [https://www.aapp.org/perspective/2025/08/202]
• 92. Quality indicators and patient outcome measures for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12221262/]
• 93. Mental health trajectories, resilience and psychosocial ... [https://www.nature.com/articles/s41598-025-00776-y]
• 94. 2025 MIPS Measure #495: Ambulatory Palliative Care ... [https://mdinteractive.com/mips_quality_measure/2025-mips-quality-measure-495]
• 95. Acceptability of palliative care approaches for patients with ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6458682/]
• 96. Ethical perspectives regarding Euthanasia, including in the ... [https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-024-01063-7]
• 97. Understanding the Experiences and Support Needs of ... [https://pubmed.ncbi.nlm.nih.gov/39092519/]
• 98. Development of the SAVE study protocol to use lived ... [https://www.nature.com/articles/s43856-025-01154-5]